Role of apoptosis factors during mouse neural stem cell differentiation by Aranha, Márcia Maria de Almeida, 1980-
 UNIVERSIDADE DE LISBOA 
FACULDADE DE FARMÁCIA 
 
 
 
 
 
 
 
 
 
 
 
ROLE OF APOPTOSIS FACTORS 
DURING MOUSE NEURAL STEM CELL 
DIFFERENTIATION 
 
 
 
Márcia Maria de Almeida Aranha 
 
 
 
DOUTORAMENTO EM FARMÁCIA 
BIOQUÍMICA 
 
 
2010 
  
 
 UNIVERSIDADE DE LISBOA 
FACULDADE DE FARMÁCIA 
 
 
 
 
 
 
 
 
 
 
 
ROLE OF APOPTOSIS FACTORS 
DURING MOUSE NEURAL STEM CELL 
DIFFERENTIATION 
 
 
Márcia Maria de Almeida Aranha 
 
Tese de Doutoramento em Farmácia (Bioquímica), apresentada à 
Universidade de Lisboa através da Faculdade de Farmácia 
 
Research advisor: 
Prof. Doutora Cecília M. P. Rodrigues 
 
Lisboa 
2010 
  
 
 
 
 
 
 
The studies presented in this thesis were performed at the Research Institute for 
Medicines and Phamaceutical Sciences (iMed.UL), Faculty of Phamacy, University of 
Lisbon under the supervision of Professor Cecília M. P. Rodrigues, and at the 
Departments of Medicine, Genetics, Cell Biology, and Development, and the Department 
of Neurosurgery, Stem Cell Institute, University of Minnesota Medical School, 
Minneapolis, Minnesota, USA, in collaboration with Professor Clifford Steer and 
Professor Walter C. Low. 
 
Márcia Maria de Almeida Aranha was the recipient of a Ph.D. fellowship 
(SFRH/BD/28429/2006) from Fundação para a Ciência e Tecnologia (FCT), Lisbon, 
Portugal.  This work was supported by grants PTDC/BIA-BCM/67922/2006 and 
PTDC/SAU-FCF/67912/2006 from FCT and FEDER. 
 
De acordo com o disposto no ponto 1 do artigo nº41 do Regulamento de Estudos         
Pós-Graduados da Universidade de Lisboa, deliberação nº 93/2006, publicada em Diário 
da República – II Série nº 153 – 5 de Julho de 2003, o Autor desta dissertação declara que 
participou na concepção e execução do trabalho experimental, interpretação dos 
resultados obtidos e redacção dos manuscritos. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aos meus queridos pais 
 
 
  
 
 
 
Resumo 
 
 
 
Resumo 
ix 
A utilização de células estaminais para tratamento de doenças neurológicas é, 
actualmente, objecto de intensa investigação.  Para que seja possível desenvolver terapias 
regenerativas, a partir destas células, é fundamental compreender os seus processos 
biológicos básicos, nomeadamente o seu mecanismo de diferenciação. 
Estudos recentes sugerem que alguns factores específicos do processo apoptótico, 
como as caspases, a proteína p53, a família Bcl-2 e, mais recentemente, os microRNAs 
(miRNAs ou miRs), possam estar envolvidos na diferenciação celular.  Assim, 
formulámos a hipótese de que algumas moléculas associadas à apoptose desempenhem 
um papel importante na diferenciação de células estaminais neurais. 
Avaliou-se, inicialmente, o envolvimento da p53 e caspase-3 na diferenciação de 
células estaminais neurais.  Observámos que, tanto a clivagem da caspase-3, como a 
fosforilação da proteína p53 e a sua capacidade de ligação ao DNA aumentaram 
significativamente ao longo da diferenciação.  A inibição das caspases e o silenciamento 
de p53 retardaram, de forma diferencial, a neurogénese e a gliogénese.  Os nossos 
resultados sugerem que a p53 e a caspase-3 desempenham um importante papel na 
diferenciação neural, que parece envolver a modulação da via do FOXO3A/Id1. 
Seguidamente quisemos determinar se os miRNAs associados à apoptose estariam, 
igualmente, envolvidos no processo de diferenciação de células estaminais neurais.  A 
determinação dos perfis de expressão dos miRNAs, juntamente com a validação dos 
níveis de expressão por PCR em tempo real, mostraram que miRNAs pró-apoptóticos, 
tais como o miR-16, o let-7a e o miR-34a, são modulados durante a diferenciação de 
células estaminais neurais.  Resultados similares foram observados na diferenciação de 
células estaminais embrionárias e de células PC12 e NT2N, o que sugere o envolvimento 
destes miRNAs no desenvolvimento neural dos mamíferos. 
Por fim, modularam-se os níveis de expressão do miR-34a em células estaminais 
neurais e concluiu-se que este miRNA regula, de forma positiva, o aparecimento de 
neurónios pós-mitóticos.  Experiências adicionais sugeriram que o miR-34a regula, 
também, a diminuição da SIRT1 e o aumento da capacidade de ligação da p53 ao DNA. 
Este trabalho clarifica o papel que algumas moléculas do processo apoptótico têm 
na diferenciação de células estaminais neurais e confirma a sua importância na definição 
do destino celular, proporcionando indicações úteis ao desenvolvimento de novas 
estratégias terapêuticas. 
Palavras chave: Apoptose – Caspase-3 - Células estaminais neurais – Diferenciação – 
miRNAs – miR-34a – p53 
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Abstract 
xiii 
Neural stem (NS) cells are under active consideration as a source of donor tissue for 
neuronal cell therapy.  Therefore, understanding basic processes of NS cell biology, 
including cell differentiation, is essential to develop regenerative therapies from the 
promise of stem cells.   
Several studies have recently provided a persuasive argument that specific factors of 
apoptosis pathways, such as caspases, p53, Bcl-2 family members, and microRNAs 
(miRNAs or miRs) are involved in the differentiation process.  Therefore, we 
hypothesized that specific apoptosis-associated molecules play a critical role in NS 
differentiation. 
In initial studies we evaluated the involvement of p53 and caspase-3 during the 
differentiation process of NS cells.  Our results revealed a significant increase in caspase-
3 activation, p53 phosphorylation, and p53 DNA-binding activity during differentiation.  
Pharmacologic inhibition of caspases delayed neuronal and glial differentiation, while 
down-regulation of p53 affected only the neuronal lineage.  Therefore, our results suggest 
that p53 and caspases play a role in the differentiation of NS cells and advance the 
potential modulation of FOXO3A/Id1 signaling in this cellular context. 
Next, we were interested in determining whether miRNAs linked to apoptosis might 
be involved in the differentiation of NS cells.  miRNA expression profiles and 
quantitative real time-PCR revealed that pro-apoptotic miRNAs, such as miR-16, let-7a 
and miR-34a, were modulated during NS cell differentiation.  Similarly, upregulation of 
pro-apoptotic miRNAs in the differentiation of embryonic stem cells, PC12 and NT2N 
cells implicates these specific miRNAs in mammalian neuronal development.   
Finally, we further investigated the effect of miR-34a modulation in NS cells 
differentiation.  We reported that miR-34a positively regulated the appearance of post-
mitotic neurons of mouse NS cells.  Additional experiments indicated that miR-34a-
mediated differentiation involved SIRT1 down-regulation and was associated with 
increased p53-DNA binding activity.  These results suggested that miR-34a was required 
for proper neuronal differentiation. 
In conclusion, these studies further clarify the role of apoptosis-associated 
molecules in the differentiation process of NS cells.  Our findings may prove useful in the 
development of novel therapeutic strategies to improve long term-survival and 
differentiation of transplanted stem cells. 
Keywords: Apoptosis – Caspase-3 – Differentiation – miRNAs – miR-34a – Neural stem 
cells – p53  
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1.1 Neural stem cells 
Neural stem (NS) cells are self-renewing multipotent cell populations present in the 
developing and adult mammalian central nervous system (CNS) (Temple, 2001a).  NS 
cells generate neurons and glia of the developing brain, and account for neuronal 
plasticity in the adult brain.   
The process of generating functionally integrated neurons from progenitor cells, 
termed neurogenesis, was traditionally believed to occur only during embryonic stages in 
the mammalian CNS (Ramon y Cajal, 1913).  However, almost forty years ago, 
pioneering work by Altman and Das suggested the existence of continuing neurogenesis 
throughout adulthood (Altman and Das, 1965).  Significant progress has been made over 
the past few years and investigators have now firmly established that new neurons are 
indeed born in restricted regions of the adult mammalian CNS (Alvarez-Buylla and 
Garcia-Verdugo, 2002; Gage, 2000; Kempermann and Gage, 2000).  Since then, stem 
cells have been isolated from many regions of embryonic and adult nervous systems (Fig. 
1.1).  The discovery of adult neurogenesis not only provides a unique model system to 
understand basic mechanisms of neural development in the mature CNS, but also may 
lead to strategies for neural tissue repair and cell-based replacement therapies of the 
nervous system. 
 
 
Figure 1.1. Location of NS cells niches.  Principal regions of embryonic and adult nervous 
systems, from which neural stem cells have been isolated.  SVZ, subventricular zone; PNS, 
peripheral nervous system.  Adapted from Temple et al. 2001. 
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1.1.1 Neural stem cells during developing CNS 
During brain development, predetermined programs give rise to different NS cell 
populations, specified in space and time (Alvarez-Buylla et al., 2001).  Neurogenesis in 
mammals begins with the induction of neuroectoderm, which forms the neural plate, at 
embryonic day 7.5 (E7.5) in mice, and then folds to give rise to the neural tube.  These 
structures are made up by a layer of neuroepithelial cells (Gotz and Huttner, 2005), which 
contact both apical (ventricular) and basal (pial) surfaces (Fig. 1.2).  Initially, 
neuroepithelial cells divide symmetrically at the ventricular surface to increase the pool of 
stem cells.  However, at a certain point, they start dividing asymmetrically, generating a 
stem cell that remains in the ventricular zone, and another cell that migrates radially 
outward (Haubensak et al., 2004).  These cells are responsible for the first wave of 
neurogenesis in the neural tube, after which they give rise to radial glia (Conti and 
Cattaneo, 2010). 
 
 
Figure 1.2. NS cells in the developing brain.  NS cell (shown in blue) transformation from 
neuroepithelial cells to radial glia, to astocyte-like cells of the lateral ventricular wall.  Neural 
stem cells can produce progeny, either directly or via an intermediate progenitor (shown in green), 
which has been either included or omitted for clarity.  (a) At early developmental stages, the CNS 
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is constituted by the neural tube, which is composed by neuroepithelial cells.  These cells can 
divide either symmetrically, at the ventricular surface, to expand the stem cell pool, or 
asymmetrically, to generate neurons.  (b) Radial glial cells arise from neuroepithelial cells, and 
divide to generate neurons or glia, either directly or via an intermediate progenitor in the SVZ.  
The radial processes of radial glial cells support the migration of neuroblasts (shown in red).  (c) 
In the adult brain, radial glia have transformed into astrocyte-like cells that have the capacity to 
generate olfactory bulb interneurons.  The ventricular zone (VZ) also disappears, but SVZ 
remains into adulthood in some areas.  Stri, striatum.  Adapted from Merkle et al. 2006. 
 
Radial glia arise in the neural tube at about E9.5 in mice.  These cells originate from 
neuroepithelial cells at the beginning of neurogenesis, and represent the main cell type in 
the developing brain, where they act both as neural progenitors and as scaffolding for 
migrating newborn neurons (Conti and Cattaneo, 2010).  Like neuroepithelial progenitors, 
radial glia are a transient population in the developing brain that exhibits definite 
morphological hallmarks.  Their soma are located in the ventricular zone, and they extend 
a long process to the pial surface.  In addition, radial glia exhibit several glial 
characteristics, such as glycogen granules (Choi and Lapham, 1978), and the expression 
of numerous glial antigens, including brain lipid binding protein (Feng et al., 1994), the 
glutamate transporter GLAST (Shibata et al., 1997), tenascin (Yuasa, 2001), and glial 
fibrillary acidic protein (GFAP) in some species (Choi and Lapham, 1978; Levitt and 
Rakic, 1980).  In vivo, radial glia have the ability to generate different neural lineages, in 
a time-controlled fashion (Anthony and Heintz, 2008; Ogawa et al., 2005).  A similar 
heterogeneity has also been observed in vitro.  In mammals, radial glial cells disappear 
from the brain soon after birth, but in many species they persist into the adulthood 
(Merkle and Alvarez-Buylla, 2006).  In mammals, the role of NS cells is filled by a 
closely related astrocyte-like cell. 
Similarly to radial glia, adult mammalian NS cells have many astrocytic 
characteristics, such as the expression of GFAP (Doetsch et al., 1999; Garcia et al., 2004; 
Imura et al., 2003).  In the adult brain, these astrocyte-like cells are mainly found in two 
regions: the subventricular zone (SVZ) of the lateral wall of the lateral ventricle, and the 
subgranular zone (SGZ) of the dentate gyrus of the hippocampus.  The astrocytic nature 
of NS cells has been confirmed when GFAP+ cells were conditionally ablated in the adult 
mouse brain, resulting in an almost complete loss of neurogenesis (Garcia et al., 2004; 
Imura et al., 2003). 
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Since radial glial cells and SVZ astrocytes share many properties, it has been 
hypothesized that they belong to the same lineage (Tramontin et al., 2003).  In particular, 
radial glial cells of the neonatal lateral ventricular wall occupy the same region as 
astrocytic stem cells of the adult SVZ.  In summary, current evidence suggests that NS 
cells gradually transform from neuroepithelial cells to radial glial cells, to astrocyte-like 
cells (Merkle and Alvarez-Buylla, 2006).   
 
1.1.2 Adult neurogenesis 
New neurons are continuously added to neural circuits in the adult vertebrate brain 
(Doetsch, 2003).  In mammals, including humans, neurons are added to restricted brain 
regions, the olfactory bulb and the hippocampus (for a review, see (Zhao et al., 2008a).  
The addition of new neurons to these regions represents a process by which the brain can 
make changes to its own functional circuitry, in addition to molecular, synaptic or 
morphological alterations in individual cells.  Indeed, this cell-level renovation is not 
static or merely restorative, rather constitutes an adaptive response to challenges imposed 
by the environment and/or internal state of the animal (Lledo et al., 2006). 
The identity of NS cells and adult neurogenesis have been most clearly defined in 
the SVZ of adult mice.  The SVZ is a layer of dividing cells that extends along the lateral 
walls of the lateral ventricle.  Neurons are born throughout the SVZ, and feed into a 
network of chains of tangentially migrating neuroblasts (Doetsch and Alvarez-Buylla, 
1996) that coalesce to form the rostral migratory stream (RMS), leading to the olfactory 
bulb (Fig. 1.3).  Here, neuroblasts, differentiate into two kinds of olfactory interneurons, 
granule and periglomerular cells (Doetsch and Scharff, 2001).  The SVZ is separated 
from the lateral ventricle by a single layer of multiciliated ependymal cells.  
Chemorepulsive factor gradients produced by these cells guide neuroblast migration in 
the adult brain (Sawamoto et al., 2006).  More than 30,000 neuroblasts exit the rodent 
SVZ for the RMS, each day (Alvarez-Buylla et al., 2001). 
Three types of precursor cells exist in the SVZ: type B GFAP+ progenitors, type C 
transit amplifying cells, and type A migrating neuroblasts (Fig. 1.3).  Type B cells are 
slowly dividing radial-glia like progenitors, which have been hypothesized to represent 
the primary NS cells in vivo (Mu et al., 2010).  They are thought to generate rapidly 
dividing progenitors, type C cells, which typically have either no or very short processes, 
and are characterized by the expression of Dlx2, Mash1, and epidermal growth factor 
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receptor (EGFR).  The majority of these intermediate progenitors subsequently give rise 
to type A cells that express both doublecortin (DCX) and poly-sialated neural cell 
adhesion molecule (PSA-NCAM).  These cells migrate into the olfactory bulb, through 
the RMS, and differentiate into GABA-producing and dopamine-producing interneurons.  
Interestingly, the differentiation potential of SVZ progenitor cells appears to be limited, 
as the fate of the progeny is determined by the positional information established during 
early development of the CNS (Merkle et al., 2007). 
 
 
Figure 1.3. Neurogenesis in the SVZ.  Progenitor cells (A–C) in the SVZ are located next to the 
ependymal cell (E) layer lining the lateral ventricles.  A subset of slowly dividing GFAP+ radial 
cells (type B cells) has the potential to serve as adult NS cells and generate rapidly dividing, 
transit-amplifying nonradial NS cells (type C cells), which in turn give rise to neuroblasts (type A 
cells) that migrate through the rostral migratory stream (RMS) toward the olfactory bulb (OB).  
Newborn neurons are integrated as granule neurons, in the granule cell layer (GCL), and as 
periglomerular neurons (not shown), in the glomerular layer (GL).  Mi, mitral cell layer; EPL, 
external plexiform layer.  Adapted from Zhao et al. 2008. 
 
The hippocampus is other major site of neurogenesis in adult mammals.  Granule 
neurons in the dentate gyrus are born locally in the SGZ, which lies between the granule 
cell layer and the hilus.  In contrast to the extensive tangential migration undertaken by 
olfactory bulb neurons, hippocampal granule neurons move only a short distance into the 
granule cell layer (Fig. 1.4).  On a superficial level, describing adult hippocampal 
neurogenesis is very straightforward.  A dividing precursor cell gives rise to daughter 
cells, which migrate away from the site of division (Kuhn et al., 1996), and start to 
differentiate into neurons (Kempermann et al., 2003).  They first extend dendrites toward 
the molecular layer, and later an axon that projects to area CA3 (Stanfield and Trice, 
Chapter 1 
8 
1988).  Over four to seven weeks, these neurons become integrated into the local neuronal 
circuits (Jessberger and Kempermann, 2003).   
 
 
Figure 1.4. Neurogenesis in the dentate gyrus.  In the adult SGZ, a population of GFAP+ Sox2+ 
radial cells corresponds to quiescent NS cells (type 1 cells).  They coexist with actively 
proliferating, GFAP- Sox2+ nonradial NS cells (type 2 cells) that generate both astrocytes and 
neuroblasts.  Neuroblasts then migrate into the granule cell layer, and predominantly differentiate 
into local glutamatergic dentate granule cells.  Progenitor cells in the dentate gyrus are influenced 
by local astrocytes (not shown) and by the vasculature (red).  GCL, granule cell layer; Mol, 
molecular layer.  Adapted from Zhao et al. 2010. 
 
Two types of neural progenitors can be identified in the SGZ, according to their 
specific morphologies and expression of unique molecular markers (Fig. 1.4).  Type 1 
hippocampal progenitors act as quiescent NS cells.  They have a radial process, spanning 
the entire granule cell layer, and ramify in the inner molecular layer.  These cells express 
nestin, GFAP, and the transcription factor sex-determining region Y-box 2, Sox2 (Fukuda 
et al., 2003; Garcia et al., 2004; Suh et al., 2007).  Although expressing the astrocyte 
marker GFAP, these cells are morphologically and functionally different from mature 
astrocytes.  They may generate actively self-renewing nonradial progenitors (type 2 
cells), expressing Sox2 and nestin, but not GFAP.  Type 2 cells, in turn, give rise to 
DCX+ neuroblasts that predominantly differentiate into local glutamatergic dentate 
granule cells (Mu et al., 2010).  A recent study showed that type 2 Sox2+ cells can self-
renew, and that a single Sox2+ cell can give rise to neurons and astrocytes, providing the 
General Introduction 
9 
first in vivo evidence of stem cell properties of hippocampal neural progenitors (Suh et 
al., 2007).  
 
1.1.3 In vitro culturing of NS cells 
For nearly 20 years, growth factor-based protocols have been developed, leading to 
NS cell expansion in both floating and adherent conditions (Kokovay et al., 2008).  In 
addition, progress in cell culture technologies has enabled researchers to induce the 
neuralization of mouse and human embryonic stem (ES) cells, derived from the inner cell 
mass of the blastocyst, in vitro (Conti and Cattaneo, 2010).  During neural differentiation, 
ES cells undergo progressive lineage restrictions, similar to those observed in normal 
fetal development (Pankratz et al., 2007), leading to the generation of a range of distinct 
neural precursor populations.  These can be used to study the molecular and cellular 
events that occur during stage-specific transitions between different populations 
(Nishikawa et al., 2007).   
Neurospheres are free-floating aggregates of neural progenitors, each potentially 
derived from a single NS cell (Reynolds et al., 1992).  Their generation relies on tissue 
microdissection, followed by exposure to growth factors (Chojnacki and Weiss, 2008).  
Neurospheres and monolayer culturing systems of NS cells can be generated from ES 
cells, induced pluripotent stem (iPS) cells  (derived from reprogrammed somatic cells) 
and from stem cell niches of the fetal and adult brain (Conti and Cattaneo, 2010).  Both 
systems have the potential to give rise to neurons, astrocytes and oligodendrocytes.  The 
different cellular compositions of the neurospheres (a mixed population, with only a 
fraction of the cells exhibiting NS cell properties) and monolayer cultures (with 
homogeneous composition) results in low and high neurogenic potential, respectively. 
Although many efforts are being made to better understand cellular and molecular 
events associated with differentiation (Abranches et al., 2009), determining the best 
sources for the in vitro derivation of NS cells and optimizing protocols for stable, clonal 
proliferation are still central goals of stem cell research. 
 
1.1.4 Potential therapeutic uses of NS cells 
Despite the presence of NS cells in the adult mammalian brain, neurons are not 
replaced in most regions after injury or pathological conditions.  However, evidence of 
neurogenic upregulation in the damaged brain has led to interest in therapeutic strategies 
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that exploit naturally existing responses.  Such approaches could prove fruitful, not only 
for stroke and trauma patients, but also in patients with degenerative brain diseases, such 
as Parkinson’s disease, Huntington’s disease and multiple sclerosis (Curtis et al., 2003; 
Jin et al., 2004).  Nevertheless, several problems must be solved before the potential 
attributed to stem cells becomes a realistic clinical strategy for cellular repair.  The 
biggest single problem still to be solved is how to direct and control the differentiation of 
specific target phenotypes required for replacement and repair in each disease.  Selection 
of appropriate starting cells and adequate parameters of in vitro manipulation are likely to 
be crucial factors in directing appropriate phenotypic differentiation.  Further, a more 
comprehensive understanding of the molecular pathways controlling stem cell self-
renewal and differentiation, in particular the apparent molecular link between 
programmed cell death and cell differentiation, would accelerate efforts to generate 
clinically relevant cell types from stem cells. 
 
1.2 Apoptosis-associated proteins in cell differentiation 
Apoptosis is a highly regulated form of cell death known to sculpt tissues during 
development, and maintain tissue homeostasis by eliminating unnecessary or harmful 
cells (Ellis et al., 1991).  Apoptosis is a genetically predetermined mechanism.  Genetic 
analysis of the nematode Caenorhabditis elegans provided the first insights into the 
molecular mechanism of apoptosis (Yuan et al., 1993).  The canonical apoptotic pathways 
are well conserved in all metazoans from invertebrates to vertebrates.  The best 
characterized and the most prominent are designated by extrinsic and intrinsic pathways 
(Kroemer et al., 2007).  In the extrinsic pathway, also known as “death receptor 
pathway”, apoptosis is triggered by ligand-induced activation of death receptors at the 
cell surface.  In the intrinsic pathway, also called “mitochondrial pathway”, apoptosis 
results from an intracellular cascade of events, mainly characterized by the mitochondrial 
membrane permeabilization (MMP). 
In the extrinsic pathway of apoptosis, ligation of death receptors causes the 
recruitment and oligomerization of the adapter molecule Fas-associating death domain-
containing protein (FADD) within the death-inducing signaling complex (DISC).  
Oligomerized FADD binds the initiator caspase-8 and -10, causing their dimerization and 
activation (Fig. 1.5) (Debatin and Krammer, 2004).  As an alternative, the extrinsic 
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pathway can be activated by the so-called dependency receptors, which are believed to be 
connected to rapid caspase activation as well.   
Fas-induced apoptosis has been shown to follow almost exclusively one of two 
different Fas signaling pathway (Scaffidi et al., 1998), mainly depending on the amount 
of active caspase-8 available in the cytosol.  In type I cells, Fas-induced apoptosis ensures 
enough activation of caspase-8, so that it can go on to activate caspase-3 and -7.  In 
contrast, in type II cells, apoptosis proceeds by an amplification loop through 
mitochondria.  In this case, caspase-8 cleaves the inactive cytoplasmic protein Bid, a pro-
apoptotic Bcl-2-family member, thus producing active truncated Bid (tBid) (Li et al., 
1998).  The carboxy-terminal fragment of Bid then translocates to the mitochondria 
leading to oligomerization of Bax or Bak and the consequent MMP, which in turn results 
in caspase-3 activation (Korsmeyer et al., 2000). 
Most cell death in vertebrates proceeds via the intrinsic or mitochondrial pathway 
of apoptosis (Green and Kroemer, 2004).  Here, the executioner caspases are cleaved and 
activated by initiator caspase-9, which is activated by multimerization on the adapter 
molecule apoptosis protease activating factor-1 (Apaf-1), within a multiprotein complex 
called “apoptosome”.  Apaf-1 preexists in the cytosol as a monomer, and its activation 
depends on the presence of cytochrome c (Cyt c) and ATP/dATP (Cain et al., 2002).  The 
release of Cyt c, which normally resides only in the inner mitochondrial space where it 
functions as an electron shuttle in the respiratory chain (Bernardi and Azzone, 1981), is 
rate-limiting for the generation of the apoptosome.  Hence MMP is the critical event 
responsible for caspase activation in the intrinsic pathway.  MMP can also commit a cell 
to die when caspases are not activated.  This “caspase-independent death” (Chipuk and 
Green, 2005; Kroemer and Martin, 2005) can occur by either an irreversible loss of 
mitochondrial function or by the mitochondrial release of caspase-independent death 
effectors, including apoptosis-inducing factor (AIF) (Susin et al., 1999), endonuclease G 
(EndoG) (Li et al., 2001), and others (Chipuk and Green, 2005; Kroemer and Martin, 
2005). 
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Figure 1.5. Intrinsic and extrinsic pathways of apoptosis in mammals.  The intrinsic pathway 
involves the mitochondria, which acts as an “intracellular death receptor”, receiving a variety of 
pro-apoptotic signals that trigger oligomerization of pro-apoptotic proteins (Bcl-2-associated 
protein, Bax, and Bcl-2-antagonist killer, Bak, to produce mitochondrial outer membrane 
permeabilization.  This leads to the release of Cyt c, which activates Apaf-1, induction of 
apoptosome formation, recruitment/activation of procaspase-9, and direct processing and 
activation of procaspase-3 and -7.  In the extrinsic pathway, the Fas receptor ligand (FasL) 
triggers the membrane-bound DISC, which recruits procaspase-8 and activates caspase-3 directly.  
In some cell types, caspase-8 can also cleave Bid to form tBid, which interacts with Bax/Bak to 
trigger mitochondrial outer membrane permeabilization, Cyt c release and apoptosome formation.  
The activation of caspase-3 and -7 is antagonized by inhibitor of apoptosis proteins (IAPs), which 
in turn can be inhibited by Smac/Diablo and Omi/HtrA2.  Activation of caspase-3 and -7 
orchestrates the demolition of the cell by cleavage of specific substrates, including poly (ADP) 
ribose polymerase (PARP), inhibitor of caspase-3-activated DNase (ICAD) and mammalian 
STE20-like kinase 1 (MST1).  Adapted from D’Amelio et al. 2010. 
 
A well-known observation in the apoptosis field is that differentiating cells are 
more refractory to apoptosis compared with less differentiated cells (Yi and Yuan, 2009).  
Next, it will be discussed the emerging evidence for nonapoptotic functions of apoptosis 
players in mediating cell fate specification and differentiation. 
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1.2.1 The tumor suppressor p53 
The tumor suppressor p53 is a central protein in mammalian stress response.  
Owing to its ability to integrate many different signals controlling cell life and death, p53 
has been named the “guardian of the genome” and plays a crucial role in maintaining 
genomic stability in somatic cells (Vousden and Prives, 2009).  Under normal 
physiological conditions p53 remains inactive and unstable, but is rapidly stabilized and 
activated by upstream kinases in response to genotoxic and oncogenic stresses, leading to 
cell cycle arrest, apoptosis or senescence (Zhao and Xu, 2010).  These functions of p53 
can protect the genome from accumulating genetic mutations, by allowing the time for 
faithful repair of DNA damage or by eliminating cells with excessive DNA damage 
(Zhao and Xu, 2010).   
p53 functions mainly as a DNA-binding, sequence-specific transcription factor that 
activates the expression of multiple genes, including p21, noxa and puma (Vousden and 
Prives, 2009), which in turn mediate p53 functions in cell cycle arrest, apoptosis and 
senescence.  In addition, p53 regulates the expression of proteins that modulate its own 
activation and stability, such as Mdm-2, forming multiple positive and negative feedback 
loops (Harris and Levine, 2005).  Posttranslational modifications of p53 are also 
important modulators of its function and stability (Bode and Dong, 2004).  In fact, 
modifications have been detected on at least 30 different sites on the p53 protein.  It has 
been proposed that the specific combination of modifications on p53 may provide 
selectivity toward a particular cell response. 
The role of p53 in controlling genomic stability is crucial in stem cell populations.  
The accumulation of unrepaired DNA in ES cells could not only promote tumorigenesis 
in multiple cell lineages, but also pass these mutations to the progeny, leading to genetic 
instability in differentiated cells (Zhao and Xu, 2010).  ES cells must have developed 
mechanisms to cope with various stresses, in particular, DNA damage insults.  However, 
p53 checkpoint pathways are compromised in ES cells, which do not induce p53-
dependent cell cycle arrest and apoptosis after certain types of physiological DNA 
damage, although p53 is expressed in abundant quantities in ES cells (Aladjem et al., 
1998). 
p53-mediated checkpoint controls can be activated during differentiation.  Recent 
studies suggest that p53 may maintain genetic stability of ES cells by inducing 
differentiation.  Following genotoxic stress, p53 can induce differentiation of ES cells by 
directly suppressing Nanog expression (Lin et al., 2005), which is the master 
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transcriptional factor that maintains self-renewal of ES cells.  Therefore, the outcome of 
p53 activation in DNA-damaged ES cells is to differentiate ES cells into other cells types 
that can undergo efficient p53-dependent cell-cycle arrest or apoptosis (Aladjem et al., 
1998; Chao et al., 2000), leading to the maintenance of genomic stability in self-renewing 
ES cells.  Importantly, p53 was shown to suppress Nanog expression also after treatment 
with retinoic acid, suggesting that p53 may be important not only to maintain genomic 
stability but also to differentiate ES cells.  Given that, p53 should be viewed not as a 
tumor suppressor protein, but rather as a crucial decision-maker molecule (Tedeschi and 
Di Giovanni, 2009; Vousden and Prives, 2009). 
 
1.2.1.1 Role of p53 during neuronal differentiation 
Before the link of p53 and Nanog had been established, mounting evidence was 
already suggesting a role for p53 in cell differentiation, including that of neuronal 
precursors.  Initially, p53 was considered non-essential to development since the majority 
of p53-null mice were considered phenotypically normal at birth, with markedly 
increased tumor development later in life (Donehower et al., 1992).  However, the 
discovery of low frequency neural tube defects in p53-/- mice (Armstrong et al., 1995; Sah 
et al., 1995) was an apparent paradox, and suggested that the role of p53 in development 
may be more complex than initially believed.  Determination of p53 mRNA levels during 
mouse embryonic development showed that it peaked during the differentiation of several 
tissues, including early neuronal precursor cells of the brain, but strongly declines during 
terminal differentiation (Louis et al., 1988; Rogel et al., 1985; Schmid et al., 1991).  In 
addition, evaluation of p53-dependent transcriptional activation during normal 
development in vivo indicated that p53 activity is at maximum during neuronal 
differentiation, and is clustered in areas that are not correlated with apoptosis (Gottlieb et 
al., 1997; Komarova et al., 1997). 
Later work supported a possible link between p53 and cell differentiation of NS 
cells through the regulation of cell-cycle progression.  One report showed that p53 
negatively regulates the proliferation and survival of adult NS cells, without affecting 
their differentiation potential (Meletis et al., 2006).  By comparing the transcriptome of 
adult NS cells from p53-null and wild-type mice, the authors identified altered expression 
of several cell cycle regulators, including downregulation of p21 expression, in the 
absence of p53.  Of note, the expression of all well-known neuronal differentiation 
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markers was not affected.  However, recent experiments of NS cells extracted from the 
olfactory bulb of wild-type and p53-null mouse embryos showed that p53 controls 
proliferation, chromosomal stability and differentiation pattern of mouse olfactory bulb 
stem cells (Armesilla-Diaz et al., 2009).  In fact, p53-null NS cells have increased 
proliferation and a bias towards neuronal phenotype, with concomitant reduction of 
astrocytes.  This effect had been previously reported in SVZ-derived stem cells from adult 
mice (Gil-Perotin et al., 2006).   
In vitro models of neuronal differentiation also suggest a role for p53 during 
differentiation.  Studies in neuronal-like PC12 pheochromocytoma and neuroblastoma 
cells revealed that p53 gene expression is induced and required during neurotrophin-
dependent neuronal differentiation and maturation (Hughes et al., 2000; Montano, 1997; 
Poluha et al., 1997; Zhang et al., 2006).  Furthermore, p53 was shown to be crucial for 
correct neurite outgrowth and maturation of cortical neurons in vitro (Di Giovanni et al., 
2006; Tedeschi et al., 2009).  p53 knockdown reduced spontaneous and directed 
differentiation rate in human ES cells (Qin et al., 2007), while activation of p53 with the 
small-molecule activator nutlin led to rapid differentiation (Maimets et al., 2008).  Still, 
although p53 protein levels were reduced after retinoic acid-induced ES cell 
differentiation, its transcriptional activity was increased (Lin et al., 2005).  Finally, the 
involvement of p53 has also been shown in spermatogenesis (Rotter et al., 1993), eye 
development (Reichel et al., 1998), renal development (Saifudeen et al., 2009), 
osteogenesis (Lengner et al., 2006), immune development (Matas et al., 2004), lung 
development (Tebar et al., 2001) and muscle differentiation (Porrello et al., 2000). 
 
1.2.1.2 Mechanism of p53 control of cell differentiation 
Despite the supporting data on transcriptional activity of p53 protein in 
differentiation, the mechanism through which p53 acts in this cellular context is still a 
puzzling question.  p53 was reported to play a critical role in nerve growth factor (NGF)-
mediated neuronal differentiation of PC12 cells, in part via regulation of TrkA 
expression, which in turn activates mitogen-activated protein kinase (MAPK) pathways 
(Browes et al., 2001; Zhang et al., 2006).  In the same study, p53 was reported to regulate 
cell cycle arrest by inducing p21 expression.  Moreover, by genome-wide chromatin 
immunoprecipitation (ChIP), Brynczka and colleagues have recently identified new 
putative p53 target genes during NGF-mediated PC12 neuronal differentiation, among 
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which are wnt7b involved in dendritic development, and the tfcp214/grhl3 grainyhead 
homolog implicated in ectodermal development (Brynczka et al., 2007).  Di Giovanni and 
co-workers showed that p53 regulates the expression of both actin-binding protein 
Coronin 1b and the GTPase Rab13, which are required for physiological neurite 
outgrowth in PC12 cells and dorsal root ganglion neurons (Di Giovanni et al., 2005).  In 
this sense, within the PC12 neuronal context, p53 may have the ability to regulate two 
critical events for neuronal differentiation, cell cycle arrest and neurite outgrowth.   
In ES cells, p53 is involved in the rapid down-regulation of Nanog expression 
during retinoic acid-induced differentiation (Lin et al., 2005).  Furthermore, p53-
dependent expression of p21, Mdm2 and Killer/DR5 were all also markedly induced 
indicating again a mechanism of action involving cell cycle regulation.  In fact, it has 
been shown that p21 can negatively regulate the self-renewal of adult NS cells (Mori et 
al., 2001).  Similar results were obtained in human ES cells (Maimets et al., 2008).   
Integrated transcriptomic profiling, in silico promoter analysis and functional 
studies of murine NS cells established that dual, but not singular, inactivation of p53 and 
Pten promotes an undifferentiated state, with high self-renewal potential, and drives 
increased Myc protein levels (Zheng et al., 2008).  Functional studies validated increased 
Myc activity as a potent contributor to impaired differentiation and enhanced self-renewal 
of NS cells doubly null for p53 and Pten. 
Studies in neuronal cells have suggested that the interaction of p53 with the 
neuronal specific and pro-differentiation transcription factor Brn-3a facilitates a shift of 
p53 transcriptional activity from cell death to neuronal differentiation (Hudson et al., 
2005).  In fact, when forming a complex with Brn-3a, p53 is not able to activate pro-cell -
death genes such as Bax and Noxa, but rather shows increased affinity for the pro-
differentiation gene p21.  Therefore, Brn-3a might play a crucial role in determining the 
pathway taken by p53, when co-expressed during development, and in controlling the cell 
fate.   
Thus, p53 may generally contribute to neuronal differentiation by targeting cell 
cycle regulators, and particularly by controlling the expression of differentiation-specific 
genes in a cell-type specific manner.  This could be directed by the interaction between 
Brn-3a and p53, which facilitates a shift of p53 transcriptional activity from cell death to 
neuronal differentiation.  
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1.2.1.3 p53 switch and multiple biological functions 
Genomic elements regulated by p53 during neuronal differentiation may be unique, 
and different from those regulated in genotoxic stress and apoptosis.  This is made 
possible by the multiple post-translational modifications that target p53 on its N- and C-
termini which are not limited to phosphorylation, but may also include acetylation, 
sumoylation, neddylation, and ubiquitination (Lavin and Gueven, 2006).  p53 post-
translational modifications directly affect the transcriptional activity of p53 and regulate 
its affinity to diverse cofactors, which in turn regulate the occupancy of p53 specific 
promoters (Sims and Reinberg, 2008). 
The best characterized p53 post-translational modifications are phosphorylation and 
acetylation.  Kinases phosphorylate several serine and threonine residues, mainly in the 
p53 N-terminal region.  Phosphorylation at Ser 15, Ser 20, Ser 33, Ser 46 and Thr 18 
promotes p53 stabilization by preventing either its nuclear export, or its recruitment to 
specific promoters.  Importantly, soon after the onset of differentiation of ES cells, 
phosphorylation of p53 at Ser 15, Ser 315 and Ser 392 is significantly increased, which is 
thought to activate p53 (Xu, 2003).  p53 phosphorylation at Ser 315 was also shown to be 
particularly important for p53-dependent suppression of Nanog during differentiation of 
ES cells (Lin et al., 2005).   
Acetylation targets mainly two distinct regions of the p53 C-terminus and, in 
neurons, involves the activity of at least two histone acetyltransferases, CREB-binding 
protein (CBP)/p300 and p300/CBP-associated protein (P/CAF).  CBP/p300 acetylates 
Lys370, Lys372, Lys373 and Lys382, whereas P/CAF acetylates only a single residue, 
Lys320 (Brooks and Gu, 2003).  Importantly, these kinase and acetyltransferase pathways 
are activated downstream from NGF and brain-derived nerve growth factor (BDNF) 
signaling during neuronal differentiation and axon outgrowth.  Interestingly, the 
acetylation of p53 at Lys 320 by P/CAF and the highly homologous acetyltransferase 
CGN5 leads to increased transcriptional activation of the p21 promoter, which triggers 
G1/S arrest and promotes neuronal differentiation in PC12 cells (Wong et al., 2004).  In 
addition, p53 acetylation in the same residue was reported to be involved in the 
promotion of neurite outgrowth (Di Giovanni et al., 2006).  Furthermore, acetylated p53 
at Lys372, Lys373 and Lys382 was reported to drive axon outgrowth and GAP-43 
expression, and to bind specific elements on the neuronal GAP-43 promoter (Tedeschi et 
al., 2009). 
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The ability of p53 to modulate different transcriptional responses in neurons, 
depending on specific signaling and transcriptional contexts might be linked not only to 
the post-transcriptional modifications of p53, but also to the cross-talk between p53 and 
post-transcriptional modifications on histones.  Histone modifications influence 
chromatin structure, which in turn influences the capacity of transcription factors to bind 
to specific promoters.  A unique chromatin environment could regulate the affinity of p53 
to specific promoters.  Specific patterns of p53 codes might lead to different biological 
outcomes, depending on the transcriptional context in a given cell or tissue (Murray-
Zmijewski et al., 2008).  Understanding the role of such mechanisms in the regulation of 
the neuronal phenotype during development undoubtedly represents an exciting challenge 
for future investigations. 
 
1.2.1.4 Role of p53 in limiting somatic cell reprogramming 
The recent demonstration of in vitro reprogramming of somatic cells into iPS cells 
by Yamanaka and colleagues represents a major advance in the field of stem cells.  This 
discovery raises hope for modeling of human diseases, especially those with complex 
genetic traits.  In addition, iPS cells could become a renewable source of autologous cells 
for transplantation into human patients.  
Reprogramming was initially achieved by transduction of four transcription factors 
(Oct3/4, Sox2, c-Myc, and Klf-4), but only a minority of donor somatic cells can be 
reprogrammed to pluripotency (Takahashi and Yamanaka, 2006).  Although alternative 
and more efficient reprogramming protocols are being subject of extensive investigation, 
it was recently shown that the inhibition of the p53/p21 pathway increased cell division 
rate and resulted in accelerated kinetics of iPS cell formation, which was directly 
proportional to the increase in cell proliferation (Hanna et al., 2009).  By comparing the 
reprogramming efficiency of wild-type and p53-deficient mouse and human fibroblasts, 
several studies have shown great increase in reprogramming frequency in p53-deficient 
cells, indicating that p53 is an effective barrier of induced pluripotency (Hong et al., 
2009; Kawamura et al., 2009; Zhao et al., 2008b).  Nevertheless, if inactivation of the p53 
pathway is a prerequisite for successful reprogramming, these findings raise concerns on 
the genomic stability and tumorigenecity of iPS cells and their derivatives. 
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1.2.2 Caspases  
Caspases are a family of cysteinyl aspartate-specific proteases that are highly 
conserved in multicellular organisms and function as central regulators of apoptosis.  To 
date, 11 genes were found in the human genome to encode 11 human caspases, caspase-1 
to -10 and caspase-14, whereas 10 genes were found in the mouse genome to encode 10 
murine caspases, caspase-1, -2, -3, -6, -7, -8, -9, -11, -12 and -14 (for a review, see Li and 
Yuan, 2008).  Human caspase-4 and -5 are functional orthologs of mouse caspase-11 and 
-12, whereas human caspase-10 is absent in the mouse genome.  The remaining caspases 
with the same numbers in human and mouse are functional orthologs of each other.  
Members of the caspase family are subdivided into upstream “initiator” caspases (in 
mammals, caspase-1, -2, -4, -5, -8, -9, -10, -11, and -12), which respond to proapoptotic 
signals, and downstream “executioner” caspases (in mammals, caspase-3, -6, -7, and -14) 
(Yi and Yuan, 2009).  Caspases are synthesized as zymogens and their activation requires 
allosteric conformational changes, specific cleavage after a selective aspartate residue, or 
both.  To date, four pathways leading to caspase activation have been characterized in 
vertebrate organisms, including the receptor-mediated pathway, the mitochondria-
mediated pathway, the granzyme B-mediated pathway, and the endoplasmic reticulum-
mediated pathway (Nicholson, 1999).  Extensive biochemical and structural analysis 
indicate that inflammatory and initiator caspases are recruited to larger complexes that 
induce caspase dimerization, autoproteolysis, and protease activation (Shi, 2004).  
Following activation, apoptotic initiator caspase-8 and -9 cleave executioner procaspase-
3, -6, and -7.  This leads to cleavage of more than 1,000 proteins (Dix et al., 2008; 
Mahrus et al., 2008) to produce the characteristic apoptotic phenotypes of membrane 
blebbing, nuclear condensation, DNA fragmentation, and ultimately phagocytosis by 
immune cells.   
Although the critical function of caspases in apoptosis is firmly established, some 
pro-apoptotic caspases, namely caspase-3, -8 and -14 also regulate differentiation in 
certain cells types (Table 1.1).  The cellular processes that stop caspases short of inducing 
apoptosis in diverse biological settings remain a mystery. 
  
Chapter 1 
20 
 
Table 1.1. Function of mammalian caspases in cell differentiation 
 
Caspase Cell Type 
1 Not determined 
2 Not determined 
3 
Epithelial lens, erythroblasts, megakaryocytes, spermatids, NS 
and ES cells, osteoclasts, bone marrow stromal and skeletal 
muscle cells 
4 Not determined  
5 Not determined 
6 Not determined 
7 Not determined 
8 Macrophages and trophoblasts 
9 Not determined 
10 Not determined 
11 Not determined 
12 Not determined 
14 Keratinocytes 
 
Adapted from Yi et al. 2009. 
 
1.2.2.1 Caspase-3 
The role of caspase-3 during terminal differentiation has been well established.  
Terminal differentiation of certain cell types, such as lens epithelial cells, erythroblasts, 
and megakaryocytes, requires the elimination of nuclei.  The enucleation process of lens 
epithelial cells is prevented after inhibition of caspase activity by the pan caspase 
inhibitor, z-VAD.fmk, suggesting that caspases are involved in the specific elimination of 
nuclei as opposed to elimination of the whole cell (Ishizaki et al., 1998).  The terminal 
maturation of erythroblasts into enucleate red blood cells also requires caspase activity.  
Caspase-3, together with caspase-9, -7 and -2 are transiently activated during erythroid 
differentiation induced by erythropoietin, and caspase inhibition completely inhibits 
erythroid differentiation at the basophilic erythroblast stage (Carlile et al., 2004; Zermati 
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et al., 2001).  Caspase activation during enucleation is associated with the cleavage of 
lamin B and acinus, which are necessary for the maintenance of nuclear integrity and 
condensed chromatin, respectively (Zermati et al., 2001).  Finally, during the 
differentiation of megakaryocytes into mature platelets, cytoplasmic fragmentation of 
megakaryocytes leads to the formation of enucleate cells, rather than removal of nucleus, 
per se (Radley and Scurfield, 1980).  Interestingly, activated caspase-3 was detected in 
maturing megakaryocytes, while the pan-caspase inhibitor z-VAD.fmk, as well as more 
specific inhibitors of caspase-3 and -9, blocked platelet differentiation (De Botton et al., 
2002).   
Localized caspase activity has been also found to play an important role during 
sperm development.  Dramatic removal of bulk cytoplasm occurs in the terminal 
differentiation of spermatid into individual sperm.  Multiple fly caspases have been 
implicated in this highly specialized cellular event, known as spermatid individualization.  
It was found that, during this process, caspase-3 is detected in the individualization 
complex, a cytoskeletal membrane complex that moves along the length of the cyst to the 
sperm tail (Arama et al., 2003). 
The function of caspase-3 in cell differentiation may extend beyond terminal 
differentiation.  In the CNS, non-apoptotic active caspase-3 expression has been located 
in proliferating and differentiating neuronal cells of the VZ and external granular layer of 
the developing cerebellar cortex (Oomman et al., 2006).  In addition, caspase-3 activation 
is also observed in glial cells within the developing cerebellum.   
In the past decade, the cell autonomous pro-differentiation effects of caspase-3 have 
been noted in diverse cell types including neurons (Rohn et al., 2004), neural and glial 
progenitor cells (Fernando et al., 2005; Oomman et al., 2006), and also osteoclasts (Mogi 
and Togari, 2003), bone marrow stromal cells (Miura et al., 2004), and skeletal muscle 
cells (Fernando et al., 2002).  Chemical or genetic blockade of caspase-3 activity leads to 
inhibition of differentiation. 
Two recent studies implicate caspase-3 in controlling fate of both ES cells and adult 
hematopoietic stem cells.  One study reported caspase-induced cleavage of Nanog in 
differentiating ES cells (Fujita et al., 2008).  Unsurprisingly, stem cells lacking the 
Caspase-3 gene showed marked defects in differentiation, while forced expression of 
caspase cleavage-resistant Nanog mutant in ES cells strongly promoted self-renewal.  
This suggests that Nanog is the key caspase substrate for limiting the self-renewing 
capacity of ES cells.  Curiously, caspase-3 was show to contribute to stem cell 
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quiescence, by dampening specific signaling events.  Alteration in caspase-3 expression 
perturbs homeostasis of primitive hematopoietic cells (Janzen et al., 2008).  Caspase-3-
deficient stem cells displayed accelerated proliferation and retarded differentiation.  At 
the molecular level, caspase-3 altered the sensitivity of primary hematopoietic cells to 
cytokine stimulation through modulation of specific signaling pathways, such as 
extracellular signal-related kinase (ERK) signaling.  These data indicate a novel role for 
caspase-3 as a governor, downregulating stem cell responsiveness to environmental 
signals. 
Interestingly, caspase-3 together with caspase-8 was recently shown to be involved 
in somatic reprogramming.  Induction of iPS cells by transduction of Oct-4, a key iPS 
transcription factor, is associated with caspase-3 and -8 activation (Li et al., 2010a).  
Inhibition of both caspases in human fibrobast cells prevented the induction of iPS cells, 
suggesting that caspase-3 and -8 may play a role in the reprogramming process.  
Finally, caspases are involved in dendritic pruning and synaptic plasticity.  Two 
studies indicate that localized caspase activity is important for the selective removal of 
sensory neuron dendrites during fly metamorphosis (Kuo et al., 2006; Williams et al., 
2006).  The involvement of caspases in dendritic pruning suggests that caspase activity is 
specific to cellular compartments, and does not cause cell death.  Furthermore, caspase-3 
activity was shown to be regulated at postsynaptic sites in the brain following stimuli 
associated with memory (Huesmann and Clayton, 2006).  In fact, caspase-3 activity is 
necessary to consolidate a persistent physiological trace of the song stimulus. 
 
1.2.2.2 Caspase-8 and -14 
Caspase-8 is involved in differentiation of macrophages.  Caspase-8 deletion in 
cells of the myelomonocytic lineages led to arrest of differentiation into macrophages 
(Kang et al., 2004).  In fact, caspase-8 activation is observed during differentiation of 
monocytes into macrophages, but not in dendritic cells (Netea et al., 2008; Sordet et al., 
2002).  An attempt to identify possible caspase substrates during macrophage 
differentiation was made, and several proteins associated with cytoskeleton 
rearrangements were identified (Cathelin et al., 2006).  Expression and activity of 
caspase-8 are also necessary for the specialized cell fusion events that are necessary for 
the differentiation of human placental villous trophoblas (Black et al., 2004).   
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Caspase-14 is implicated in terminal differentiation of keratinocytes into enucleate 
cells that form the skin outer layer.  Caspase-14 expression is highly specific for 
keratinocytes during the enucleation process (Lippens et al., 2000).  Caspase-14-deficient 
mice present a unique phenotype of shiny and lichenified skin (Denecker et al., 2007).  
Although it was previously though that caspase-14 lacked protease activity (Van de Craen 
et al., 1998), caspase-14 was found to directly cleave filaggrin, an abundant protein in the 
epidermis, in vitro (Denecker et al., 2007).  These findings indicate that caspase-14 plays 
a surprising role in maintaining the integrity of skin, although it is uncertain whether it 
directly regulates the enucleation process of keratinocytes.   
 
1.2.2.3 Death versus differentiation phenotypes 
It is still unclear how differentiating cells restrain active caspases without 
compromising cellular integrity.  One explanation is that the choice between death and 
differentiation derives largely from caspase targeting and activation of specific substrates 
or cofactors that are unique to each event.  In this regard, it was shown that during 
differentiation, but not during apoptosis, the chaperone protein Hsp70 protects the 
transcription factor GATA-1, a master regulator of erythroid maturation, from caspase-
mediated proteolysis during the enucleation process of erythroids (Ribeil et al., 2007).  It 
is unclear, however, whether the selective masking of caspase substrates by Hsp70 
provides a universal control mechanism for substrate specificity.  Clearly, a systematic 
investigation of each caspase substrate is needed to clarify whether these proteins 
maintain a regulatory role in both apoptosis and cell differentiation. 
In the absence of substrate selectivity, a plausible explanation for death versus 
differentiation phenotypes may originate with the timing and intensity of signal pathway 
activation.  Specifically, the degree of caspase activity required to effectively act on 
differentiation signals was lower than that observed to induce apoptosis (Weber and 
Menko, 2005).  In addition to temporal kinetics, the final choice between death and 
differentiation may also depend on subcellular localization of activated caspases and their 
constituent regulatory pathways.  Finally, negative control by inhibitory proteins of the 
inhibitor of apoptosis protein (IAP) family (Plenchette et al., 2004) may account for the 
maintenance of cell survival during caspase-mediated differentiation. 
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1.2.3 Bcl-2 family members 
In vertebrates, the Bcl-2 family regulates the mitochondrial pathway of apoptosis by 
complex interactions that dictate the integrity of the outer mitochondrial membrane 
(Green and Evan, 2002).  Bcl-2 family includes over 20 members that are functionally 
classified as either anti-apoptotic or pro-apoptotic, and are grouped into three subfamilies 
based on the number of homology (BH) domains they share.  Most cells express a variety 
of anti-apoptotic and pro-apoptotic Bcl-2 proteins, and the regulation of their interactions 
dictates survival or commitment to apoptosis. 
The anti-apoptotic subfamily of proteins includes Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and 
A1/Bfl-1, which possess four BH domains (BH1-4).  The next two subfamilies are pro-
apoptotic proteins with three BH (BH1-3) domains, represented by Bax, Bak and Bok, 
and BH3-only proteins, which are characterized by the presence of only the BH3 domain, 
and include Bik, Egl-1, Bim, Bmf, Noxa, Bid, Bad, Bnip3, and Beclin-1 (Lomonosova 
and Chinnadurai, 2008).  Importantly, these BH domains serve as mediators for 
protein:protein interactions, forming either homo- or heterodimers. 
Data implicating Bcl-2 family members during differentiation are scarce and mainly 
involve antiapoptotic Bcl-2 and Bcl-xL. 
 
1.2.3.1 Bcl-2 
Bcl-2 deficient mice are viable and no severe abnormality in the neuronal system 
was encountered (Kamada et al., 1995; Veis et al., 1993).  In the peripheral nervous 
system, however, more direct evidence from the Bcl-2 knockout mice indicates that Bcl-2 
accelerates the differentiation of trigerminal ganglionic neurons (Middleton et al., 1998).  
Intriguingly, immunohistochemistry of human and mouse embryonic and fetal tissues has 
disclosed high expression of Bcl-2 in organ systems undergoing morphogenesis and 
differentiation (LeBrun et al., 1993; Lu et al., 1993), including neural cells of the 
developing brain (Abe-Dohmae et al., 1993; Merry et al., 1994).  Furthermore, Bcl-2 
proteins in the nervous system are subject to developmental regulation, with high 
expression levels in neuroepithelial cells of the ventricular zones, and in post-mitotic 
neurons before adulthood (Merry et al., 1994).  Therefore, it has been suggested that Bcl-
2 might be important, though not crucial, during neuronal cell differentiation.  Bcl-2 may 
be required for a more effective differentiation during the limited term in embryonic and 
post-embryonic development. 
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In vitro, Bcl-2 expression was associated with neural differentiation of human 
neural-crest-derived tumor cell line, Paju (Zhang et al., 1996), and with retinoic acid-
mediated differentiation of CNS neurons (Wang et al., 2001).  This is in agreement with 
the observation that Bcl-2 gene is induced by retinoic acid (Niizuma et al., 2006).  In 
PC12 cells, Bcl-2 was shown to induce differentiation as a result of prevention of cell 
death induced by serum free medium (Sato et al., 1994).  In the absence of Bcl-2, NGF-
mediated differentiation resulted in neurite elongation, whereas Bcl-2 overexpression 
accelerated neurite formation (Suzuki and Tsutomi, 1998).  Importantly, Bcl-2 
overexpression was reported to increase neurite extension, but differentiation markers 
were not affected (Eom et al., 2004).   
Bcl-2 may be a direct effector of neuronal differentiation by influencing MAPK 
signaling pathways.  It was recently shown that Bcl-2 gene expression is directly 
correlated with p38α activation, and triggers the formation of neuronal networks when 
overexpressed in a global p38α-repressed environment (Trouillas et al., 2008).  
Furthermore, specific activation of c-Jun N-terminal kinase (JNK) was involved during 
Bcl-2 mediated neurite extention of MN9D dopaminergic neuronal cells overexpressing 
Bcl-2 (Eom et al., 2004).   
Taken together, these data indicate that Bcl-2 may act as an intercellular factor that 
control neurite extension and axonal regeneration.  Importantly, transplantation of ES 
cells overexpressing Bcl-2 further increased the survival of transplanted ES cells, as well 
as neuronal differentiation, and functional outcome (Wei et al., 2005).  Thus, 
manipulation of Bcl-2 should be valuable for improving transplantation efficacy of NS 
cells.  
 
1.2.3.2 Bcl-xL 
Bcl-xL is the most potent antiapoptotic protein among Bcl-2 family members, both 
in vitro and in vivo (Gonzalez-Garcia et al., 1995; Krajewska et al., 2002).  More 
specifically, Bcl-xL is essential for neuronal survival during brain development and in the 
adult CNS (Motoyama et al., 1995; Parsadanian et al., 1998).  Similar to Bcl-2, Bcl-xL 
expression increases through the early developmental phase of the brain and peaks during 
the neurogenesis period (Krajewska et al., 2002).  Bcl-xL facilitates the in vitro 
differentiation of both mouse and human ES cells into the neuronal lineage (Liste et al., 
2004; Shim et al., 2004).  Also, recent data from conditional Bcl-xL mutant mice add 
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support to these observations (Chang et al., 2007a; Savitt et al., 2005).  Bcl-xL directs the 
fate of both immortalized and naïve human NS cells and was found to enhance neuron 
generation by increasing proliferation of neuronal progenitors, while decreasing glia 
generation (Liste et al., 2007).  These findings support the possibility that the 
determination of neuronal versus astroglial lineages may be actively regulated by 
balanced levels of anti- and pro-apoptotic Bcl-2 family proteins in neural precursors 
(Chang et al., 2007a).  In fact, Chang and coworkers found that Bcl-xL instructively 
directs the fate of embryonic cortical precursors toward neurons (Chang et al., 2007a). 
Finally, the expression of Bcl-xL has been shown to be down-regulated during 
differentiation of human hematopoietic progenitor cells along the granulocyte lineage, but 
increased during differentiation into monocytes/macrophages (Sanz et al., 1997).  In 
addition, Bcl-xL increased along the erythroid differentiation of progenitor cells (Gregoli 
and Bondurant, 1997) and in K562 cell differentiation into megakaryocyte (Terui et al., 
1998). 
 
1.2.3.3 Bax and Bim 
Scarce data is available on the role of Bax during neural differentiation.  In fact, 
during neurodevelopment, Bax expression is coincident with that of astrocyte formation 
(Sauvageot and Stiles, 2002), and declines during postnatal development (Krajewska et 
al., 2002).  In accordance, Bax was shown to instruct embryonic cortical precursors to 
undergo astrocytic differentiation (Chang et al., 2007a).  Bax has no effect on neuronal 
differentiation, which is supported by the observation that Bax levels decreased or 
remained unchanged in differentiating PC12 cells (Vekrellis et al., 1997) and retinoic 
acid-mediated differentiation of NTera-2/DI cells (Guillemain et al., 2000), respectively.   
The BH3-only protein Bim was recently added to the list of pro-apoptotic proteins 
with a function in cell differentiation.  Using gene-deficiency mice, Bunk and coworkers 
reported a possible role of pro-apoptotic Bim in neuronal differentiation of adult-born 
neural precursor cells (Bunk et al., 2010).  Despite bim and puma deficiency did not 
change early markers of neuronal differentiation in dentate gyrus, BrdU/NeuN double-
labeling revealed that the deficiency of bim, but not puma, accelerated the differentiation 
of newly generated cells into a neuronal phenotype.  In apoptotic context, Bim binds to 
and “neutralizes” Bcl-2.  It is therefore possible that endogenous Bim levels determine the 
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amount of sequestered Bcl-2, and by doing so influence neuronal differentiation or axonal 
outgrowth. 
 
1.2.4 Others apoptotic players in cell differentiation 
Death receptors are cell-surface receptors belonging to the tumor necrosis factor 
(TNF) superfamily that includes CD95 (FAS/APO-1), TNF-receptor type I (TNFR1) and 
tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptors.  TNF is a 
major mediator of apoptosis as well as inflammation and immunity, and it has been 
implicated in the pathogenesis of a wide spectrum of human diseases, including cancer 
(Wang et al., 2009) and autoimmune diseases (Zapata et al., 2009).  TNF binds to two 
specific receptors, TNFR1 and TNFR2 which differ in structure and function.  A death 
domain is present only in TNFR1, and thus, TNFR2 activation does not directly lead to 
caspase activation.  TNFR2 is believed to initiate primarily pro-inflammatory and pro-
survial signaling.  On the other hand, TNFR1 activation leads to recruitment of 
intracellular adaptor proteins that activate multiple signal transduction pathways (Tracey 
et al., 2008).  Recently, members of the TNF family have emerged as apoptosis-
associated proteins that operate in differentiation-related processes. 
Current experiments suggest that lower concentrations of TNF can elicit myoblast 
differentiation and engage behavior associated activated muscle stem cells, such as 
enhanced chemotaxis (Chen et al., 2005; Torrente et al., 2003).  Furthermore, recent 
evidence also suggests that components of the TNF/TRAIL dependent pathways stimulate 
differentiation in a variety of cell types, including dendritic and human intestinal cells 
(Chomarat et al., 2003; Rimondi et al., 2006).  In addition, TNF-α was recently shown to 
have a pro-neurogenic effect in neonatal SVZ cell cultures of mice, which also involved 
TNFR1 activation (Bernardino et al., 2008). 
Stimulation of the death receptor, CD95 in NS cell does not trigger apoptosis but 
unexpectedly leads to stem cell survival and neuronal specification (Corsini et al., 2009).  
These effects are mediated via activation of the Src and phosphatidylinositol 3-kinase 
(PI3K)-Akt-mTOR signaling pathway, ultimately leading to a global increase in protein 
translation. 
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1.3 microRNAs 
The recent discovery of microRNAs (miRNAs or miRs) introduces a novel 
regulatory control over gene expression in several processes, including neuronal 
differentiation.  miRNAs comprise a large family of single stranded non-coding RNAs, ~ 
21-nucleotide-long that have emerged as key post-transcriptional regulators of gene 
expression in metazoans and plants (Bartel, 2009).  miRNAs undergo several processing 
steps until the mature miRNA is produced and exerts its biological role.  Many miRNAs 
tend to be in close genomic proximity, accounting for about 37% of miRNAs transcribed 
as polycistronic transcripts (Altuvia et al., 2005).  Transcription of miRNA genes is 
regulated in a similar manner to that of protein-coding genes, and is a major level of 
control responsible for tissue-specific or development-specific expression of miRNAs 
(Krol et al., 2010). 
In mammals, miRNAs are predicted to control the activity of ~ 50% of all protein-
coding genes (for review, see Krol et al., 2010).  Functional studies indicate that miRNAs 
participate in the regulation of almost every cellular process investigated so far, and that 
changes in miRNA expression are associated with many human pathologies.  Indeed, 
stem cell and miRNA fields have converged with the identification of stem cell-specific 
and lineage-specific miRNAs (Gangaraju and Lin, 2009).  Owing to their functions in the 
regulation of translation, miRNAs can regulate stem cell fate and behavior by fine-tuning 
the protein levels of various factors required for stem cell proliferation and 
differentiation. 
 
1.3.1 Overview of miRNA biogenesis and function 
The majority of miRNAs are transcribed from independent genes by RNA 
polymerase II, giving rise to a 5’ 7-methyl-guanosine capped and 3’ polyadenilated 
primary miRNA (pri-miRNAs) (Cai et al., 2004) (Fig. 1.6).  Pri-miRNA transcripts can 
originate from intergenic regions, where the miRNA can reside within an exon, or an 
intron of a non-coding transcript.  However, many mammalian miRNAs reside in introns 
of protein coding genes, and display a similar transcription pattern to that of protein-
coding genes (Baskerville and Bartel, 2005; Rodriguez et al., 2004). 
pri-miRNAs present a typical hairpin structure, and act as substrates for two 
members of the RNase III family of enzymes, Drosha and Dicer.  The product of Drosha 
cleavage, an ~ 70-nucleotide precursor miRNA (pre-miRNA), is exported to the 
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cytoplasm, where Dicer processes it to an ~ 20-bp miRNA duplex.  One strand of this 
duplex, the guide strand, is then incorporated into the miRNA-induced silencing complex 
(RISC).  As part of the RISC, miRNAs basepair to target mRNAs and induce their 
translational repression of deadenylation and degradation.  The Argonaute (AGO) protein, 
which directly interact with miRNAs, and glycine-tryptophan protein of 182 kDa (GW 
182) proteins, which act as downstream effectors in the repression, are key factors in the 
assembly and function of RISC.  Furthermore, the role of both Drosha and Dicer in 
miRNA maturation is assisted by a number of cofactors or accessory proteins, with some 
playing an important regulatory function (Krol et al., 2010). 
 
 
Figure 1.6. Schematic overview of miRNA biogenesis.  miRNAs are transcribed as primary 
transcripts (pri-miRNA) by RNA polymerase II.  Each miRNA is cleaved in two steps, catalyzed 
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by two members of the RNase III family of enzymes, Drosha and Dicer, operating together with 
specific cofactors, such as DiGeorge syndrome critical region gene 8 (DGCR8) and 
transactivation-responsive (TAR) RNA-binding protein (TRBP) in mammals.  In the first nuclear 
step, the Drosha-DGCR8 complex processes pri-miRNA into a ~ 70-nucleotide stem loop known 
as the precursor miRNA (pre-miRNA), which is exported to the cytoplasm by exportin 5.  
Cleavage of pre-miRNA by Dicer, assisted by TRBP, yields an ~ 20-bp mature miRNA duplex in 
the cytoplasm.  Following processing, the guide strand of the duplex is preferentially incorporated 
into a miRNA-induced silencing complex (RISC), whereas the other strand (passenger) is 
released and degraded (not shown).  Mature miRNA allows the RISC to recognize target mRNA 
through partial sequence complementarity with its target.  The target mRNA can be either cleaved 
by AGO2, or deadelylated, decapped and exonucleolyticaly degraded.  Adapted from Inui et al. 
2010. 
 
Recent discoveries have revealed a model in which complex miRNA regulatory 
events are woven into the known transcription factor and signaling networks that control 
cell fate and differentiation, modulating their activity through positive and negative 
feedback loops to reinforce cellular decisions.  The important regulatory role of miRNAs 
in development and differentiation clearly emerged from the study of ES cells null for the 
Dicer gene.  Ablation of Dicer leads to defects in embryonic stem cell division and 
proliferation (Murchison et al., 2005), causing death in mice and complete loss of 
pluripotent stem cells (Bernstein et al., 2003).  In addition, Dicer ablated embryonic stem 
cells also fail to differentiate.  Therefore, miRNAs can affect stem cell behavior at both 
proliferation and differentiation levels.  
 
1.3.2 Apoptosis-associated miRNAs as regulators of differentiation and cell fate 
decision 
Based on the capacity of miRNAs to regulate pro- and antiapoptotic genes, 
Garofalo et al. recently classified miR-15 and miR-16, let-7 family, members of miR-34 
family, miR-122, miR-101 and miR-29 family members as pro-apoptotic miRNAs 
(Garofalo et al., 2010).  Not surprisingly, some of these miRNAs are reported to be 
involved in cell differentiation. 
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1.3.2.1 miR15 and miR-16 
miR-15a and miR-16-1 are deleted or downregulated in the majority of chronic 
lymphocytic leukemias, and they are known to negatively regulate Bcl-2 expression 
levels (Cimmino et al., 2005).  Interestingly, miR-15a and miR-16 were reported to 
decrease considerably during human monocyte-macrophage differentiation (Li et al., 
2010b).  In addition, miR-15a was shown to play a role during hematopoietic 
differentiation (Zhao et al., 2009).  Furthermore, miRNA profile in mouse inner ear 
tissues identified miR-15a-1 as having a differential expression profile during 
development of mouse inner ear tissue (Friedman et al., 2009), which was also observed 
during zebrafish inner ear development and morphogenesis.  Interestingly, both miR-15a 
and miR-16-1 were upregulated in retinoic acid-mediated granulocytic differentiation of 
NB4 cells (Garzon et al., 2008).  These results are correlated with downregulation of Bcl-
2 mRNA and protein levels during retinoic acid treatment.  Importantly, the miR-15a/16-
1 cluster also downregulates expression of cyclin dependent kinase 6 (CDK6), caspase 
recruitment domain-containing protein 10 (CARD10), and cell division cycle protein 27 
(CDC27), preventing cells from entering S phase, which can also contribute to a role in 
cell differentiation (Ivey and Srivastava, 2010). 
 
1.3.2.2 Let-7 family 
The lethal-7 (let-7) gene was initially discovered in C. elegans (Reinhart et al., 
2000).  let-7 and its family members are highly conserved across species, from worms to 
humans, in sequence and function (Pasquinelli et al., 2000).  Misregulation of let-7 leads 
to a less differentiated cellular state and the development of cell-based diseases, such as 
cancer.  The size of the let-7-family can differ between organisms; in invertebrates is 
smaller, only nine related family members in nematodes and one let-7 in fly (Lagos-
Quintana et al., 2001), compared with 13 closely related let-7 family genes in humans 
(Roush and Slack, 2008). 
The major role of let-7 is to promote differentiation of cells.  It was shown to 
regulate stem cell differentiation in C. elegans (Reinhart et al., 2000), neuromusculature 
development and adult behavior in flies (Caygill and Johnston, 2008; Sokol et al., 2008), 
limb development in chicken and mouse (Lancman et al., 2005; Schulman et al., 2005), 
and cell proliferation and differentiation (Wulczyn et al., 2007; Yu et al., 2007a; Yu et al., 
Chapter 1 
32 
2007b).  Still, let-7 was reported to be strongly induced during neural differentiation of 
ES cells and embryocarcinoma cells (Rybak et al., 2008; Wulczyn et al., 2007). 
In mammals, let-7 levels increase during embryogenesis and during brain 
development (Schulman et al., 2005; Wulczyn et al., 2007).  Let-7 is undetectable in 
human and mouse embryonic stem cells, and increases following differentiation 
(Wulczyn et al., 2007).  This high expression of let-7 is then maintained in various adult 
tissues (Sempere et al., 2002).  However, the direct contribution of let-7 in development 
has not been demonstrated.  It was recently shown that the introduction of let-7 miRNAs 
can suppress the self-renewal in Dgrc8-/- mouse ES cells (Melton et al., 2010).  
Furthermore, inhibition of the let-7 family promotes de-differentiation of somatic cells 
into iPS cells.  Together, these findings suggest that let-7 miRNAs act in order to stabilize 
the self-renewing versus differentiated cell fates. 
Differentiation is tightly linked with exit from cell cycle and numerous genes whose 
products promote G1/S or G2/M transitions, including CDK6, CDC25A, and CCND2, are 
direct let-7 targets (Ivey and Srivastava, 2010).  In addition, let-7 indirectly influences 
cell cycle by negatively regulating oncogenes such as MYC (Sampson et al., 2007), RAS 
(Johnson et al., 2005) and high-mobility group AT-hook 2 HGMA2 (Park et al., 2007), 
which would otherwise promote proliferation.  Caspase-3 was also reported to be a direct 
let-7 target (Tsang and Kwok, 2008).  However, the relative importance of these targeting 
in a differentiation context is unknown. 
 
1.3.2.3 miR-34 family 
The miRNA-34 family comprises three members in mammalians; miR-34a, which 
is generated from a larger transcriptional unit on chromosome 1p36, and miR-34b and 
miR-34c, both of which are generated by processing of a bicistronic transcript from 
chromosome 11q23 (for a review, see Hermeking, 2010).  In mice, miR-34a is 
ubiquitously expressed with the highest expression in the brain (Lodygin et al., 2008), 
whereas miR-34b/c is mainly expressed in lung tissues (Bommer et al., 2007).  
Importantly, several reports showed that members of the miR-34 family are direct p53 
targets, and their upregulation induces apoptosis and cell cycle arrest (Bommer et al., 
2007; Chang et al., 2007b; Corney et al., 2007; He et al., 2007a; Raver-Shapira et al., 
2007; Tarasov et al., 2007) (Fig. 1.7).   
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Figure 1.7. Involvement of members of miR-34 family in p53 network.  Under genotoxic 
stress, p53 is activated by upstream kinases and transactivates several target genes, including 
miRNA-34 family members.  After processing, mature miR-34a, -b, and -c mediates inhibition of 
translation or RNA degradation of the indicated validated, and presumably many others not yet 
confirmed targets, leading to apoptosis, cell cycle arrest, senescence or inhibition of migration.  
Adapted from Hermeking, 2010. 
 
Despite the involvement of miR-34 family members in mediating p53 effect on 
apoptosis and cell cycle, emerging evidence suggests a role for miR-34a during cell 
differentiation.  miR-34a was shown to be involved in monocyte-derived dendritic cell 
differentiation (Hashimi et al., 2009), megakaryocytic differentiation of K562 cells 
(Ichimura et al., ; Navarro et al., 2009), and differentiation of mouse embryonic stem cells 
(Tarantino et al.).  In addition, targets of miR-34a were distinct in each differentiation 
context and include JAG1, CDK4 and CDK6, MYB, mitogen-activated protein kinase 
kinase 1 (MEK1) and silent information regulator 1 (SIRT1).  Interestingly, the induction 
of miR-34a during megakaryocytic differentiation of K562 cells was shown to be 
independent of p53 (Navarro et al., 2009).  However, the same attempt to analyze a 
possible link between p53 and miR-34a expression in a differentiation context was not 
performed in the others studies and therefore the hypothesis that miR-34a mediates p53 
effect in a differentiation context deserves further investigation. 
 
1.3.2.4 miR-122, miR-101, and miR-29 family 
miR-122 is a highly abundant, liver-specific miRNA whose expression is 
specifically turned on in the mouse liver during embryogenesis (Chang et al., 2004).  
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Therefore, it is expected to be involved in liver development.  In addition, Lin et al. 
demonstrated that the anti-apoptotic Bcl-w is a direct target of miR-122 (Lin et al., 2008).  
Recently, miR-122 was shown to contribute to liver development by regulating the 
balance between proliferation and differentiation of hepatocytes, at least in part by 
targeting CUTL1, a transcriptional repressor of genes specifying terminal differentiation 
(Xu et al., 2010). 
miR-101 was suggested to have pro-apoptotic functions by targeting Mcl-1 (Su et 
al., 2009).  The only link between miR-101 expression and cell differentiation came from 
the study of Garzon and coworkers that showed an upregulation of miR-101 during 
megakaryocyte differentiation (Garzon et al., 2006). 
The miR-29 family of miRNAs consists of miR-29a, -29b, and -29c.  In addition, 
Mcl-1 was also confirmed to be a target of miR-29b (Mott et al., 2007).  Interestingly, 
miR-29b was suggested to be a key regulator of development of the osteoclast phenotype 
by targeting anti-osteogenic factors and modulating bone extracellular matrix proteins (Li 
et al., 2009b).  The other members of miR-29 family, miR-29a and miR-29c, are also 
upregulated during osteoblastic differentiation in vitro, possibly induced by Wnt signaling 
(Kapinas et al., 2009).  In addition, miR-29 was reported to be more expressed in 
astrocytes than neurons (Smirnova et al., 2005), and was also shown to accelerate 
myogenesis (Wang et al., 2008a).   
Although the above data suggest a possible role for apoptosis-associated miRNAs 
in cell differentiation, it is important to further explore the mechanism(s) by which 
apoptosis-associated miRNAs regulate cell differentiation, adding to our understanding 
the potential of miRNAs to define the fate of developing cells. 
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Objectives 
 
The studies presented in this thesis were driven by the hypothesis that specific 
apoptosis-associated signaling pathways play a critical role in NS differentiation.  Three 
main objectives were designed.  First, our goal was to determine the involvement of 
specific apoptosis-associated proteins in mouse NS cell differentiation, and investigate 
their interaction with proliferation to commit cells to differentiation.  Second, we sought 
to evaluate the potential involvement of apoptosis-associated miRNAs in different models 
of neural differentiation.  Finally, we aimed to further explore the role of miR-34a, an 
apoptosis-associated miRNA whose expression is induced by p53, during NS cell 
differentiation.  Specifically, we wanted to identify putative targets of miR-34a, and 
further clarify the mechanism(s) by which miR-34a regulates cell differentiation. 
The specific questions addressed in this thesis are: 
1. Are apoptosis-associated proteins integral components of the differentiation 
process of NS cells?  Do they interfere with proliferation pathways, such as 
the PI3K/Akt signaling pathway?  
2. Are apoptosis-associated miRNAs involved in the differentiation process of 
neural cells? 
3. What is the role of miR-34a expression during NS cell differentiation?  
Which molecular pathways does it modulate? 
The overarching goal of the research presented in this thesis is to increase our 
understanding regarding the basic molecular mechanisms of NS cells differentiation that 
require specific factors of the apoptosis machinery.  The results may have broad 
implications in advancing our understanding of differentiation and its modulation.  
Further, our findings may prove useful in the development of novel therapeutic strategies 
to improve long term-survival and differentiation of transplanted stem cells. 
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2.1 Abstract 
Neural stem cells (NSCs) differentiate into neurons and glia, and a large percentage 
undergoes apoptosis.  The engagement and activity of apoptotic pathways may favor 
either cell death or differentiation.  In addition, Akt represses differentiation by up-
regulating the inhibitor of differentiation 1 (Id1), through phosphorylation of its repressor 
FOXO3A.  The aim of this study was to investigate the potential cross-talk between 
apoptosis and proliferation during mouse NSC differentiation.  We determined the time of 
neurogenesis and gliogenesis using neuronal β-III tubulin and astroglial GFAP to confirm 
that neurogenesis and gliogenesis occur at ~ 3 and 8 days, respectively.  p-Akt, p-
FOXO3A, and Id1 were significantly reduced throughout differentiation.  Caspase-3 
processing, p53 phosphorylation, and p53 transcriptional activation increased at three 
days of differentiation, with no evidence of apoptosis.  Importantly, in cells exposed to 
the pancaspase inhibitor z-VAD.fmk, p-FOXO3A and Id1 were no longer down-
regulated, p53 phosphorylation and transcriptional activation were reduced, while 
neurogenesis and gliogenesis were significantly delayed.  The effect of siRNA-mediated 
silencing of p53 on FOXO3A/Id1 was similar to that of z-VAD.fmk only at 3 days of 
differentiation.  Interestingly, caspase inhibition further increased the effect of p53 
knockdown during neurogenesis.  In conclusion, apoptosis-associated factors such as 
caspases and p53 temporally modulate FOXO3A/Id1 signaling and differentiation of 
mouse NSCs. 
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2.2 Introduction 
Neural stem cells (NSCs) are defined by their capacity for self-renewal and ability 
to generate major cell types of the mammalian central nervous system (Doe, 2008).  
These features make them a therapeutic tool to treat a broad spectrum of human 
neurological disorders, including Parkinson’s, Alzheimer’s, and Huntington’s diseases as 
well as acute stroke (Schwarz et al., 2006).  Despite the therapeutic potential of NSCs, 
major hurdles must be overcome to render these cells a reliable and efficient system to 
produce specific cell types for neuro-replacement therapies (Hsu et al., 2007).  Tight 
regulation of the differentiation process remains a critical issue.  In fact, the mechanisms 
controlling differentiation and lineage specification of NSCs are still poorly understood, 
and many molecules and their specific functions are yet unknown. 
Apoptosis is often thought to result from a failure of cells to correctly exit the cell 
cycle and differentiate.  In this respect, it has been postulated that apoptotic pathways 
may also regulate other basic cell functions that do not involve cell death per se (Garrido 
and Kroemer, 2004).  It was recently suggested that several conserved elements of 
apoptosis are also integral components of terminal differentiation.  Therefore, it is not 
surprising that during differentiation, specific cellular changes occur in a similar manner 
to those observed during apoptosis (Chasis and Schrier, 1989).  Terminal erythroid 
differentiation, for example, is characterized by major morphological changes that include 
chromatin condensation and complete removal of the nucleus (Garrido and Kroemer, 
2004).  In addition, it has been demonstrated that the fate of erythroid precursors is 
determined downstream of caspase activation by the pattern of cleaved targets (Ribeil et 
al., 2005). 
Caspases have recently been implicated in the differentiation process for a variety 
of model systems (Schwerk and Schulze-Osthoff, 2003).  Specifically, caspase-8 was 
shown to be required for T cell activation (Misra et al., 2007), while bone morphogenetic 
protein-induced differentiation of osteoblastic cells has been associated with transient and 
potent activation of caspase-8, -2, and -3 (Mogi and Togari, 2003).  In addition, it has 
been demonstrated that NSC differentiation depends on endogenous caspase-3 activity 
that may influence the kinase activity associated with changes in phenotype (Fernando et 
al., 2005).  The time of engagement and activity level of these pathways is thought to 
ultimately determine the choice between cell death or maturation (Fernando and 
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Megeney, 2007).  Nevertheless, the precise role of caspase-3 in NSC differentiation is 
still largely unknown. 
Curiously, widespread neurogenesis and gliogenesis occur in the adult mammalian 
nervous system in response to certain stress conditions, including hypoxia (Magavi et al., 
2000).  The tumor suppressor p53 is known to regulate key cellular functions involved in 
differentiation.  p53 is activated by cellular stress, hyperproliferative signals, and 
developmental stimuli.  One well characterized outcome of p53 activation is irreversible 
cell cycle exit required for either apoptosis, senescence, or differentiation (Stiewe, 2007).  
In fact, p53 was shown to contribute to differentiation of mouse embryonic stem cells by 
suppressing expression of Nanog, which is known to maintain self-renewal and the 
undifferentiated state of stem cells (Lin et al., 2005).  In addition, reduced p53 expression 
in human embryonic stem cells has been shown to decrease spontaneous differentiation 
and slow differentiation (Qin et al., 2007).  Other studies have shown that p53 is required 
for differentiation of PC12 cells (Zhang et al., 2006), myoblasts (Porrello et al., 2000), 
and epithelial cells (Saifudeen et al., 2002). 
Interestingly, p53 may contribute to differentiation by limiting self-renewal and the 
undifferentiated state of cells through inactivation of the Akt-mediated phosphoinositide 
3-kinase (PI3K) survival pathway.  In fact, p53 may inhibit the Akt proliferation pathway 
by modulating important downstream targets, such as the lipid phosphatase and tensin 
homolog deleted from chromosome 10 (PTEN) (Stambolic et al., 2001).  Moreover, 
differentiation of PC12 cells has been associated with enhanced expression of 
proapoptotic molecules and reduced activation of Akt survival signaling (Mielke and 
Herdegen, 2002).  Finally, Akt represses cellular differentiation by up-regulating the 
inhibitor of differentiation 1 (Id1), through phosphorylation of its repressor FOXO3A.  
Akt regulates the sub-cellular localization of FOXO3A by phosphorylation, thereby 
preventing its nuclear translocation and inhibition of Id1 (Birkenkamp et al., 2007). 
Having provided a rationale for similarities between apoptosis and differentiation 
cell machineries, the next challenge will be to further define and manipulate an operative 
pathway common to each process.  Half of all neurons produced during neurogenesis die 
through apoptosis before maturation of the nervous system.  This could be explained, at 
least in part, by the high rate of cell death that occurs during the G1/S cell cycle 
checkpoint (Liu and Greene, 2001).  In this regard, it is crucial to understand which 
apoptosis mechanism(s) overlaps with neuronal differentiation pathways that reduce cell 
death and improve lineage specification for potential neuro-replacement therapies. 
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Here, we further investigate the role of caspases and p53 during mouse NSC 
differentiation, and elucidate the cross-talk between apoptosis-associated elements and 
the Akt survival pathway.  Our data strongly indicate that caspases and p53 act in a 
synergistic manner in suppressing p-FOXO3A/Id1 signaling and, thereby inducing 
neurogenesis of NSCs. 
 
2.3 Methods 
2.3.1 Mouse NSC Culture and Differentiation 
Mouse NSCs containing a constitutively expressed marker for green fluorescence 
protein (GFP) were used to investigate the process of neuronal differentiation.  Cells were 
obtained from E14 mouse embryo central nervous system and cultured as described by 
Rietze et al (Rietze and Reynolds, 2006) and Reynold and Weiss (Reynolds and Weiss, 
1992).  Mouse NSCs were maintained as neurospheres in undifferentiation medium, 
serum-free, 1:1 mix of DMEM/F12 (Invitrogen Corp., Grand Island, NY) with 1× N-2 
supplement (Invitrogen Corp.), 20 ng/ml EGF, 20 ng/ml b-FGF (R & D Systems Inc., 
Minneapolis, MN), and 1% penicillin-streptomycin (Invitrogen Corp.), at 37ºC in 
humidified atmosphere of 5% CO2.  Subculture occurred at day 7 with mechanical 
dissociation of neurospheres.  Cellular plating was performed at 5 × 104 cell/ml density 
on T75 flasks and half of the culture medium was changed after 3 days.  The 
differentiation of mouse NSCs in vitro was induced by culturing dissociated cells in 
differentiation medium containing DMEM/F12 with 1× N-2 supplement, 100 ng/ml b-
FGF, 10% FBS (Invitrogen Corp.), 500 nM all-trans retinoic acid (Sigma Chemical Co., 
St. Louis, MO), 50 µM taurine (Sigma Chemical Co.), 10 ng/ml TGF-β2 (R & D Systems 
Inc.) and 1% penicillin-streptomycin in tissue culture plates pre-coated with poly-D-
lysine (Sigma Chemical Co.).  The culture medium was changed every 3 days.  
Differentiated cells at 5 × 104 cells/ml were fixed at days 3, 6, 8, 10, 12, 14 and 17 and 
processed for immunostaining and evaluation of differentiation.  Neurons and astrocytes 
were obtained at 3 and 8 days, respectively, in differentiation medium.  For western blot 
analysis, cultures at 5 × 105 cells/ml were processed at days 1, 3, and 8 to assess the role 
of apoptosis during both neuron and astrocyte differentiation.  All experiments were 
performed using adherent cells only to exclude detached apoptotic cells.  
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2.3.2 Immunocytochemistry 
Mouse NSCs were fixed with 4% paraformaldehyde in phosphate-buffered saline 
(PBS) for 30 minutes during differentiation.  Cells were then blocked for 1 hour at room 
temperature in PBS containing 0.1% Triton-X-100, 1% FBS, and 10% normal donkey 
serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).  Subsequently, 
cells were incubated with either monoclonal antibodies to glial fibrillary acidic protein 
(GFAP) (1:1000), neuronal nuclei (NeuN) (1:100) and oligodendrocyte marker O4 
(1:100) (Chemicon Int., Temecula, CA) or the polyclonal antibody to β-III tubulin at a 
dilution of 1:1000 (Covance, Princeton, NJ) and to active caspase-3 (1:50) (R&D 
Systems, Inc.) in blocking solution, overnight at 4ºC.  After three washes with PBS, cells 
were incubated with the AMCA-anti-mouse (Invitrogen Corp.) or the Alexa Fluor 594-
anti-rabbit conjugated secondary antibodies (Invitrogen Corp.) for 2 hour at room 
temperature.  The localization of GFAP, NeuN, O4, β-III tubulin, and caspase-3 were 
visualized using an Axioskop fluorescence microscope (Carl Zeiss, Jena, Germany).  
Total GFP-positive cells were counted on a computer screen grid from at least four 
random fields (x400).  Results were expressed as the average percentage of GFP-positive 
cells, which co-labeled for β-III tubulin or GFAP. 
 
2.3.3 Evaluation of Apoptosis 
Hoechst labeling and the TUNEL staining of mouse NSCs were used to detect 
apoptotic nuclei.  In brief, for morphologic evaluation of apoptosis, the medium was 
gently removed at the indicated times with minimal detachment of the cells.  Attached 
cells were fixed with 4% paraformaldehyde in PBS, pH 7.4, for 10 minutes at room 
temperature, incubated with Hoechst dye 33258 (Sigma Chemical Co.) at 5 µg/ml in PBS 
for 5 minutes, washed with PBS and mounted using PBS:glycerol (3:1, v/v).  Fluorescent 
nuclei were scored blindly and categorized according to the condensation and staining 
characteristics of chromatin.  Normal nuclei showed non-condensed chromatin dispersed 
over the entire nucleus.  Apoptotic nuclei were identified by condensed chromatin, 
contiguous to the nuclear membrane, as well as nuclear fragmentation of condensed 
chromatin.  Three random microscopic fields per sample were counted and mean values 
expressed as the percentage of apoptotic nuclei.  For TUNEL staining, apoptotic cells 
were quantitated using the deoxynucleotidyltransferase-mediated dUTP nick end labeling 
(TUNEL) assay.  Cells were fixed with 4% formaldehyde and processed using an 
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Apoptag in situ apoptosis detection kit (Chemicon Int., Temecula, CA).  The number of 
TUNEL-positive cells was counted on a computer screen grid from at least three random 
fields (400x). 
 
2.3.4 Total, Cytosolic, and Nuclear Protein Extraction 
For total protein extracts, adherent mouse NSCs were lysed in ice-cold buffer (10 
mM Tris-HCl, pH 7.6, 5 mM MgCl2, 1.5 mM KAc, 1% Nonidet P-40, 2 mM DTT, and 
protease inhibitor cocktail tablets (Complete; Roche Applied Science, Mannheim, 
Germany)) for 30 minutes, and then homogenized with 20 strokes in a loose fitting 
Dounce.  The lysate was centrifuged at 3200g for 10 minutes at 4ºC and the supernatant 
recovered.  For nuclear and cytosolic extracts, cells were lysed with hypotonic buffer (10 
mM Tris-HCl, pH 7.6, 5 mM MgCl2, 1.5 mM KAc, 2 mM DTT, and protease inhibitors), 
homogenized with 20 strokes in a loose fitting Dounce, and centrifuged at 500g for 10 
minutes at 4ºC.  The cytosolic proteins were recovered in the supernatant while the 
nuclear pellet was washed in buffer containing 10 mM Tris-HCl, pH 7.6, 5 mM MgCl2, 
0.25 M sucrose, 0.5% Triton X-100, and protease inhibitors, then resuspended and 
sonicated in buffer containing 10 mM Tris-HCl, pH 7.6, 0.25 M sucrose with protease 
inhibitors.  Finally, the suspension was centrifuged through 0.88 M sucrose at 2000g for 
20 minutes at 4ºC, and nuclear proteins were recovered in the supernatant. 
 
2.3.5  Immunoblotting 
Steady-state levels of p53, p-p53 (Ser15), p-Akt (Ser473), Akt1/2, p-FOXO3A 
(Thr32), FOXO3A, and Id1 as well as caspase-3 processing were determined by Western 
blot, using primary rabbit polyclonal antibodies reactive to p-p53 (Ser15) (Calbiochem, 
Darmstadt, Germany), p-Akt (Ser473), total Akt, Id1 and caspase-3 (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), FOXO3A and p-FOXO3A (Thr32) (Chemicon 
Int.) or primary mouse monoclonal antibody to p53 (Santa Cruz Biotechnology); as well 
as secondary antibodies conjugated with horseradish peroxidase (Bio-Rad Laboratories, 
Hercules, CA, USA).  Membranes were processed for protein detection using Super 
SignalTM substrate (Pierce, Rockford, IL, USA).  β-actin was used to control for lane 
loading while acetyl-histone H3 was used as a marker for nuclear protein extraction.  
Protein concentrations were determined using the Bio-Rad protein assay kit according to 
the manufacture’s specifications. 
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2.3.6 p53-DNA Binding ELISA Assay 
The Universal EZ-TFA p53 Transcription Factor Assay Chemiluminescent Kit 
(Upstate-Millipore, Billerica, MA) was used according to the manufacturer’s protocol.  
Nuclear extracts of mouse NSC cells were applied to plates containing biotinylated 
oligonucleotides with a p53 consensus binding site (5`-
GGACATGCCCGGGCATGTCC-3`).  After 1 hour incubation at room temperature, 
plates were washed and incubated with diluted p53 antibody (1:1000) for an additional 1 
hour.  Diluted anti-rabbit horseradish peroxidase-conjugated antibody (1:500) was then 
added to previously washed plates.  The chemiluminescence substract solution was added 
and incubated for 5-8 minutes to allow luminescence development.  The reaction was 
stopped and samples read at 1-second integration time in a microplate luminometer.  A 
p53 specific competitor oligonucleotide having the same consensus sequence as the p53 
capture probe, but not biotinylated was used as negative control. 
 
2.3.7  Inhibition of Caspase Activity 
Mouse NSC were exposed to 50 µM of the pan-caspase inhibitor z-VAD.fmk 
(Calbiochem, La Jolla, CA) 23 h after platting in differentiation medium, and then 
collected after 1, 3, and 8 days.  The culture medium supplemented with z-VAD.fmk was 
changed after 3 days in culture.  Total proteins were extracted for immunobloting.  
Attached cells were fixed for Hoechst staining and immunocytochemistry analysis. 
 
2.3.8 Short Interference RNA and Transfection 
A pool of 4 short interference RNA (siRNA) nucleotides designed to knockdown 
p53 gene expression in mouse was purchased from Dharmacon (Waltham, MA).  A 
control siRNA containing a scrambled sequence that does not result in degradation of any 
known cellular mRNA was used as control.  Twenty-four hours after platting, the culture 
differentiation medium was changed to medium without 1% penicillin-streptomycin.  
Mouse NSCs were transfected using Lipofectamine™ Transfection Reagent for siRNA 
(Polyplus Transfections, Illkirch, France), according to the manufacturer’s instructions for 
an additional 24 h.  The final concentration of siRNAs was 100 nM.  To assess gene 
silencing, transcript and protein levels of p53 were determined by RT-PCR and Western 
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blot, respectively.  Our results indicated that the silencing efficiency of the siRNAs for 
p53 was ~ 90% in mouse NSC.  To investigate the effect of p53 siRNA throughout the 
differentiation process, attached cells treated or non-treated with z-VAD.fmk were either 
harvested for immunoblot or used for immunocytochemistry assays after 3 and 8 days of 
differentiation.  Attached cells were also fixed for Hoechst staining. 
 
2.3.9 RNA Isolation and RT-PCR  
Transcript expression of p53 was determined by RT-PCR.  Total RNA was 
extracted from mouse NSCs using the TRIZOL reagent (Invitrogen Corp.).  For RT-PCR, 
5 µg of total RNA was reverse-transcribed using oligo(dT) (Integrated DNA 
Technologies Inc., Coralville, IA) and SuperScript II reverse transcriptase (Invitrogen 
Corp.).  Specific oligonucleotide primer pairs were incubated with cDNA template for 
PCR amplification using the Expand High FidelityPLUS PCR System from Roche Applied 
Science.  The following sequences were used as primers: p53 sense 
5’-GTGAAGCCCTCCGAGTGTCAGGAGC-3’; p53 antisense 5’-GGTGGGCAG 
CGCTCTCTTTGCGC-3’; β-actin sense 5’-GTGGGCCGCTCTAGGCACCAA-3’; and 
β-actin antisense 5’-CTCTTTGATGTCACGCACGATTTC-3’.  The product of the 
β-actin RNA was used as control. 
 
2.3.10 Densitometry and Statistical Analysis 
The relative intensities of protein and nucleic acid bands were analyzed using the 
Quantity One Version 4.6 densitometric analysis program (Bio-Rad Laboratories).  
Results from different groups were compared using the Student’s t test, or one-way 
ANOVA.  Kruskal-Wallis or the Mann-Whitney U tests were also used whenever the 
assumptions of the parametric test were not satisfied.  Values of p < 0.05 were considered 
statistically significant.  All statistical analysis was performed with GraphPad InStat 
software (GraphPad Software, Inc, San Diego, CA). 
 
2.4 Results 
2.4.1 The Akt/p-FOXO3A/Id1 Pathway is Down-Regulated during Differentiation 
To investigate the potential cross-talk between survival and differentiation 
pathways during mouse NSC differentiation, we first determined the time of neurogenesis 
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and gliogenesis by immunocytochemistry of differentiated mouse NSC.  Neurogenesis 
was detected at ~ 3 days, when ~ 5% of cells were β-III tubulin-positive, but no astrocytic 
GFAP staining was detected (Fig. 2.1).  Gliogenesis, in turn, was detected at 8 days of 
differentiation, when ~ 16% of cells were GFAP positive .  At 8 days, the number of β-III 
tubulin-positive cells was increased; however, the absence of NeuN staining indicates that 
neurons were not yet fully differentiated (data not shown).  In these conditions, we did 
not find any evidence for the presence of immature oligodendrocytes, as visualized by the 
absence of O4 staining (Fig. 2.1).  
 
Figure 2.1. Time course of neurogenesis and gliogenesis.  Differentiated mouse NSCs were 
fixed at different time points and processed for immunostaining analysis.  Neurons and astrocytes 
were identified with a fluorescent-labeled antibody raised against β-III tubulin and glial fibrillary 
acidic protein (GFAP), respectively.  In these conditions, we found no evidence for the presence 
of oligodendrocytes (O4).  Representative immunostaining images from at least 3 independent 
experiments. 
 
Activation of the Akt survival pathway may result in FOXO3A phosphorylation 
(Brunet et al., 1999).  p-FOXO3A is retained in the cytosol, and does not repress Id1 
(Birkenkamp et al., 2007).  Thus, we next evaluated the involvement of Akt/p-
FOXO3A/Id1 signaling during differentiation of mouse NSCs.  Interestingly, our results 
showed a marked reduction in total levels of p-Akt (Ser473) and p-FOXO3A (Thr32) 
both at 3 and 8 days of differentiation (p < 0.05) (Fig. 2.2A).  Id1 was also strongly 
down-regulated throughout differentiation (p < 0.01). 
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Figure 2.2. The Akt/p-FOXO3A/Id1 signaling pathway is downregulated during mouse NSC 
differentiation.  NSCs were induced to differentiate for 1, 3 and 8 days.  Total, nuclear, and 
cytosolic proteins were extracted for immunoblot analysis.  A) Representative immunoblots of p-
Akt (Ser473), Akt1/2, p-FOXO3A (Thr32), FOXO3A, and Id1 protein expression.  B) 
Representative immunoblots (top) and corresponding histograms (bottom) of cytosolic levels of p-
FOXO3A and nuclear levels of FOXO3A in mouse NSCs through differentiation.  The results are 
expressed as mean ± SEM arbitrary units of at least 6 independent experiments.  *p < 0.05 and †p 
< 0.01 from 1 day of differentiation.  β-actin was used as loading control.  Cytosolic and nuclear 
fractions were also immunobloted for acetyl-histone H3. 
 
The regulation of FOXO3A was further characterized by evaluating cytosolic p-
FOXO3A (Thr32) and nuclear FOXO3A (Fig. 2.2B).  Curiously, the inactive form of 
FOXO3A, p-FOXO3A (Thr32), decreased by ~ 60% in the cytosol at 3 days, and was 
almost undetectable at 8 days of differentiation (p < 0.01).  In contrast, nuclear levels of 
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active, non-phosphorylated FOXO3A, increased by ~ 2- and 3-fold at 3 and 8 days, 
respectively.  Thus, modulation of the Akt/p-FOXO3A/Id1 survival pathway during 
differentiation of mouse NSCs appears to be an important regulatory event.  Specifically, 
downregulation of Id1, possibly through FOXO3A, appears to be required for the 
induction of mouse NSC differentiation.  
 
2.4.2 Apoptosis Factors are Increased during Differentiation 
Components of the cell death machinery have been implicated in the differentiation 
program (Fernando and Megeney, 2007; Lin et al., 2005).  We next evaluated activation 
of caspase-3 and total levels of p53 during mouse NSC differentiation using only 
adherent cells to exclude dead detached cells.  Interestingly, the results demonstrated that 
caspase-3 processing increased 3- and 2-fold at 3 and 8 days of differentiation, 
respectively (p < 0.05) (Fig. 2.3A).  This was confirmed through detection of active 
caspase-3 by immunocytochemistry (Fig. 2.3B).  Caspase-3 activity increased 20% from 
day 3 to day 8 of differentiation (data not shown).  Total levels of p53 were not 
significantly modulated during differentiation (Fig. 2.3A).  Nevertheless, phosphorylation 
of p53 at serine 15, which regulates p53 stability and activity (Xu, 2003) and is typically 
required for transactivation was up-regulated in early stages of differentiation.  In fact, p-
p53 (Ser15) increased by > 2-fold at 3 days, returning to control levels at 8 days of 
differentiation.  In addition, p53 DNA binding activity was increased by ~ 3- and 2-fold 
at 3 and 8 days of differentiation (p < 0.05) (Fig. 2.3C), respectively, further indicating 
that regulation of p53 transcriptional activity is an important event for differentiation of 
mouse NSCs.  Finally, both nuclear morphology analysis and TUNEL assays showed 
only ~ 2% of apoptotic cells during differentiation (Fig. 2.3D).  This indicates that 
changes in pro-apoptotic molecules were not associated with increased cell death. 
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Figure 2.3. p53 activity and caspase-3 cleavage are modulated during mouse NSC 
differentiation.  NSCs were induced to differentiate for 1, 3 and 8 days.  Cells were fixed and 
processed for morphological evaluation of apoptosis. Total proteins were extracted for 
immunoblot analysis, while nuclear extracts were used for p53-DNA binding assays.  A) 
Representative immunoblots of caspase-3 processing, and total p53 and phosphorylated p53 
(Ser15) expression.  β-actin was used as loading control.  B) Detection of active caspase-3.  
Representative immunostaining images from at least 3 independent experiments.  C) p53-DNA 
binding activity.  Nuclear protein extracts were prepared as described in “Material and Methods”.  
The level of p53 present in nuclear lysates that can bind to its DNA consensus recognition 
sequence was determined by the Universal EZ-TFA p53 assay and expressed as fold change 
relative to day 1 of differentiation.  *p < 0.05 from day 1.  D) Evaluation of apoptosis by Hoechst 
staining and TUNEL assay.  Representative images from at least 3 independent experiments.  
GFP, green fluorescent protein. 
 
2.4.3 Caspases Inhibit p-FOXO3A/Id1 Signaling during Differentiation 
We next characterized possible interactions between apoptosis executioners and 
regulation of the Akt/p-FOXO3A/Id1 pathway during differentiation of mouse NSCs.  
For this purpose, we suppressed caspase activity with a pan-caspase inhibitor, z-
VAD.fmk, and re-evaluated changes in Akt/p-FOXO3A/Id1 expression, p53 
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phosphorylation (Ser 15), and p53-DNA binding activity.  As expected, cells treated with 
z-VAD.fmk showed reduced caspase-3 activation at both 3 and 8 days of differentiation 
(Fig. 2.4A).  Notably, caspase suppression markedly decreased p-p53 (Ser15) expression 
(Fig. 2.4A) and p53 transcriptional activation (Fig 2.4B) (p < 0.05).  More importantly, in 
the absence of caspase activity, the p-FOXO3A/Id1 pathway was not down-regulated 
during differentiation.  Indeed, p-FOXO3A (Thr32) increased ~ 2-fold at 3 (p < 0.01) and 
8 (p < 0.05) days.  Id1, in turn, increased 40% at 3 days (p < 0.05) and remained 
unchanged at 8 days of differentiation.  p-Akt (Ser473) was maintained throughout 
differentiation (data not shown).  Finally, the absence of significant nuclear fragmentation 
and TUNEL-positive cells after caspase inhibition (Fig. 2.4C) suggests that z-VAD.fmk-
induced changes were not associated with increased cell death.  Thus, our results indicate 
that caspases are required, at least in part, to down-regulate p-FOXO3A and Id1, 
facilitating differentiation of mouse NSCs. 
 
 
Figure 2.4. Pan-caspase inhibition modulates p53 activity and interferes with the Akt/p-
FOXO3A/Id1 pathway during mouse NSC differentiation.  NSCs were incubated with a pan-
caspase inhibitor, z-VAD.fmk, and collected after 3 and 8 days in differentiation medium.  Cells 
were fixed and stained for morphological evaluation of apoptosis.  Total proteins were extracted 
for immunoblot analysis, while nuclear extracts were used for p53-DNA binding assays.  A) 
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Caspase-3 processing, and p-p53 (Ser15), p-FOXO3A (Thr32) and Id1 total levels in control and 
z-VAD.fmk-treated cells.  β-actin was used as loading control.  Representative immunoblots are 
shown from at least three independent experiments.  B)  The level of p53 present in nuclear 
lysates that can bind to its DNA consensus recognition sequence was determined by the Universal 
EZ-TFA p53 assay and expressed as fold-change relative to controls. C) Evaluation of apoptosis 
by Hoechst staining and TUNEL assay in z-VAD.fmk-treated cells at 3 and 8 days of 
differentiation.  Representative images are shown from at least 3 independent experiments. 
 
2.4.4 Caspase Inhibition Delays Differentiation 
To further clarify the role of caspases in regulating the differentiation process, we 
tested the influence of caspase inhibition on the ability of NSCs to differentiate by 
immunocytochemical analysis (Fig. 2.5).  Caspase suppression by z-VAD.fmk 
significantly inhibited differentiation (p < 0.05).  In fact, β-III tubulin-positive cells were 
reduced by ~ 40% at 3 days, and GFAP-positive cells by ~ 60% at 8 days.  Interestingly, 
the effect of caspase inhibition was not detectable at 8 and 17 days of neurogenesis and 
gliogenesis, respectively.  This suggests that caspase suppression delays differentiation of 
mouse NSCs, although cells may have additional mechanisms of differentiation.  
Nevertheless, caspases appear to be integral components of both neurogenesis and 
gliogenesis of mouse NSCs. 
 
 
Figure 2.5. Inhibition of caspase activation delays neuronal and glial differentiation of 
mouse NSCs.  NSCs were incubated with a pan-caspase inhibitor, z-VAD.fmk, and collected 
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after 3, 8, and 17 days in differentiation medium.  Differentiated cells were fixed at indicated 
times and processed for immunostaining assays.  Neurons and astrocytes were identified with a 
fluorescent-labeled antibody raised against β-III tubulin and glial fibrillary acidic protein (GFAP), 
respectively.  A) Representative immunocytochemistry images from at least 3 independent 
experiments.  B) Corresponding histograms of β-III tubulin and GFAP positive cells throughout 
differentiation.  The results are expressed as mean ± SEM arbitrary units of at least 3 independent 
experiments.  *p < 0.05 from controls. 
 
2.4.5 p53 Represses p-FOXO3A/Id1 Signaling in Early Stages of Differentiation 
We next investigated whether caspases require p53 to regulate differentiation of 
NSCs.  First, we determined the effect of siRNA-mediated silencing of p53 on p-
FOXO3A and Id1.  p53 mRNA and protein expression decreased by ~ 90 and 70%, 
respectively, in mouse NSCs after transfection with siRNAs for p53 (p < 0.01) (Fig. 
2.6A).  More importantly, siRNA-mediated silencing of p53 reversed the down-regulation 
of p-FOXO3A (Thr32) and Id1 at 3 days of differentiation, but not at 8 days (Fig. 2.6B).  
In fact, at 3 days of differentiation, p-FOXO3A (Thr32) and Id1 increased by ~ 50 (p < 
0.01) and 30% (p < 0.05) after p53 suppression, respectively.  Inhibition of p53 resulted 
in increased caspase-3 cleavage (data not shown), suggesting that caspases may act 
upstream of p53 to decrease p-FOXO3A and Id1 during early stages of differentiation.  In 
contrast, the absence of p53 does not influence p-FOXO3A/Id1 signaling at 8 days of 
differentiation.  We then treated p53 siRNA-transfected cells with z-VAD.fmk and 
evaluated changes at 3 days of differentiation.  Notably, the suppression of both caspases 
and p53 induced a ~ 4-fold increase in p-FOXO3A compared with 2-fold in cells only 
transfected with p53 siRNA (p < 0.05).  Id1, in turn, was ~ 4-fold greater after z-
VAD.fmk incubation in p53 siRNA-transfected cells compared with control siRNA-
transfected cells (p < 0.05).  Thus, at 3 days of differentiation, caspase inhibition further 
enhanced p53 silencing effects, indicating that caspases do not act simply in a p53-
dependent manner.  Rather, caspases might work with p53 in regulating p-FOXO3A and 
Id1. 
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Figure 2.6. Silencing of p53 decreases p-FOXO3A and Id1 expression levels during mouse 
NSC differentiation, without potentiating z-VAD.fmk effects.  NSCs were incubated with 
either control or p53 siRNA and collected after 3 and 8 days in differentiation medium.  Cells 
were fixed and stained to assess apoptosis.  Total proteins were extracted for immunoblot 
analysis.  A) Representative RT-PCR (left) and Western blot (right) of p53 and β-actin in cells 
transfected with either control or p53 siRNA.  B) Representative immunoblots of p-FOXO3A 
(Thr32) and Id1 in cells transfected with either control siRNA, p53 siRNA, or p53 siRNA plus z-
VAD.fmk.  β-actin was used as loading control.  C) Evaluation of apoptosis by Hoechst staining 
and TUNEL assay in p53 siRNA transfected cells at 3 days (top) and 8 days (bottom) of 
differentiation in the presence or absence of z-VAD.fmk.  Representative images from at least 3 
independent experiments are shown  
 
Finally, morphology and TUNEL assays revealed that p53 siRNA-mediated effects 
were not associated with increased cell death throughout differentiation of mouse NSCs 
(Fig. 2.6C top and bottom).  Therefore, our results demonstrated that p53 might be 
required for early differentiation, and that p53 effects in repressing p-FOXO3A and Id1 is 
further enhanced by caspase activation. 
 
2.4.6 Caspases and p53 Act in a Synergistic Manner to Modulate Neurogenesis 
To confirm the role of p53 in regulating the differentiation process, we tested the 
influence of p53 knockdown on the ability of NSCs to differentiate into neurons and 
astrocytes through immunocytochemical analysis of cells transfected with either control 
or p53 siRNA.  Our results showed that p53 suppression significantly reduced the number 
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of positive cells for β-III tubulin compared with control siRNA-transfected cells (Fig. 
2.7A).  In addition, inhibition of neurogenesis by p53 siRNA increased after caspase 
suppression at 3 days, again implying that caspases and p53 might act in a synergistic 
manner.  In contrast, siRNA-mediated silencing of p53 did not change the number of 
positive cells for GFAP (Fig. 2.7B), suggesting that p53 is not crucial for astrocyte 
maturation.  Curiously, the silencing effect of p53, in the presence or absence of caspase 
inhibition, was not present at 8 days of neurogenesis.  This indicates that downregulation 
of p53 only delays neurogenesis in mouse NSCs.  Nevertheless, caspases and p53 are 
crucial elements of differentiation in mouse NSCs, acting in a synergistic manner for 
regulating neurogenesis.  In contrast, the mechanism that regulates gliogenesis in mouse 
NSCs appears to involve caspases, which in turn bypass p53 to promote glial cell 
differentiation. 
 
 
Figure 2.7. Downregulation of p53 delays neuronal and glial differentiation of mouse NSCs.  
NSCs transfected with control siRNA, p53 siRNA, or p53 siRNA plus z-VAD.fmk, and collected 
after 3, 8, and 17 days in differentiation medium.  Cells were fixed at indicated times and 
processed for immunostaining assays.  Neurons and astrocytes were identified with a 
fluorescent-labeled antibody raised against β-III tubulin and glial fibrillary acidic protein (GFAP), 
respectively.  A) Representative immunocytochemistry from at least 3 independent experiments.  
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B) Corresponding histograms of β-III tubulin and GFAP positive cells throughout the 
differentiation period.  The results are expressed as mean ± SEM arbitrary units of at least 3 
independent experiments.  *p < 0.05 from controls. 
 
2.5 Discussion 
Neural stem cell differentiation and commitment to either neuronal or glial lineage 
have important implications in developmental, pathological, and regenerative processes.  
It is, therefore, crucial to thoroughly understand the molecular mechanisms involved in 
NSC processing.  It has been previously reported that cell death and differentiation 
processes may use similar molecular pathways (Fernando and Megeney, 2007).  Our 
results provide an extended mechanism of action for the apoptosis executioners 
throughout the differentiation process.  Specifically, they show that caspases are integral 
components of differentiation of mouse NSCs that together with p53 can induce 
neurogenesis or gliogenesis.  Moreover, these specific apoptotic factors interfere with 
elements of the Akt/p-FOXO3A/Id1 intracellular signaling pathway to promote 
differentiation of NSCs. 
It has been demonstrated that Akt/p-FOXO3A/Id1 signaling is an important 
regulator of cell differentiation.  In fact, the phosphorylation of the forkhead transcription 
factor FOXO3A was shown to play a pivotal role in maintaining the hematopoietic stem 
cell pool (Miyamoto et al., 2007); and the down-regulation of active FOXO3A accelerates 
cellular senescence in human dermal fibroblasts (Kyoung Kim et al., 2005).  In addition, 
it was recently demonstrated that active FOXO3A is a negative target of Notch signalling 
(Mandinova et al., 2008), thus supporting its role of maintaining cells in an 
undifferentiated state.  Our results indicate that this downstream target of Akt is indeed 
altered during differentiation of mouse NSCs.  In fact, Akt phosphorylation was 
decreased throughout differentiation and this was associated with reduced levels of 
cytosolic p-FOXO3A.  Akt expression was also attenuated in the early stages of 
differentiation in human endothelial progenitor cells and gradually upregulated during 
cell maturation (Mogi et al., 2008).  Subsequently, we showed that a reduction in Akt-
induced FOXO3A phosphorylation lead to increased activity of FOXO3A, and 
subsequently decreased Id1 in the nucleus.  The link between FOXO3A and Id1 in 
triggering differentiation has already been established in other cell types (Birkenkamp et 
al., 2007).  The decrease in Id1 expression in mouse NSCs may, in turn, allow basic helix 
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loop helix (bHLH) transcription factors to induce expression of differentiation-associated 
genes (Norton, 2000). 
Importantly, the present study reveals that apoptosis executioners interfere with 
FOXO3A/Id1 signalling to promote both neurogenesis and gliogenesis in mouse NSCs.  
Several studies have already elucidated the importance of programmed cell death in 
establishing cell lineage for model systems of neural differentiation.  However, a precise 
role for apoptosis-associated elements in the generation of both neurons and astrocytes is 
still largely unknown.  Curiously, it was recently reported that members of the Bcl-2 
family such as Bcl-XL and Bax play an instructive role in determining the fate of 
embryonic cortical precussor cells (Chang et al., 2007a).  Bcl-XL and Bax mediate 
differentiation of neurons and astrocytes, respectively, independently from their roles in 
cell survival and apoptosis. 
Herein, we investigated whether caspases and p53 were upregulated during mouse 
NSC differentiation.  Our data indicated that cleavage of caspase-3 was significantly 
increased at both 3 and 8 days of differentiation.  In fact, the non-proteolytic functions of 
caspases in the regulation of cell survival, differentiation, and inflammation had already 
suggested that caspases may become activated without inducing an apoptotic cascade 
(Lamkanfi et al., 2007).  For example, in erythroblasts, keratinocytes, and lens epithelial 
cells undergoing differentiation, enucleation has been regarded as a caspase-mediated 
incomplete apoptotic process.  In addition, others have previously shown that caspase 
activation specifically contributes to the differentiation of monocytes into macrophages, 
in the absence of cell death (Sordet et al., 2002).  Differentiation-associated caspase 
activation involved the release of cytochome c from the mitochondria and led to cleavage 
of the protein acinus, while poly(ADP-ribose)polymerase remained uncleaved.  In our 
study, the role of caspases during differentiation of mouse NSCs was further 
characterized.  We evaluated the potential cross-talk of caspases with the proliferation 
pathway Akt/p-FOXO3A/Id1 in mouse NSCs.  Our results revealed that both p-FOXO3A 
(Thr 32) and Id1 increased after caspase inhibition, which in turn resulted in delayed 
neuronal and astrocyte formation at 3 and 8 days of differentiation, respectively.  In 
addition, although total levels of p53 were unchanged, its DNA-binding activity 
significantly increased throughout differentiation, suggesting that p53 might be also 
important for both neuronal and astrocyte formation. 
The role of p53 on NSC differentiation was further investigated by using siRNA-
mediated p53 silencing.  In fact, the results showed that p53 is pivotal for inducing 
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neurogenesis, and its function is not associated with cell death.  Although, we did not 
observe an increase of p-p53 (Ser15) at 8 days of differentiation, this does not exclude the 
involvement of p53, since this transcription factor may be activated by phosphorylation in 
many other residues.  Nevertheless, p53 silencing did not compromise both p-FOXO3A 
and Id1 at 8 days of differentiation, and even astrocyte generation.  The absence of p53 
silencing effect at 8 days of differentiation could be explained by several potential 
mechanisms.  First, silencing of p53 at day 1 of differentiation may not be sufficient to 
inhibit p53 expression throughout the course of differentiation.  Indeed, mouse NSCs may 
re-establish normal levels of p53 mRNA at 8 days of differentiation.  Nevertheless, this 
hypothesis was excluded when we further transfected cells with p53 siRNA at 4 days of 
differentiation, and both p-FOXO3A and Id1 total levels remained unchanged (data not 
shown).  An alternate explanation is the potential substitution of p53 function by other 
family members at day 8 of differentiation (Stiewe, 2007).  In fact, it has been 
demonstrated that knockouts for p53, p63 or p73 show only slight delays on development.  
However, viability is compromised when double or triple knockouts for these genes are 
generated, indicating that other members of this family are able to substitute the lack of 
one transcription factor (Stiewe, 2007). 
Importantly, we have demonstrated that at 3 days of differentiation, caspases and 
p53 act in a synergistic manner to induce p-FOXO3A/Id1 repression.  In fact, caspase 
suppression not only decreased p53-DNA binding activity but it also further increased 
siRNA p53 effects during early differentiation of mouse NSCs.  Interestingly, in contrast 
with the apoptosis cascade, where p53 acts upstream of caspases, our data strongly 
suggest that caspases may act upstream of p53 during neurogenesis.  Indeed, caspase 
inhibition significantly reduced both p53-DNA binding activity and p-p53 (Ser15) 
expression levels, and p53 silencing did not decrease caspase-3 cleavage (data not 
shown).  However, caspases might act in a p53-independent manner, since the inhibition 
of both caspases and p53 did not promote the same level of inhibition in neurogenesis, but 
rather a cumulative effect.  Therefore, caspases and p53 may act, at least in part, 
independently to induce neuronal differentiation of mouse NSC. 
Our results coupled with previous studies showing that overexpression of Bcl-2, a 
negative target of p53, significantly reduced the number of neurons (Esdar et al., 2001), 
support the pivotal role of p53 activation during neurogenesis.  Further, the critical 
involvement of p53 for the fate of neuronal cells was indeed demonstrated by others, 
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showing that p53 is required for neurite outgrowth in cultured cells including primary 
neurons as well as for axonal regeneration in mice (Di Giovanni et al., 2006). 
It remains to be investigated whether p53 downregulates Akt activity or whether 
Akt repression induces p53 activity during neurogenesis of NSC.  Interestingly, it has 
been demonstrated that Akt downregulation may induce p53 transcriptional activation 
through Sirt2.  In fact, 14-3-3 β/γ augment deacetylation and down-regulate p53 
transcriptional activity by Sirt2 in an Akt-dependent manner (Jin et al., 2008).  However, 
p53 may also repress the Akt pathway through PTEN (Stambolic et al., 2001). 
In addition, the transcription factor FOXO3A might be phosphorylated by either 
serum- and glucocorticoid-inducible kinase (SGK1) (You et al., 2004) or IκB kinase 
(IKK) (Hu et al., 2004).  In fact, SGK1 expression was markedly increased by p53 (You 
et al., 2004).  In this respect, p53 silencing would lead to decreased p-FOXO3A.  On the 
other hand, corroborating our results, the β subunit of IKK may be negatively regulated 
by p53 (Gu et al., 2004).  Indeed, p53 might have acted on differentiation via the IKK 
kinase, after levels of p-FOXO3A were markedly increased by p53 knockdown in mouse 
NSCs.  Importantly, it has been shown that Id1 may be downregulated in a p53-dependent 
manner (Qian and Chen, 2008).  
Finally, it will be important to investigate which cofactors and/or molecular 
pathways interfere with caspases and p53 to influence differentiation versus apoptosis in 
mouse NSCs.  One explanation for this commitment derives largely from caspase 
targeting and activation of substrates or cofactors that are unique to each event.  Most 
likely, levels of activation of apoptosis executioners are different between apoptosis and 
differentiation.  In addition, our results do not exclude the possibility that suphydryl-
dependent enzymes other than caspases might also be involved.  Thus, the precise role of 
caspases and the identification of specific pertinent caspases during differentiation should 
be further elucidated. 
This study provides an extended mechanism of action for apoptosis-associated 
elements, linking major components of cell death with the differentiation process of 
mouse NSCs.  Caspases modulate differentiation, further enhancing p53 effects at 3 days 
of differentiation.  Nevertheless, both caspases and p53 were shown to signal the p-
FOXO3A pathway and inhibit repression of differentiation by Id1.  Collectively, our 
results may contribute to the identification of novel targets for NSC differentiation 
procedures that may translate ultimately into improved neuro-replacement therapies. 
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3.1 Abstract 
MicroRNAs (miRs or miRNAs) regulate several biological processes in the cell.  
However, evidence for miRNAs that control the differentiation program of specific neural 
cell types has been elusive.  Recently, we have shown that apoptosis-associated factors, 
such as p53 and caspases participate in the differentiation process of mouse neural stem 
(NS) cells.  To identify apoptosis-associated miRNAs that might play a role in neuronal 
development, we performed global miRNA expression profiling experiments in NS cells.  
Next, we characterized the expression of proapoptotic miRNAs, including miR-16, let-7a 
and miR-34a in distinct models of neural differentiation, including mouse embryonic 
stem cells, PC12 and NT2N cells.  In addition, the expression of antiapoptotic miR-19a 
and 20a was also evaluated. 
The expression of miR-16, let-7a and miR-34a was consistently upregulated in 
neural differentiation models.  In contrast, expression of miR-19a and miR-20a was 
downregulated in mouse NS cell differentiation.  Importantly, differential expression of 
specific apoptosis-related miRNAs was not associated with increased cell death.  
Overexpression of miR-34a increased the proportion of postmitotic neurons of mouse NS 
cells. 
In conclusion, the identification of miR-16, let-7a and miR-34a, whose expression 
patterns are conserved in mouse, rat and human neural differentiation, implicates these 
specific miRNAs in mammalian neuronal development.  The results provide new insights 
into the regulation of neuronal differentiation by apoptosis-associated miRNAs. 
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3.2 Introduction 
Adult neural stem (NS) cells and embryonic stem (ES) cells are capable of 
differentiating into multiple cell types of the adult nervous system (Doetsch, 2003; 
Temple, 2001b).  This unique property promises future medical applications, ranging 
from regenerative medicine to drug screening.  However, the therapeutic use of NS cells 
and ES cells will require the identification of cellular conditions that promote the efficient 
commitment of these progenitors to particular cell phenotypes. 
Much progress has been made toward the elucidation of specific differentiation 
signaling pathways.  Surprisingly, recent evidence suggests a functional role for 
apoptosis-associated proteins such as p53 (Maimets et al., 2008; Porrello et al., 2000), 
caspases (Fernando et al., 2005) and Bcl-2 (Zhang et al., 1996) in differentiation and 
development.  In addition, the recent discovery of microRNAs (miRs or miRNAs) 
introduced a novel type of regulatory control of gene expression during developmental 
processes (Ambros, 2004; Bartel, 2004).  miRNAs are a class of endogenous noncoding, 
highly conserved RNAs of ~ 22 nucleotides in length (Du and Zamore, 2005).  They 
regulate mRNA expression either by translation repression or cleavage of targeted mRNA 
(Bartel, 2004).  In the past few years, our understanding of miRNAs has expanded, and a 
role for apoptosis-associated miRNAs in cell differentiation is emerging. 
Let-7a, a member of the let-7 family, is associated with apoptosis by directly 
targeting caspase-3 (Tsang and Kwok, 2008).  Let-7 was first identified in Caenorhabditis 
elegans and reported to control the timing of fate specification during larval development 
(Reinhart et al., 2000).  In addition, let-7a was also implicated in neuronal differentiation 
(Liu et al., 2009; Sempere et al., 2004).  However, the mechanism by which let-7a 
regulates cell differentiation is unknown. 
Members of the miR-34 family are direct p53 targets, and their upregulation 
induces apoptosis and cell cycle arrest (Bommer et al., 2007; Chang et al., 2007b; Corney 
et al., 2007; He et al., 2007a; Raver-Shapira et al., 2007; Tarasov et al., 2007).  In this 
regard, miR-34a has been shown to regulate genes involved in cell cycle control and 
apoptosis, including cyclin-dependent kinase 4 (CDK4), CDK6, cyclin D1, E2F3 and 
SIRT1 (He et al., 2007a; Sun et al., 2008; Welch et al., 2007).  A role for miR-34a in 
megakaryocytic differentiation was recently reported, where the miRNA regulates the 
expression of MYB, and CDK4 and CDK6, thus promoting cell cycle arrest (Navarro et 
al., 2009).  Furthermore, miR-34a is involved in dendritic cell differentiation (Hashimi et 
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al., 2009), and is required for proper differentiation of mouse ES cells by targeting Sirt1 
(Tarantino et al., 2010). 
miR-16 is implicated in induction of apoptosis by targeting Bcl-2 (Cimmino et al., 
2005), and is involved in cell cycle regulation by targeting CDK6, cell division cycle 
protein 27 (CDC27), the caspase recruitment domain-containing protein 10 (CARD10), 
cyclin D1 and cyclin E (Chen et al., 2008; Linsley et al., 2007; Liu et al., 2008).  
Nevertheless, an involvement of miR-16 in cell differentiation is virtually unknown. 
To gain further insight into the role of apoptosis-associated factors during cell 
differentiation, we monitored specific apoptosis-associated miRNAs during NS cell 
differentiation.  Our results showed that the differential expression of miR-16, let-7a and 
miR-34a during mouse NS cell differentiation was not associated with cell death.  In 
addition, upregulation of these miRNAs observed in distinct models of neural 
differentiation strongly suggests that apoptosis-associated miRNAs may play a role in 
differentiation. 
 
3.3 Methods 
3.3.1 Cell Lines 
Mouse NS Cells.  Mouse NS cells containing a constitutively expressed marker for 
green fluorescent protein (GFP) were used to investigate the process of neural 
differentiation.  Primary cells were obtained from central nervous system tissue of 
embryonic mice and cultured primarily as previously described (Reynolds and Weiss, 
1992, 1996; Rietze and Reynolds, 2006).  Mouse NS cells were maintained as 
neurospheres in undifferentiation medium, serum-free, 1:1 mix of DMEM/F12 
(Invitrogen Corp., Grand Island, NY) with 1× N-2 supplement (Invitrogen Corp.), 20 
ng/ml epidermal growth factor (EGF) (R & D Systems Inc., Minneapolis, MN), 20 ng/ml 
basic fibroblast growth factor (bFGF) (PeproTech EC, London, UK), and 1% penicillin-
streptomycin (Invitrogen Corp.), at 37ºC in humidified atmosphere of 5% CO2.  
Subculture occurred at day 7 with mechanical dissociation of neurospheres.  The 
differentiation of mouse NS cells in vitro was induced by culturing dissociated cells in 
differentiation medium containing DMEM/F12 with 1× N-2 supplement, 100 ng/ml 
bFGF, 10% fetal bovine serum (FBS) (Invitrogen Corp.), 500 nM all-trans retinoic acid 
(Sigma Chemical Co., St. Louis, MO), 50 µM taurine (Sigma Chemical Co.), 10 ng/ml 
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transforming growth factor-β2 (TGF-β2) (R & D Systems Inc.) and 1% penicillin-
streptomycin in tissue culture plates pre-coated with poly-D-lysine (Sigma Chemical 
Co.).  The culture medium was changed every 3 days.  Differentiated cells at 5 × 104 
cells/ml were fixed at different time points, and processed for immunostaining and 
evaluation of differentiation.  Cultures at 5 × 105 cells/ml were processed for western blot 
and PCR analysis. 
In parallel experiments, cell death was prevented by adding tauroursodeoxycholic 
acid (TUDCA; Sigma Chemical Co.) to the culture medium.  Briefly, cells with 3 days of 
differentiation were treated with 50 µM of TUDCA for 72 hours.  At 6 days, cells were 
collected and processed for evaluation of apoptosis and miRNA expression. 
miR-34a expression was modulated using 100 nM of precursor control and pre-
miR-34a (Applied Biosystems, Foster City, CA).  Mouse NS cells (2.5 × 105 cells/ml) 
were transfected at 3 or 5 days of differentiation using Lipofectamine 2000 (Invitrogen 
Corp) following manufacturer’s instructions. 
 
Mouse ES Cells.  The ES cell line 46C (Sox1-GFP) (Ying et al., 2003) was grown 
and maintained as previously reported (Abranches et al., 2009) and induced to 
differentiate  using a monolayer protocol.  Specifically, ES cells were plated in serum-
free medium ESGRO Complete Clonal Grade medium (Millipor Inc.) at high density.  
After 24 hours, ES cells were gently dissociated and plated onto 0.1% (v/v) gelatin-coated 
tissue culture plastic at 1 × 104 cells/cm2 in RHB-A media (StemCell Science Inc.).  For 
replating on day 4, cells were dissociated and plated at 2 × 104 cells/cm2 in laminin-
coated tissue culture plastic, using RHB-A medium supplemented with 5 ng/ml murine 
bFGF (PeproTech EC, London, UK).  Cells at days 4 and 8 of differentiation were 
collected to evaluate expression levels of differentiation markers and apoptosis-associated 
miRNAs.  A positive control for neural differentiation was also included at day 8 using 
LY411575, a γ-secretase inhibitor known to inhibit the Notch pathway and thus enhance 
neuronal differentiation.  Cells were supplemented with either 0.01% DMSO (control) or 
10 nM LY411575 (in 0.01% DMSO) for 12 hours.  LY411575-treated cells and 
respective controls were photographed under an inverted microscope Leica DMIL using a 
DC200 camera (Leica Wetzlar, Germany) 
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PC12 Cells.  Rat adrenal pheochromocytoma (PC12) cells were propagated in 
RPMI 1640 medium (Invitrogen Corp.) supplemented with 10% horse serum (Invitrogen 
Corp.), 5% FBS (Invitrogen Corp.) and appropriate antibiotics in an humidified incubator 
maintained at 37ºC with 5% CO2.  PC12 cells were differentiated in RPMI 1640 medium 
containing 1% horse serum and antibiotics with either none, 5 or 50 ng/ml mouse nerve 
growth factor, (NGF 2.5S) (Chemicon, Temecula, CA) at 24 hours.  Differentiation 
medium was replaced and fresh NGF 2.5D was added every third day to differentiating 
cells.  Cells were collected at 1, 2, 4 and 7 days prior to differentiation to evaluate 
expression levels of apoptosis-associated miRNAs. 
 
NT2N Cells.  The human teratocarcinoma-derived Ntera2/D1 neuron-like (NT2N) 
cells were obtained based on standard protocols with minor alterations (Cheung et al., 
1999; Megiorni et al., 2005).  Briefly, cells were differentiated by treating adherent 
dividing cells with 10 µM all-trans retinoic acid (Sigma Chemical Co.) for up to 3 weeks.  
Cells were collected at various time points (0, 14 and 21 days); and for some a replate 
onto Matrigel coated culture dishes after 14 days of retinoic acid was performed.  
Replated cells were incubated with mitosis inhibitors (1 µM cytosine D-
arabinofuranoside, 10 µM fluorodeoxyuridine, 10 µM uridine) (Sigma Chemical Co.), in 
the absence of retinoic acid, and collected 7 days after treatment to evaluate expression 
levels of apoptosis-associated miRNAs. 
 
3.3.2 RNA isolation and semiquantitative reverse-transcriptase-polymerase chain 
reaction (RT-PCR) 
Total RNA was isolated from mouse NS cells, PC12 and NT2N cells by TRIzol 
reagent (Invitrogen Corp.) according to manufacturer’s protocol.  ES cell RNAs were 
extracted using High Pure RNA Isolation kit (Roche Diagnostics), with the inclusion of 
DNAse I treatment according to manufacturer’s instructions.  For semiquantitative RT-
PCR, 0.5-1 µg of total RNA from NS and ES cells were reverse-transcribed using 
oligo(dT) (Integrated DNA Technologies Inc., Coralville, IA) and SuperScript II reverse 
transcriptase (Invitrogen Corp.).  Specific oligonucleotide primer pairs were incubated 
with cDNA template for PCR amplification using the Expand High FidelityPLUS PCR 
System from Roche Applied Science.  The following sequences were used as primers: 
Nestin sense 5’-CTGGAACAGAGATTGGAAGGCCGCT-3’; Nestin antisense 
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5’-GGATCCTGTGTCTTCAGAAAGGCTGTCAC-3’; Mash1 sense 5’-AGATGAG 
CAAGGTGGAGACG-3’; Mash1 antisense 5’-TGGAGTAGTTGGGGGAGATG-3’; 
Ngn1 sense 5’-ATGCCTGCCCCTTTGGAGAC-3’; Ngn1 antisense 5’-TGCA 
TGCGGTTGCGCTCGC-3’; Ngn2 sense 5’-ACCGCATGCACAACCTAAAC-3’; Ngn2 
antisense 5’-AGCGCCCAGATGTAATTGTG-3’; β-III tubulin sense 5’-AATGAG 
GCCTCCTCTCACAA-3’; β-III tubulin antisense 5’-CTTGCTGATGAG 
CAGTGTGC-3’; GFAP sense 5’-CCAAACTGGCTGATGTCTACC-3’; and GFAP 
antisense 5’-GCTTCATGTGCCTCCTGTCTA-3’¸ GAPDH sense 5’-ATTCAA 
CGGCACAGTCAAGG-3’; and GAPDH antisense 5’-TGGATGCAGGGATGAT 
GTTC-3’.  The ribosomal RNA subunit 28S was used as control when using mouse NS 
cells, while GAPDH was used as control in mouse ES cells. 
 
3.3.3 Preparation of labeled RNA and array hybridization 
Microarray analysis was performed using a custom microarray platform, highly 
sensitive, allowing the profiling of even weakly expressed miRNAs (Kalscheuer et al., 
2008).  Briefly, a miRNA probe set containing ~1140 oligonucleotides as probes, 
complementary to Caenorhabditis elegans, Drosophila, zebra fish, mouse, rat and human 
miRNAs was purchased from Invitrogen.  The set also included a number of internal and 
negative control probes.  Oligonucleotides were printed in quadruplicates on Corning 
GAPSII-coated slides in the Microarray Facility at the University of Minnesota.  For 
RNA labeling, 25 µg of total RNA was ligated to 0.5 µg of a synthetic linker, pCU-
DY547 (Dharmacon, Lafayette, CO, USA).  To control the hybridization process, 
reference DNA oligonucleotides complementary to a subset of mammalian miRNAs were 
combined and labeled with a ULYSIS Alexa Fluor 647 Kit (Invitrogen Corp.).  Labeled 
RNAs and DNAs were then mixed and hybridized to microarray slides (Thomson et al., 
2004).  Finally, slides were scanned with a ScanArray 5000 machine (Perkin Elmer, 
Waltham, MA, USA).  Microarray images were processed with Bluefuse software 
(BlueGnome, Cambridge, UK) to quantify pixel intensities.  Individual spots on the slides 
were further inspected to exclude abnormal spots from subsequent calculations. 
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3.3.4 Evaluation of miRNAs expression levels by quantitative Real Time-PCR 
Real-time PCR was performed in an Applied Biosystems 7300 Sequence Detection 
System (Applied Biosystems, Foster City, CA).  Ten nanograms of total RNA were 
reverse transcribed using a TaqMan® MicroRNA Reverse Transcription (RT) kit from 
Applied Biosystems.  Each RT reaction contained 1x stem-loop RT specific primer, 1x 
reaction buffer, 0.25 mM each of dNTPs, 3.33 U/µl Multiscribe RT enzyme and 0.25 
U/µl RNase inhibitor.  The 15-µl reactions were incubated for 30 min at 16ºC, 30 min at 
42ºC, and 5 min at 85ºC and then held at 4ºC.  The PCR reaction was performed using a 
standard TaqMan® PCR kit protocol (Applied Biosystems).  Briefly, following the RT 
step, 1.33 µl of the RT reaction were combined with 1 µl of a TaqMAn MicroRNA Assay 
(20x; forward primer, reverse primer and probe) and 17.67 µl of TaqMan® Universal 
PCR Master Mix, No AmpErase® UNG in a 20 µl final volume.  The reactions were 
incubated at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min; 
and were run in triplicate.  miRNA expression levels relative to GAPDH (mouse NS cells, 
ES cells, and PC12) or RNU6B (NT2N) were calculated on the basis of ∆∆Ct method.  
GeNorm and Norm-Finder were used to identify the best stable combination of reference 
genes/single gene for normalization in real-time PCR assays.  Calibration was set using 
undifferentiated mouse NS cells, mouse ES cells with 4 days of differentiation or 
untreated with LY411575, PC12 with 1 day of differentiation and undifferentiated NT2N 
cells or non-replated NT2N cells.  The n-fold change in miRNAs expression was 
determined according to the method of 2-∆∆CT.  
 
3.3.5 Immunoblotting 
Steady-state levels of β-III tubulin, neuronal nuclei (NeuN) and glial fibrillary 
acidic protein (GFAP) were determined by Western blot.  Total protein extracts of mouse 
NS cells were prepared in lysis buffer, following standard established protocols.  Protein 
content was measured by the Bio-Rad protein assay kit according to the manufacture’s 
specification, using bovine serum albumin as standard.  50-80 µg of total protein extracts 
were separated on 12% sodium dodecyl sulphate-polyacrylamide electrophoresis gel and 
then subjected to immunoblots using primary mouse monoclonal antibody reactive to β-
III tubulin (Tuj1, Covance, Princeton, NJ), NeuN (MAB377, Chemicon International), 
and GFAP (MAB360, Chemicon International).  Blots were subsequently incubated with 
secondary antibodies conjugated with horseradish peroxidase (Bio-Rad Laboratories, 
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Hercules, CA, USA).  Finally, membranes were processed for protein detection using 
Immobilon (Millipore Corporation, Billerica, MA) or SuperSignal reagent (Pierce, 
Rockford, IL).  Ponceau S staining was used to assess equal gel loading (Romero-Calvo 
et al.). 
 
3.3.6 Immunocytochemistry 
Mouse NS cells were fixed with paraformaldehyde (4% w/v) in phosphate-buffered 
saline (PBS) and blocked for 1 hour at room temperature in PBS containing 0.1% Triton-
X-100, 1% FBS, and 10% normal donkey serum (Jackson ImmunoResearch Laboratories, 
Inc., West Grove, PA).  Subsequently, cells were incubated with either anti-β-III tubulin 
(rabbit, polyclonal; Chemicon International) or anti-GFAP antibodies (mouse, 
monoclonal; Chemicon International) at a dilution of 1:1000 in blocking solution, 
overnight at 4ºC.  Cells were then incubated with either anti-mouse or anti-rabbit IgG 
conjugated to AMCA (Jackson ImmunoResearch Laboratories, Inc.) and Alexa 594 
(Molecular Probes-Invitrogen), respectively, for 2 hour at room temperature.  Samples 
were mounted using Fluoromount-G™ (Beckman Coulter, Inc.).  Fluorescence 
microscopy assessments were performed with a Zeizz AX10 microscope (Carl Zeiss, 
Jena, Germany) equipped with a Leica DFC490 camera (Leica Weitzlar, Germany).  
Living undifferentiated cells were photographed under an inverted microscope Leica 
DMIL with a DC200 camera (Leica Weitzlar, Germany). 
 
3.3.7 Assessment of apoptosis 
Apoptosis was assessed by evaluating DNA fragmentation, nuclear morphology and 
phosphatidylserine exposure. 
Evaluation of DNA fragmentation by TUNEL assay.  Apoptosis-induced DNA 
fragmentation was determined using the transferase mediated deoxyuridine triphosphate 
(dUTP)-digoxigenin nick-end labeling (TUNEL) assay.  Cells were fixed with 4% (w/v) 
paraformaldehyde and processed using an Apoptag in situ apoptosis detection kit 
according to the manufacturer’s protocol (Chemicon Int., Temecula, CA).  The samples 
were examined using a Leica DM 2500 bright-field microscope (Leica Weitzlar, 
Germany). 
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Morphologic evaluation of apoptosis.  Hoechst labeling of mouse NS cells was used 
to detect apoptotic nuclei.  In brief, the medium was gently removed at the indicated 
times with minimal detachment of the cells.  Attached cells were fixed with 4% (w/v) 
paraformaldehyde in PBS, pH 7.4, for 10 minutes at room temperature, incubated with 
Hoechst dye 33258 (Sigma Chemical Co.) at 5 µg/ml in PBS for 5 minutes, washed with 
PBS and mounted using PBS:glycerol (3:1, v/v).  Microscopy assessments were 
performed with a Zeizz AX10 microscope (Carl Zeiss, Jena, Germany) equipped with a 
Leica DFC490 camera (Leica Weitzlar, Germany).  Normal nuclei showed non-
condensed chromatin dispersed over the entire nucleus.  Apoptotic nuclei were identified 
by condensed chromatin, contiguous to the nuclear membrane, as well as nuclear 
fragmentation of condensed chromatin. 
 
Cytofluorometric analysis of apoptosis.  Apoptotic cells were quantified by 
cytofluorometric analysis using a FACSCalibur (Becton Dickinson, Mountain View, CA) 
as described previously (Schutte et al., 1998).  Cells were stained with the vital dye 
propidium iodide (PI; 5µg/mL; Sigma, Steinheim, Germany) and concomitantly with 
Annexin-V-APC (eBioscience, Inc.) according to manufacturer’s instructions to 
determine the phosphatidylserine exposure.  Data were statistically evaluated using 
FlowJo software (Tree Star, Inc, Ashland, OR). 
 
3.3.8 Flow Cytometry 
Cells were trypsinized (0.025% trypsin/EDTA; Invitrogen Corp.) and harvested in 
Ca2+-free and Mg2+-free PBS and 2% FBS.  After washing, 0.5 - 1 × 106 cells were fixed 
with paraformaldehyde (4% w/v) in PBS for 20 min on wet ice, and blocked for 20 min in 
PBS, containing 0.25% saponin (Fluka, Biochemika, Switzerland) and 5% normal donkey 
serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).  Subsequently, 
cells were incubated with anti-NeuN (MAB377; Chemicon International) at a dilution of 
1:20 in PBS, containing 0.1% saponin and 5% normal donkey serum, for 30 min.  Cells 
were then incubated with anti-mouse antibody conjugated to Cy5 (Jackson 
ImmunoResearch Laboratories, Inc.), for 20 min.  Cells were analyzed using a 
FACSCalibur (Becton Dickinson, Mountain View, CA). 
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3.3.9 Statistical Analysis 
Results from different groups were compared using the Student’s t test, or one-way 
ANOVA.  Kruskal-Wallis or the Mann-Whitney U tests were also used whenever the 
assumptions of the parametric test were not satisfied.  Values of p < 0.05 were considered 
statistically significant.  All statistical analysis was performed with GraphPad InStat 
software (GraphPad Software, Inc, San Diego, CA). 
 
3.4 Results 
3.4.1 NS cells have both neurogenic and gliogenic potential in vitro 
It is known that both embryonic neural tissue and certain regions of the adult 
vertebrate central nervous system contain resident populations of progenitor/precursor 
stem cells (Alvarez-Buylla and Garcia-Verdugo, 2002).  NS cells can be isolated and 
expanded as undifferentiated floating clusters called neurospheres in the presence of 
bFGF and/or EGF (Tropepe et al., 1999).  In addition, NS cells have the ability to 
differentiate into neurons, astrocytes and oligodendrocytes in a time controlled fashion 
(Qian et al., 2000).  Thus, NS cells represent a powerful in vitro model system for 
studying and elucidating the molecular mechanisms that underlie neural differentiation.  
Using mouse NS cells constitutively expressing GFP (Fig. 3.1A), we confirmed the 
differentiation potential toward neuronal and glial fates by monitoring the appearance of 
various cell-specific markers. 
The proneural basic helix–loop–helix (bHLH) transcription factor Neurogenin1 
(Ngn1) was not expressed in neurospheres, while Mash1 was readily detected (Fig. 3.1B).  
Following incubation in differentiation medium, cells displayed a sharp increase in 
markers for neurons and neural precursors.  Ngn1 was readily detected at 6 hours and 
tended to decrease during cell differentiation.  Mash1 was slightly increased but not 
significantly modulated.  Upregulation of proneural bHLH transcription factors was 
associated with a subsequent increase in β-III tubulin at both the mRNA and protein 
levels, indicating that neurogenesis is induced early after cell incubation in differentiation 
medium.  At the protein level, β-III tubulin expression peaked at 1 day of differentiation 
and gradually decreased thereafter (Fig. 3.1C).  These results suggested that the 
neurogenic potential of mouse NS cells rapidly decreased with differentiation. 
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Figure 3.1. Mouse NS cells have both neurogenic and gliogenic potential in vitro.  Mouse NS 
cells were expanded in the presence of EGF and bFGF, and induced to differentiate as described 
in Materials and Methods.  Cells were harvested for total RNA and protein extraction, or fixed at 
different time points and processed for immunostaining analysis.  Neuronal differentiation was 
readily detected after incubation in differentiation medium, while glial production was only 
observed from day 3.  A) Mouse NS cells constitutively expressing GFP were grown in 
suspension as neurospheres that increased in number and size with cell proliferation (phase 
contrast and GFP fluorescence images).  B) Semi-quantitative RT-PCR analysis for selected 
markers of lineage commitment at successive time-points of mouse NS cell differentiation.  
Neurospheres (undifferentiated NS cells) collected before platting in differentiation medium were 
considered 0 time differentiation.  Data was normalized to 28S.  C) Representative immunoblots 
showing protein expression of neuronal (β-III tubulin and NeuN) and glial (GFAP) markers 
during mouse NS cell differentiation.  Ponceau S was used as loading control.  D) Mouse NS cells 
labeled with anti-β-III tubulin and anti-GFAP antibodies, to visualize neurons and glial cells, 
respectively.  Representative immunostaining images were from at least 3 independent 
experiments.  Scale bar: 50 µm.  Ngn1, neurogenin1; GFAP, glial fibrillary acidic protein; NeuN, 
neuronal nuclei; h, hours; d, days. 
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In cell culture, there is an inverse relationship between Ngn expression and the 
propensity of the neural progenitors to undergo differentiation into astrocytes, suggesting 
that proneural bHLH factors might act to suppress the formation of astrocytes (Sun et al., 
2001).  In agreement with these observations, the glial marker GFAP was only detected at 
day 3, in association with decreased levels of Ngn1 and concomitant with a reduction in 
the number of neurons.  Importantly, analysis of NeuN protein expression revealed 
postmitotic neurons after 6 days of differentiation.  Finally, analysis by 
immunocytochemistry using β-III tubulin and GFAP markers further confirmed the 
decreased neurogenic potential of mouse NS cells throughout differentiation, and the 
generation of glial cells after the peak of neuronal production (Fig. 3.1D). 
 
3.4.2 Apoptosis-associate miRNAs are differentially modulated during mouse 
neural stem cell differentiation 
miRNAs are thought to play a role in cancer pathogenesis.  In fact, a specific subset 
of miRNAs is upregulated in most cancer profiles, and are, therefore, considered to be 
antiapoptotic miRNAs (Garofalo et al., 2010).  The best characterized of that subgroup 
are miR-21, miR-222, miR-221, miR-17-92 cluster, miR-106 and miR-155.  In contrast, 
proapoptotic miRNAs are usually downregulated in cancer, and include miR-15, miR-16, 
the let-7 family and members of the miR-34 family.  Importantly, we have recently shown 
that apoptosis-associated factors temporally modulate mouse NS cell differentiation 
(Aranha et al., 2009).  As miRNAs have recently been implicated in neural differentiation  
(Li and Jin, 2010), we sought to investigate whether apoptosis-specific miRNAs are 
particularly relevant during mouse NS cell differentiation. 
Global miRNA expression profiling studies revealed differential expression patterns 
of apoptosis-related miRNAs throughout mouse NS cell differentiation (Tables 3.1 and 
3.2).  In general, let-7 family members were upregulated at 3 days, and decreased at 8 
days of differentiation.  Interestingly, and similar to miR-34a/b/c, miR-16 was 
upregulated at both 3 and 8 days of neural differentiation.  In contrast, antiapoptotic 
miRNAs were in general downregulated at 8 days.  Further analysis of the differentially 
expressed miRNAs involved clustering analysis into different groups, according to 
variations in the apoptosis-associated miRNAs expression.  Less differentiated cells (1 
and 3 days) were grouped separately from those that were more differentiated (8 days) 
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(data not shown).  Importantly, similar grouping was not achieved in clustering analysis 
using all detected miRNAs. 
 
Table 3.1. Proapoptotic miRs expression during mouse NS cell differentiation 
 
 Time (days) 
miR 1 3 8 
    
miR-15a 1.00 0.75 0.71 
miR-15b 1.00 1.11 0.61 
miR-16 1.00 1.91 4.09 
    
Let-7a 1.00 1.72 0.91 
Let-7b 1.00 3.68 0.72 
Let-7c 1.00 1.84 0.60 
Let-7d 1.00 1.31 0.40 
Let-7e 1.00 0.83 0.38 
Let-7f 1.00 2.20 0.75 
Let-7g 1.00 1.40 1.13 
Let-7i 1.00 1.20 0.77 
    
miR-34a 1.00 3.01 3.39 
miR-34b 1.00 2.36 2.56 
miR-34c 1.00 1.18 1.67 
    
miR-122a 1.00 0.85 0.60 
    
miR-29a 1.00 0.66 0.52 
miR-29b 1.00 0.98 0.21 
miR-29c 1.00 1.09 0.78 
    
miR-101 1.00 4.33 4.70 
 
Results are presented as fold change variation versus day 1 of differentiation.  Data are 
mean values from two independent experiments.    
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Table 3.2. Antiapoptotic miRs expression during mouse NS cell differentiation 
 
 Time (days) 
miR 1 3 8 
    
miR-21 1.00 0.68 1.03 
    
miR-221 1.00 0.51 0.61 
miR-222 1.00 0.72 1.68 
    
miR-106b 1.00 0.44 0.29 
miR-93 1.00 0.88 0.82 
miR-25 1.00 1.21 2.58 
    
miR-17-5p 1.00 0.64 0.47 
miR-17-3p 1.00 2.98 1.48 
miR-18a 1.00 1.16 0.46 
miR-19a 1.00 1.78 0.57 
miR-19b 1.00 0.21 0.18 
miR-20a 1.00 0.35 0.22 
miR-92b 1.00 1.03 1.04 
    
miR-155 1.00 1.62 0.41 
 
Results are presented as fold change variation versus day 1 of differentiation.  Data are 
mean values from two independent experiments.   
 
Based on a possible link between miR-16, let-7a and miR-34a with known 
apoptotic molecules that have already been associated with differentiation, we decided to 
validate microarray data for the three proapoptotic miRNAs throughout mouse NS cell 
differentiation by quantitative real time-PCR (Fig. 3.2).  Antiapoptotic miR-19a and miR-
20a, two miR-17-92 cluster members were also investigated.  Proapoptotic miRNAs were 
confirmed to be upregulated during mouse NS cell differentiation.  Notably, miR-16 
Apoptosis-associated miRNAs and differentiation 
77 
expression levels were significantly increased from 12 hours to 3 days of differentiation, 
when compared with undifferentiated cells (p < 0.05) (Fig. 3.2).  Still, its expression 
levels remained elevated throughout differentiation.  Similarly, let-7a was significantly 
upregulated following induction of differentiation, increasing almost 4- and 3-fold at 6 
and 12 hours, respectively (p < 0.05).  After returning to basal levels at day 2, let-7a 
expression was again significantly upregulated at day 3 and 6, by 2.6- and 3.5-fold, 
respectively (p < 0.05), slightly decreasing at day 8 (p < 0.01).  miR-34a, in turn, was 
modulated primarily beyond the third day of differentiation.  After a 3-fold increase at 3 
days (p < 0.01), miR-34a was further upregulated at day 6 by ~ 11-fold (p < 0.001), 
comparing with undifferentiated cells.  Similarly to miR-16 and let-7a, a decrease in miR-
34a expression occurred from day 6 to day 8. 
 
 
Figure 3.2. Apoptosis-associated miRNAs are modulated during mouse NS cell 
differentiation.  Expression of specific proapoptotic (miR-16, let-7a and miR-34a) and 
antiapoptotic miRNAs (miR-20a and miR-19a) were analyzed by quantitative Real Time-PCR 
from 10 ng of total RNA using specific Taqman primers and GAPDH for normalization.  *p < 
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0.05, †p < 0.01 and §p < 0.001 compared to day 0 (undifferentiated cells).  Expression levels were 
calculated by the ∆∆Ct method using undifferentiated cells as calibrator.  Data represent mean ± 
SEM of four independent experiments. 
 
The synchronous induction of proapoptotic miRNAs suggested that they may play a 
role during mouse NS cell differentiation.  In contrast, antiapoptotic miR-20a was mainly 
downregulated throughout neural differentiation.  In fact, its expression levels were ~ 2-
fold downregulated from 6 days and beyond (p < 0.001), compared to undifferentiated 
cells.  Curiously, miR-19a expression was mostly increased during the first 3 days of 
differentiation, gradually decreasing toward control levels.  The onset of miR-19a 
expression correlates with induction of proliferation during the first 3 days of 
differentiation (data not shown). 
 
3.4.3 Expression of apoptosis-related miRNAs is not associated with increased cell 
death during mouse NS cell differentiation 
To exclude the possibility that expression of proapoptotic miRNAs is associated 
with increased cell death, we evaluated cellular apoptosis during mouse NS cell 
differentiation using Hoechst staining, TUNEL assay and cytofluorometric analysis.  
Undifferentiated cells exhibited major apoptosis-associated alterations, including 
chromatin condensation and nuclear fragmentation (Fig. 3.3A, Hoechst), DNA 
fragmentation (Fig. 3.3A, TUNEL), exposure of phosphatidylserine on the outer leaflet of 
the plasma membrane (detected with annexin V-APC conjugates) (Fig. 3.3B and C), as 
well as membrane permeabilization, as indicated by the staining with the vital dye PI.  
Importantly, induction of cell differentiation resulted in minor alterations in nuclear 
morphology, while DNA fragmentation was slightly detected during the first two days of 
differentiation.  In addition, phosphatidylserine exposure was only slightly increased from 
day 3 to day 6, but always less than 6% during differentiation.  Furthermore, no 
significant loss of cell viability was observed.  Taken together, our results indicated that 
differentiation of mouse NSC was not associated with a significant increase of cell death. 
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Figure 3.3. Differentiation of mouse NS cells is not associated with increased cell death.  
Mouse NS cells at different days of differentiation were fixed and processed for either 
morphological evaluation of apoptosis or TUNEL assay, or were stained with Annexin-V-
APC/PI.  A) Evaluation of apoptosis by Hoechst staining and TUNEL assay.  Representative 
images from at least three independent experiments.  Arrows indicate apoptotic cells.  B) 
Representative FACS diagrams depicting the percentages of either dying (Annexin+/PI-) or dead 
(Annexin+/PI+) cells.  C) Quantitation of the data depicted in FACS diagrams.  Results are mean 
± SEM.  This experiment was repeated at least three times, yielding comparable results.  Scale 
bar: 10 µm.  d, days. 
 
All three proapoptotic miRNAs increased from day 3 to day 6 of differentiation.  In 
addition, a concomitant increase in cell death was also observed.  Thus, to exclude the 
role of these specific miRNAs in apoptosis, we inhibited apoptosis at 6 days and 
reevaluated changes on miRNA expression (Fig. 3.4).  Incubation with the antiapoptotic 
TUDCA for 72 hours, reduced Annexin+/PI- cells from 6.4% to 5.3% (Fig. 3.4A and B).  
In addition, loss of cell viability (Annexin+/PI+ cells) was significantly reduced from 
14.2% to 10.6% (p < 0.05).  More importantly, the decrease in cell death after TUDCA 
treatment did not decrease the expression of proapoptotic miRNAs (Fig. 3.4C).  These 
results strongly suggested that modulation of miR-16, let-7a and miR-34a was most likely 
due to cell differentiation rather than cell death. 
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Figure 3.4. Inhibition of apoptosis by TUDCA was not associated with a decrease in 
proapoptotic miRNAs expression.  Mouse NS cells with 3 days of differentiation were either 
untreated or treated with 50 µM of TUDCA for 72 hours.  Collected cells were stained with 
Annexin-V-APC/PI to evaluate cell death, or processed for total RNA extraction and miRNAs 
expression evaluation by quantitative Real Time-PCR.  A) Representative Annexin V-APC/PI 
stainings showing decreased cell death after TUDCA incubation.  B) Quantitation of either dying 
(Annexin+/PI-) or dead (Annexin+/PI+) cells depicted in FACS diagrams.  Results are mean ± 
SEM of triplicates.  C) Expression of proapoptotic miRNAs at 3 and 6 days, with or without 
TUDCA treatment.  miR-16, let-7a and miR-34a expression were evaluated from 10 ng of total 
RNA, using specific primers for each miRNA, and GAPDH for normalization.  Expression levels 
were calculated by the ∆∆Ct method using differentiated cells at 3 days as calibrator.  Data 
represent mean ± SEM of three independent experiments.  *p < 0.05 compared to respective 
nontreated cells at 6 days. 
 
3.4.4 Apoptosis-associated miRNAs are upregulated in different models of neural 
differentiation 
To further validate the role of the proapoptotic miRNAs, miR-16, let-7a and miR-
34a in neural cell differentiation, we investigated whether they were upregulated in other 
neural differentiation models, including mouse ES cells, PC12 and NT2N cell lines.  The 
generation of neurons from ES cells has reproducibly been characterized in vitro 
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(Abranches et al., 2009; Ying et al., 2003).  Neural progenitors derived from ES cells 
organize themselves into rosette-like structures that can subsequently differentiate into 
neurons, astrocytes and oligodendrocytes.  Using the same differentiation protocol, 
neurogenesis was evidenced by increased Ngn2 and β-III tubulin mRNA expression 
levels at 8 days of differentiation (Fig. 3.5A).   
 
 
Figure 3.5. miR-16, let-7a and miR-34a are increased during mouse ES cell differentiation.  
Mouse ES cells (Sox1-GFP 46C) were differentiated using an adherent monolayer protocol.  Cells 
at 4 and 8 days were collected for total RNA extraction and subsequently processed for evaluation 
of specific differentiation markers, as well as proapoptotic miRNA expression by quantitative 
Real Time-PCR.  A positive control for neural differentiation was also performed at day 8 by 
treating cells with either 10 nM LY411575 or 0.01%DMSO (control) for 12 hours.  A) Semi-
quantitative RT-PCR analysis for selected markers of lineage commitment in day 4 and 8, as well 
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as in LY411575-treated and untreated cells.  B) Representative bright-field, phase contrast images 
showing increased neuronal differentiation after LY411575 incubation compared with control 
(DMSO-treated) cells.  C) Expression of miR-16, Let-7a and miR-34a at 4 and 8 days of ES cell 
differentiation and in control (DMSO-treated) and LY411575-treated rosette cultures at 8 days.  
miRNAs expression were evaluated from 10 ng of total RNA, using specific primers for each 
miRNA, and GAPDH for normalization.  Expression levels were calculated by the ∆∆Ct method 
using either differentiated cells at 4 days or LY411575-untreated cells as calibrator.  Data 
represent mean ± SEM of three independent experiments.  *p < 0.05 compared to respective 
nontreated cells.  Scale bar: 50 µm.  d, days. 
 
The neural progenitor marker Nestin was also increased, suggesting a concomitant 
increase in neural progenitors.  In fact, at this stage of differentiation, expression levels of 
miR-16, let-7a and miR-34a were increased when compared with day 4 (Fig. 3.5B).  The 
inhibition of Notch pathway at 8 days of differentiation by LY411575 treatment resulted 
in increased neuronal production.  In fact, neuronal markers, particularly Ngn2, were 
increased, and morphological evaluation was consistent with the presence of 
differentiated cells (Fig. 3.5A and C).  Notably, LY411575-induced neurogenesis resulted 
in a significant increased of miR-16 and miR-34a, by 3- and 2-fold (Fig. 3.5B), 
respectively (p < 0.05), supporting the potential involvement of both miRNAs in neuronal 
differentiation.  Glial differentiation was not detected in the time points analyzed (data 
not shown). 
It has been previously described that differentiation of PC12 cells can be induced by 
NGF (Greene and Tischler, 1976).  Cell differentiation increases during the first 7 days of 
treatment with NGF, as measured by neuronal outgrowth and mRNA levels of specific 
neurofilaments (Schimmelpfeng et al., 2004).  Moreover, this correlation decreases with 
lower NGF concentrations.  Our results demonstrated that treatment of PC12 cells with 50 
ng/ml of NGF markedly induced miR-16 expression at 2 and 4 days, compared with 
NGF-untreated cells (Fig. 3.6A). Indeed, miR-16 expression increased by 1.8- (p < 0.01) 
and 1.4-fold (p < 0.05) at 2 and 4 days, respectively.  Nevertheless, no difference in miR-
16 expression levels was detected at 7 days, under different NGF treatments.  
Interestingly, 24 hours after treatment with 50 ng/ml of NGF, let-7a expression was ~ 5-
fold upregulated in differentiated PC12 cells (p < 0.05).  Under identical conditions, let-
7a expression remained elevated throughout the time course (p < 0.05).  Notably, miR-
34a expression was also gradually upregulated after NGF treatment.  Although to a lesser 
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extent, similar results were obtained for all three miRNAs under suboptimal NGF 5 ng/ml 
concentrations.  None of the selected miRs were modulated in NGF-untreated cells. 
Human teratocarcinoma NT2 cells generate postmitotic neurons (NT2N) in 
response to retinoic acid and mitotic inhibitors (Hara et al., 2008).  Retinoic acid 
treatment of NT2 cells induced neuronal differentiation as evidenced by the expression of 
the neuronal marker NeuroD at 14 and 21 days, as well as increased expression of β-III 
tubulin (data not shown).  In NT2N, miR-16 expression was increased by 3.6-fold at day 
14 (p < 0.001) and almost 4-fold at day 21 (p < 0.05) of differentiation (Fig. 3.6B).  
Similarly, let-7a was highly upregulated, particularly at 21 days of retinoic acid treatment 
(p < 0.05).  In contrast, miR-34a was not modulated during cell differentiation.  Replated 
cells showed increased differentiation, as evidenced by the increase in β-III tubulin-
positive cells and detection of NeuN-positive cells (data not shown).  Surprisingly, 
increased differentiation after replating was associated with a significant decrease in both 
miR-16 and let-7a expression by ~ 2 (p < 0.05) and 5-fold (p < 0.001), while miR-34a 
increased by 4.5-fold (p < 0.05), compared with non-replated cells. 
 
 
Figure 3.6. Differentiation of PC12 and NT2N cells were associated with modulated levels of 
miR-16, let-7a and miR-34a expression.  PC12 cells were differentiated upon NGF treatment at 
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1 day with either 5 or 50 ng/ml.  NGF-untreated cells were also prepared.  Cells were collected at 
1, 2 4 and 7 days.  NT2N cells were induced to differentiate with 10 µM all-trans retinoic acid and 
collected at 0, 14 and 21 days.  In parallel experiments, cells were replated at 14 days in Matrigel, 
deprived of retinoic acid and incubated with mitotic inhibitors and further cultured for 7 days.  
Control cells were maintained in initial retinoic acid treatment.  Both PC12 and NT2N-collected 
cells were processed for total RNA extraction and evaluation of miRNAs expression levels using 
quantitative Real Time-PCR.  A and B) miR-16, let-7a and miR-34a expression during PC12 and 
NT2N differentiation, respectively.  miRNAs expression were evaluated from 10 ng of total RNA, 
using specific primers for each miRNA.  GAPDH and RNU6B were used for normalization in 
PC12 and NT2N cells, respectively.  Expression levels were calculated by the ∆∆Ct method.  
NGF-untreated cells at 1 day was used as calibrator in PC12 cells, while undifferentiated (day 0) 
or unreplated cells were used as calibrator in NT2N cells.  Data represent mean ± SEM of three 
independent experiments.  A) *p < 0.05 and †p < 0.01 compared to 1 day.  miR-16 and let-7a 
expressions in cells treated with 5 and 50 ng/ml NGF were also significantly different from NGF 
untreated cells at day 4 (p < 0.05) and day 2 (p < 0.01), respectively.  B) *p < 0.05 and §p < 0.001 
compared to day 0; †p < 0.05 and ‡p < 0.001 compared to unreplated cells.  d, days. 
 
miR-34a was the most significantly upregulated miRNA during mouse NS cell 
differentiation (~ 11-fold between days 3 and 6; p < 0.001) compared to other apoptosis-
associated miRNAs.  Because miR-34a upregulation coincides with the onset of 
postmitotic neurons, we investigated the effect of miR-34a upregulation in this population 
by evaluating NeuN expression.  We used flow cytometry to determine the proportion of 
the postmitotic neuronal population.  The proportion of NeuN-positive cells was 
significantly increased when compared to cells transfected with unrelated RNA duplexes 
(Fig. 3.7A).  In fact, NeuN-positive cells increased from 29.7 to 38.9% 24 h after 
transfection.  This increase was further enhanced from 27.3 to 66.6% at 72 h post-
transfection.  In addition, these results were confirmed by Western blot analysis (Fig. 
3.7B).  No changes were detected in the proportion of astrocytes in the pre-miR-34a 
transfected cells (data not shown).  These results indicated that miR-34a contributes to 
neuronal differentiation in mouse NS cells. 
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Figure 3.7. miR-34a overexpression increases the ratio of postmitotic neurons in mouse NS 
cells.  Mouse NS cells were transfected using 100 nM of either control or pre-miR-34a, and 
collected 24 and 72 h after transfection.  Collected cells were labeled for NeuN detection by flow 
cytometry, or processed for total protein extraction and NeuN expression evaluation by Westen 
blot.  A) Percentage of NeuN positive cells in negative control and pre-miR-34a-transfected cells, 
24 and 72 h after transfection.  In independent repetitions of these experiments, similar increases 
in the relative number of NeuN-positive cells were observed in cultures overexpressing miR-34a 
when compared to control pre-miR-transfected cells.  B)  Representative blot showing increased 
NeuN expression in pre-miR-34a transfected cells. 
 
3.5 Discussion 
Differentiation of NS and ES cells in vitro has attracted wide interest as an 
experimental system for investigating specific molecular pathways of cell development.  
Here, we have demonstrated neuronal and glial conversion of mouse NS cells.  In this 
model, the neuronal population is formed mainly during the first 2 days, as indicated by 
the upregulation of β-III tubulin.  Nevertheless, commitment to mature neurons was 
confirmed by the expression of NeuN at 6 days, which indicates the presence of immature 
postmitotic neurons.  Astrocytic population peaked at 6 days, and this was maintained 
throughout differentiation. 
Functional studies of apoptosis-associated miRNAs have focused intensely on 
cancer research.  However, our results demonstrate that specific miRNAs regulating pro- 
and antiapoptotic genes may also participate in differentiation processes.  The 
involvement of miR-16 in cell differentiation has not been previously reported.  Indeed, 
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miR-16 expression was markedly increased throughout mouse, rat and human neural 
differentiation.  Nevertheless, the onset of miR-16 expression during mouse NS cell 
differentiation was not associated with the appearance of any specific cell type.  miR-16 
was shown to be implicated in cell cycle regulation, as well as apoptosis induction by 
targeting Bcl-2 (Chen et al., 2008; Cimmino et al., 2005; Linsley et al., 2007; Liu et al., 
2008).  Apoptosis is not markedly regulated during mouse NS cell differentiation, and 
Bcl-2 expression is increased (data not shown).  Therefore, a possible role for miR-16 in 
the context of differentiation may be associated with cell cycle control in downregulating 
the proliferation potential of differentiating cells.  During differentiation of neural 
precursors, a tightly coordinated regulation of cell cycle exit is crucial for the generation 
of appropriate number of neurons and proper wiring of neuronal circuits (Politis et al., 
2008).  Nevertheless, here-to-fore unrecognized miR-16 targets may exert distinct, yet 
crucial functions during cell differentiation. 
The let-7 family consists of eleven very closely related genes (Pasquinelli et al., 
2000).  They are highly conserved in animals from worms to humans, and their 
expression increases after differentiation and maturation of tissues (Lee et al., 2005).  In 
addition to regulating apoptosis by targeting caspase-3 (Tsang and Kwok, 2008), it was 
also demonstrated that let-7 family members regulate RAS and HMGA2 oncogene 
through the 3’UTR (Akao et al., 2006; Johnson et al., 2005; Lee and Dutta, 2007).  In the 
present study, let-7a expression was shown to be cyclic during mouse NS cells 
differentiation, and corresponded to the onset of neurogenesis and gliogenesis.  This 
suggests that let-7a expression is associated with a general mechanism of differentiation 
rather than differentiation of specific cell types.  Our results are supported by the previous 
report showing that let-7a is a critical regulator of neuronal differentiation (Liu et al., 
2009; Sempere et al., 2004).  In fact, increased let-7a expression during ES cells, PC12 
and NT2N differentiation also underscores the important role of let-7a during general 
differentiation.  Additional studies are warranted to evaluate the mechanism(s) by which 
let-7a regulates cell differentiation.  Importantly, although highly modulated during cell 
differentiation, both let-7a and miR-16 were significantly expressed in neurospheres (data 
not shown).  Therefore, it is possible that additional mechanisms exist to antagonize let-
7a and miR-16 expression during NS cell differentiation. 
A specific role for miR-34a during neuronal differentiation has not been reported.  
Interestingly, herein we showed a significant upregulation of miR-34a during mouse NS 
cell differentiation, and this paralleled the appearance of postmitotic neurons.  In addition, 
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in vitro transient overexpression of miR-34a increased the proportion of NeuN-positive 
cells.  Given that miR-34a has been shown to regulate genes involved in cell cycle arrest, 
it is possible that miR-34a upregulation is related to cell cycle exit and the subsequent 
appearance of immature postmitotic neurons.  In fact, miR-34a upregulation in ES cells 
after LY treatment, as well as in NT2N cells after incubation with the mitosis inhibitor, 
supports this hypothesis.  In addition, it has been previously shown that miR-34a can 
suppress cell-cycle genes and induce neural phenotype in neuroblastoma tumors (Wei et 
al., 2008).  Importantly, it has been previously reported that miR-34a overexpression had 
no effect on cell cycle arrest and survival/apoptosis of astrocytes (Guessous et al., 2010; 
Li et al., 2009a).  However, additional studies are required to confirm the influence of 
miR-34a in neurogenesis and evaluate whether it mediates p53 effects on cell 
differentiation.  In fact, several potential miR-34a targets might be involved in the 
transition towards postmitotic neurons.  It was previously demonstrated that miR-34a 
targets Sirt1 and is regulated by p53, which in turn, is activated by Sirt1 suppression.  In 
addition, miR-34a may also regulate the differentiation process by influencing Notch 
signaling pathway (Guessous et al., 2010; Hermeking, 2010).  In contrast to let-7a and 
miR-16, miR-34a was barely detected in undifferentiated cells, supporting its specific 
involvement in cell differentiation. 
miR-19a and miR-20a are members of the miR-17-92 cluster (Bonauer and 
Dimmeler, 2009), which consists of seven mature miRNAs, previously linked to 
tumorigenesis.  Recently, additional functions have been assigned to this cluster, 
particularly to miR-20a and miR-19a.  Specifically, miR-20a was shown to control 
monocyte differentiation (Fontana et al., 2007).  In fact, transfection of hematopoietic 
progenitors with miR-20a increased the proliferation of monocytes and blocked 
differentiation, whereas inhibition of miR-20a caused a decrease in proliferation and more 
rapid differentiation and maturation.  Our results, showing that miR-20a decreases during 
mouse NS cell differentiation, are in agreement with this previous report. 
Only limited information is available regarding the physiological role of miR-19a.  
It has been demonstrated that it acts as a positive regulator of antiapoptotic Stat3/IL-6 
receptor signaling by directly suppressing SOCS-1, thereby facilitating malignant growth 
of multiple myeloma (Pichiorri et al., 2008).  Further, miR-19 appears to affect the level 
of proapoptotic protein Bim, thereby preventing apoptosis and promoting cell survival.  
The possible role of miR-19a on cell survival, may explain why this miRNA was 
upregulated at early stages after the induction of mouse NS cell differentiation.  However, 
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additional studies are required to determine the specific role of both miR-20a and miR-
19a during cell differentiation, and also evaluate if their expression is restricted to a 
specific cell type. 
In conclusion, our results demonstrate that apoptosis-associated miRNAs are 
differentially expressed during neural differentiation, in the absence of cell death, and 
identify miR-16, let-7a and miR-34a as important players. 
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4.1 Abstract 
MicroRNAs (miRNAs or miRs) participate in the regulation of several biological 
processes, including cell differentiation.  Recently, miR-34a has been implicated in 
differentiation of monocyte-derived dendritic cells, human erythroleukemia cells, and 
mouse embryonic stem cells.  In addition, members of the miR-34 family have been 
described as direct p53 targets.  However, the function of miR-34a in the control of the 
differentiation program of specific neural cell types remains largely unknown.  Here, we 
investigated the role of miR-34a in regulating mouse neural stem (NS) cell 
differentiation.  miR-34a overexpression increased the proportion of postmitotic neurons 
of mouse NS cells, whereas miR-34a downregulation had the opposite effect.  SIRT1 was 
identified as a target of miR-34a and shown to mediate miR-34a effects on neuronal 
differentiation.  In addition, p53-DNA binding activity was increased and cell death 
unchanged after miR-34a overexpression, thus reinforcing the role of p53 during neural 
differentiation.  Interestingly, in conditions where SIRT1 was activated by pharmacologic 
treatment with resveratrol, miR-34a overexpression increased the proportion of astrocytes 
through a SIRT1-independent mechanism.  In conclusion, our results extend the 
molecular mechanism by which miR-34a modulates neural differentiation, suggesting that 
miR-34a is required for proper neuronal differentiation, in part, by targeting SIRT1 and 
affecting p53 activity. 
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4.2 Introduction 
MicroRNAs (miRNAs or miRs) are small, ~ 21-nucleotide-long regulatory RNA 
molecules encoded in plant and animal genomes.  miRNAs regulate the expression of 
target genes by binding to the 3’-untranslated regions of specific mRNAs and triggering 
mRNA destabilization or suppression of translation (Bartel, 2004).  They fine-tune gene 
expression by effecting more subtle and rapid changes than global transcriptional control 
mechanisms (Shivdasani, 2006).  Each miRNA have the capacity to regulate multiple 
genes; in mammals, miRNAs are predicted to control the activity of ~ 50% of all protein-
coding genes (Krol et al., 2010). 
Functional studies indicate that miRNAs participate in the regulation of almost 
every cellular processes investigated so far, including cell differentiation.  The important 
regulatory role of miRNAs in development and differentiation clearly emerged from the 
study of embryonic stem cells null for the Dicer gene, which encodes an RNase III 
required for miRNA biogenesis.  Ablation of Dicer leads to defects in embryonic stem 
cell division and proliferation (Murchison et al., 2005), causing death in mice and 
complete loss of pluripotent stem cells (Bernstein et al., 2003).  In addition, Dicer ablated 
embryonic stem cells also fail to differentiate.  Therefore, miRNAs can affect stem cell 
fate at the levels of both proliferation and differentiation.  
miR-34a is a member of the miR-34 family which comprises three processed 
miRNAs in mammals: miR-34a, -34b and -34c (Hermeking, 2010).  miR-34a is encoded 
by its own transcript, whereas miR-34b and miR-34c share a common primary transcript.  
In mice, miR-34a is ubiquitously expressed with the highest expression in the brain 
(Lodygin et al., 2008), whereas miR-34b and c are mainly expressed in lung tissue 
(Bommer et al., 2007).  Importantly, several reports showed that members of the miR-34 
family are direct p53 targets, and their upregulation induces apoptosis and cell cycle 
arrest (Bommer et al., 2007; Chang et al., 2007b; Corney et al., 2007; He et al., 2007a; 
Raver-Shapira et al., 2007; Tarasov et al., 2007).  However, emerging evidence suggests a 
role for miR-34a during cell differentiation.  miR-34a was shown to be involved in 
monocyte-derived dendritic cell differentiation by targeting JAG1 (Hashimi et al., 2009).  
In addition, miR-34a regulates phorbol ester-induced megakaryocytic differentiation of 
K562 cells by inhibiting cell proliferation and inducing cell cycle arrest, through direct 
regulation of its known targets cyclin-dependent kinase 4 and 6 (CDK4 and CDK6), 
MYB and mitogen-activated protein kinase kinase 1 (MEK1) (Ichimura et al., 2010; 
Navarro et al., 2009).  Recently, miR-34a was shown to modulate mouse embryonic stem 
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cell differentiation by regulating silent information regulator 1 (SIRT1) expression levels 
(Tarantino et al., 2010).  Nevertheless, the precise role of miR-34a during neuronal 
differentiation has never been reported. 
SIRT1 is a NAD-dependent deacetylase involved in cellular resistance to stress, 
metabolism, aging, and tumor suppression (Blander and Guarente, 2004; Finkel et al., 
2009; Haigis and Guarente, 2006; Mantel and Broxmeyer, 2008).  In mammals, SIRT1 
function is mediated by its deacetylating activity not only on histones, but also on key 
transcription factors, such as p53 (p53), forkhead transcription factors (FOXO), p300 
histone acetyltransferase, tumor suppressor protein p73 (p73), E2F transcription factor 1 
(E2F1), DNA repair factor Ku antigen 70-kDa subunit (Ku70), nuclear factor κ-B (NF-
κB), and androgen receptor (AR) (for review, see (Guarente and Picard, 2005).  In 
addition, SIRT1 knockout mice demonstrated embryonic and postnatal developmental 
defects (Wang et al., 2008b), suggesting that SIRT1 is important in embryonic 
development.  Indeed, SIRT1 has been identified as a redox sensor in mouse embryonic 
fibroblasts and undifferentiated muscle cells, in which it controls proliferation, cell cycle 
arrest and differentiation (Brunet et al., 2004; Fulco et al., 2003).  SIRT1 was also 
reported to play a role in cellular differentiation of human keratinocytes (Blander et al., 
2009), in mouse embryonic stem cell differentiation and hematopoiesis (Ou et al., 2010), 
and in differentiation of neural progenitors (Hisahara et al., 2008; Prozorovski et al., 
2008). 
Here, we identified the role of miR-34a in regulating mouse neural stem (NS) cell 
differentiation by a mechanism that involves SIRT1 downregulation and increased p53-
DNA binding activity. 
 
4.3 Methods 
4.3.1 Cell Culture 
Mouse NS cells containing a constitutively expressed marker for green fluorescent 
protein (GFP) were used to investigate the process of neural differentiation.  Primary cells 
were obtained from central nervous system tissue of embryonic mice, and cultured 
primarily as previously described (Reynolds and Weiss, 1992, 1996; Rietze and 
Reynolds, 2006).  Mouse NS cells were maintained as neurospheres in undifferentiation 
medium, serum-free, 1:1 mix of DMEM/F12 (Invitrogen Corp., Grand Island, NY) with 
1× N-2 supplement (Invitrogen Corp.), 20 ng/ml epidermal growth factor (EGF) (R & D 
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Systems Inc., Minneapolis, MN), 20 ng/ml basic fibroblast growth factor (bFGF) 
(PeproTech EC, London, UK), and 1% penicillin-streptomycin (Invitrogen Corp.), at 
37ºC in humidified atmosphere of 5% CO2.  Subculture occurred at day 7 with 
mechanical dissociation of neurospheres.  The differentiation of mouse NS cells in vitro 
was induced by culturing dissociated cells in differentiation medium containing 
DMEM/F12 with 1× N-2 supplement, 100 ng/ml bFGF, 10% fetal bovine serum (FBS) 
(Invitrogen Corp.), 500 nM all-trans retinoic acid (Sigma Chemical Co., St. Louis, MO), 
50 µM taurine (Sigma Chemical Co.), 10 ng/ml transforming growth factor-β2 (TGF-β2) 
(R & D Systems Inc.) and 1% penicillin-streptomycin in tissue culture plates pre-coated 
with poly-D-lysine (Sigma Chemical Co.).  The culture medium was changed every 3 
days.  Differentiated cells at 5 × 105 cells/ml were processed for immunobloting assays.  
Transfections and cell treatments were carried out at 2.5 × 105 cells/ml cellular density. 
 
4.3.2 Small interfering RNA transfections, overexpression/antisense experiments 
and cell treatments 
miR-34a expression was modulated using 100 nM of pre-anti-miR negative control 
and pre-anti-miR-34a (Applied Biosystems, Foster City, CA).  The sequences of small 
interfering RNA (siRNA) duplex for SIRT1 were sense 
5’-GUGAGAAAAUGCUGGCCUA-3’ and antisense 5’-UAGGCCAGCAUUU 
UCUCAC-3’ Cells were transfected using 100 nM of SIRT1 siRNA or treated with 5 µM 
resveratrol.  Mouse NS cells were transfected at 2 or 3 days of differentiation using 
Lipofectamine 2000 (Invitrogen Corp) following manufacturer’s instructions.  
Efficiencies of miR-34a modulation and SIRT1 silencing were assessed by quantitative 
real-time RT-PCR and immunoblotting, respectively. 
4.3.3 Evaluation of miR-34a expression levels by quantitative Real Time-PCR 
Real-time PCR was performed in an Applied Biosystems 7300 Sequence Detection 
System (Applied Biosystems, Foster City, CA).  Ten ng of total RNA isolated by TRIzol 
reagent (Invitrogen Corp.) were reverse transcribed using a TaqMan® MicroRNA 
Reverse Transcription (RT) kit from Applied Biosystems.  Each RT reaction contained 1x 
stem-loop RT specific primer, 1x reaction buffer, 0.25 mM each of dNTPs, 3.33 U/µl 
Multiscribe RT enzyme and 0.25 U/µl RNase inhibitor.  The 15-µl reactions were 
incubated for 30 min at 16ºC, 30 min at 42ºC, and 5 min at 85ºC and then held at 4ºC.  
The PCR reaction was performed using a standard TaqMan® PCR kit protocol (Applied 
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Biosystems).  Briefly, following the RT step, 1.33 µl of the RT reaction were combined 
with 1 µl of a TaqMAn MicroRNA Assay (20x; forward primer, reverse primer and 
probe) and 17.67 µl of TaqMan® Universal PCR Master Mix, No AmpErase® UNG in a 
20 µl final volume.  The reactions were incubated at 95°C for 10 min, followed by 40 
cycles of 95°C for 15 s and 60°C for 1 min; and were run in triplicate.  miRNA 
expression levels relative to GAPDH were calculated on the basis of ΔΔCt method.  The 
n-fold change in miRNAs expression was determined according to the method of 2-ΔΔCT.  
 
4.3.4 Flow cytometry analysis of Nestin, β-III Tubulin, NeuN and GFAP 
Cells were trypsinized (0.025% trypsin/EDTA; Invitrogen Corp.) and harvested in 
Ca2+-free and Mg2+-free PBS and 2% FBS.  After washing, 0.5 - 1 × 106 cells were fixed 
with paraformaldehyde (4% w/v) in PBS for 20 min on wet ice, and blocked for 20 min in 
PBS, containing 0.25% saponin (Fluka, Biochemika, Switzerland) and 5% normal donkey 
serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).  Subsequently, 
cells were incubated with antibodies reactive to Nestin (MAB 353), neuronal nuclei 
(NeuN) (MAB377), glial fibrillary acidic protein (GFAP) (MAB360; Chemicon 
International, Temecula, CA ) and β-III Tubulin (Tuj1) at a dilution of 1:100, 1:20, 
1:2000 and 1:500, respectively, in PBS containing 0.1% saponin and 5% normal donkey 
serum, for 30 min.  Cells were then incubated with anti-mouse antibody conjugated to 
Cy5 (Jackson ImmunoResearch Laboratories, Inc.), for 30 min.  Cells were analyzed 
using a FACSCalibur (Becton Dickinson, Mountain View, CA). 
 
4.3.5 Immunoblotting 
Steady-state levels of SIRT1 were determined by immunoblotting.  Total protein 
extracts of mouse NS cells were prepared in lysis buffer, following standard established 
protocols.  Protein content was measured by the Bio-Rad protein assay kit according to 
the manufacture’s specification, using bovine serum albumin as standard.  50-80 µg of 
total protein extracts were separated on 12% sodium dodecyl sulphate-polyacrylamide 
electrophoresis gel and then subjected to immunoblots using primary rabbit polyclonal 
antibody reactive to SIRT1 (07-131, Chemicon International).  Blots were subsequently 
incubated with secondary antibodies conjugated with horseradish peroxidase (Bio-Rad 
Laboratories, Hercules, CA, USA).  Finally, membranes were processed for protein 
Chapter 4 
96 
detection using Immobilon (Millipore Corporation, Billerica, MA) or SuperSignal reagent 
(Pierce, Rockford, IL).  Ponceau S staining was used to assess equal gel loading 
(Romero-Calvo et al., 2010). 
 
4.3.6 Immunocytochemistry 
Mouse NS cells were fixed with paraformaldehyde (4% w/v) in phosphate-buffered 
saline (PBS) and blocked for 1 hour at room temperature in PBS containing 0.1% Triton-
X-100, 1% FBS, and 10% normal donkey serum (Jackson ImmunoResearch Laboratories, 
Inc., West Grove, PA).  Subsequently, cells were incubated with either anti-SIRT1 
(rabbit, polyclonal), anti-Nestin, anti-β-III Tubulin or anti-GFAP (mouse, monoclonal) 
antibodies (Chemicon International) at a dilution of 1:200, 1:100, 1:500 and 1:1000, 
respectively, in blocking solution, overnight at 4ºC.  Cells were then incubated with either 
anti-mouse or anti-rabbit IgG conjugated to AMCA (Jackson ImmunoResearch 
Laboratories, Inc.) and Alexa 594 (Molecular Probes-Invitrogen), respectively, for 2 h at 
room temperature.  For GFAP detection, an Alexa 568-conjugated anti-mouse antibody 
(Molecular Probes-Invitrogen) was used.  Samples were mounted using Fluoromount-
G™ (Beckman Coulter, Inc.).  Fluorescence microscopy assessments were performed 
with a Zeizz AX10 microscope (Carl Zeiss, Jena, Germany) equipped with a Leica 
DFC490 camera (Leica Weitzlar, Germany).   
 
4.3.7 Nuclear protein extraction 
Nuclear extracts from p53- and miR-34a-overexpressing cells were prepared as 
previously described (Schreiber et al., 1989).  p53-overexpressing cells were obtained by 
transfecting 8 ug of wild-type p53 (pCMV-p53wt). 
 
4.3.8 Electrophoretic mobility shift assay 
Electrophoretic mobility shift assay (EMSA) was performed as previously 
described (Milagre et al., 2008).  DNA probe and competitors were generated by 
hybridization with complementary single-stranded oligonucleotides and used in double-
stranded form (supplementary Table 1).  Briefly, 8 µg nuclear extracts were incubated 
with γ32P-labeled oligonucleotide probe (p53-cons) containing a p53 consensus binding 
site for 20 min.  In competition assays, excess unlabeled oligonucleotide was pre-
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incubated for 30 min, prior to incubation with the probe p53-cons for additional 20 min.  
Super-shift reactions were performed with 1 µl of anti-p53 (DO-1 X, Santa Cruz 
Biotechnology), which was added to the reaction media after incubation of the probe.  
Protein-DNA complexes were resolved on 5% non-denaturing PAGE gels (29:1 
acrylamide:bisacrylamide) in 0.5 × Tris-borate buffer (45 mM Tris-borate, 1 mM EDTA).  
The gels were eletrophoresed for 2 h and 30 m, at 20 mA. 
 
4.3.9 Cytofluorometric analysis of apoptosis 
Apoptotic cells were quantified by cytofluorometric analysis using a FACSCalibur 
(Becton Dickinson, Mountain View, CA) as described previously (Schutte et al., 1998).  
Cells were stained with the vital dye propidium iodide (PI; 5µg/mL; Sigma, Steinheim, 
Germany) and concomitantly with Annexin-V-APC (eBioscience, Inc.) according to 
manufacturer’s instructions to determine phosphatidylserine exposure.  Data were 
statistically evaluated using FlowJo software (Tree Star, Inc, Ashland, OR). 
 
4.3.10 Statistical Analysis 
Results from different groups were compared using the Student’s t test, or one-way 
ANOVA.  Values of p < 0.05 were considered statistically significant.  All statistical 
analysis was performed with GraphPad InStat software (GraphPad Software, Inc, San 
Diego, CA). 
 
4.4 Results 
4.4.1 miR-34a modulates the proportion of postmitotic neurons 
We have previously reported that induction of mouse NS cell differentiation results 
in a mixed cell population composed by both neuronal and glial cells, which in turn 
differentiate in a time-controlled fashion within 8 days (Aranha et al., 2009).  In addition, 
we have shown that miR-34a expression is increased during mouse NS cell differentiation 
concomitantly with the appearance of postmitotic neurons and astrocytes (Aranha et al., 
2010).  To determine the effect of miR-34a on neural differentiation, we explored the 
effect of miR-34a modulation on the percentage of neural progenitors (Nestin+), neuronal 
precursors (β-III Tubulin+), postmitotic neurons (NeuN+) and astrocytes (GFAP+).  Pre- 
and anti-miR-34a, as well as respective controls, were transfected into differentiating 
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mouse NS cells at 3 days.  miR-34a expression was analyzed by real-time RT-PCR 24 h 
later, to confirm its functional modulation (data not shown).  Flow cytometry analysis 
revealed substantial alterations in NeuN expression, when cells were transfected with 
either anti- or pre-miR-34a (Fig. 4.1A).   
 
 
Figure 4.1. miR-34a modulates the proportion of NeuN-positive cells.  Mouse NS cells were 
transfected using 100 nM of either anti- or pre-miR-34a at 3 days, and collected after 24 and 72 h, 
respectively.  Cells were subsequently labeled for Nestin, β-III Tubulin, NeuN and GFAP 
detection by flow cytometry.  A) Representative histograms of Nestin, β-III Tubulin, NeuN and 
GFAP detection in anti-miR-control (red line) and anti-miR-34a-transfected cultures (blue line) 
(top), or in pre-miR-control (red line) and pre-miR-34a-transfected cultures (blue line) (bottom).  
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In four independent repetitions of these experiments, similar alterations in the relative number of 
positive cells for each marker were observed.  B) Fold change increase in NeuN-positive cells 
after miR-34a modulation.  Results are shown as mean ± SEM.  *p < 0.05 from cells transfected 
with respective control.   
 
Notably, transfections with anti-miR-34a for 24 h reduced the proportion of NeuN+ 
cells by 26%, compared with cells transfected with an anti-miR negative control (p < 
0.05).  Further, the percentage of NeuN+ cells significantly increased by 93% after pre-
miR-34a transfection for 72 h (p < 0.05) (Fig. 4.1B).  Modulation of miR-34a had no 
effect on the number of Nestin+ and β-III Tubulin+, while GFAP+ cells were only slightly 
affected.  Importantly, cell counting and apoptosis assessment suggested that alterations 
in the number of NeuN+ cells are not related with altered cell number or increased cell 
death (data not shown). 
 
4.4.2 SIRT1 expression is modulated by miR-34a during neural differentiation 
Several signaling pathways can be potentially affected by miR-34a, and implicated 
in the transition of dividing neuronal precursors to immature postmitotic neurons.  SIRT1 
has recently been suggested to be a target of miR-34a during embryonic stem cell 
differentiation (Tarantino et al., 2010).  In addition, SIRT1 expression was shown to be 
downregulated during differentiation of human embryonic stem cells (Calvanese et al., 
2010).  To investigate the role of SIRT1 during miR-34a-mediated neural differentiation, 
we analyzed SIRT1 expression throughout the differentiation period.  Immunoblot 
analysis revealed that SIRT1 was highly expressed in undifferentiated neurospheres and 
also in differentiating mouse NS cells during the first 2 days.  Notably, SIRT1 expression 
markedly decreased from the third day of differentiation onwards (Fig. 4.2A).  Curiously, 
decreased SIRT1 expression at day 3 is concomitant with previously described miR-34a 
upregulation (Aranha et al., 2010).  Immunofluorescence staining of SIRT1 at 2 days of 
differentiation revealed that SIRT1 staining was mostly nuclear and present in distinct 
cell populations, including Nestin+ and β-III Tubulin+ cells (Fig. 4.2B).  Next, we 
evaluated whether overexpression of miR-34a resulted in decreased SIRT1 at the protein 
level.  SIRT1 protein was significantly decreased after miR-34a overexpression (p < 0.05) 
(Fig. 4.2C), suggesting that the effect of miR-34a on the number of postmitotic neurons is 
mediated by SIRT1. 
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Figure 4.2. SIRT1 expression levels decrease after miR-34a overexpression.  SIRT1 
expression in mouse NS cells was detected by immunoblotting at different times of differentiation 
or by immunocytochemistry at 2 days of differentiation.  Cells transfected with either control or 
pre-miR-34a at 3 days of differentiation were also processed for SIRT1 detection by 
immunoblotting.  A) Representative immunoblot showing a marked decrease in SIRT1 expression 
levels from day 3 of differentiation onwards.  Ponceau S was used as loading control.  B) 
Immunofluorescence detection of cells labeled with anti-SIRT1, anti-Nestin and anti-β-III tubulin 
antibodies to visualize SIRT1 expression in neural progenitors and neuronal precursors, 
respectively.  Scale bar: 10 µm.  C) Representative immunoblot (top) and corresponding 
densitometry analysis (bottom) showing decreased SIRT1 expression in pre-miR-34a transfected 
cells.  Data represent mean ± SEM of three independent experiments.  *p < 0.05 from cells 
transfected with control. 
4.4.3 miR-34a regulates neuronal differentiation through a SIRT1-mediated 
mechanism 
To further confirm if SIRT1 participates in miR-34a-mediated neural 
differentiation, we determined whether SIRT1 modulation affects the percentage of 
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postmitotic neurons.  To address this question, cells were either incubated with 
resveratrol, a pharmacologic SIRT1 activator, or transfected with SIRT1 siRNA, at 12 h 
after incubation in differentiation medium.  Changes in percentage of NeuN+ cells were 
evaluated by flow cytometry at 3 days of differentiation.  SIRT1 silencing efficiency was 
confirmed by immunoblotting at 24 h after transfection (Fig. 4.3A).  
 
 
Figure 4.3. miR-34a promotes the appearance of post-mitotic neurons by downregulating 
SIRT1 expression.  SIRT1 expression was modulated in mouse NS cells at 12 h after induction 
of differentiation.  Inhibition of SIRT1 was achieved by transfecting cells with either scrambled 
control or 100 nM of SIRT1 siRNA, while activation of SIRT1 was performed by treating cells 
with either DMSO (control) or 5 µM of resveratrol.  In parallel experiments, miR-34a expression 
was modulated using anti- or pre-miR-34a and respective controls at 100 nM.  Cells were 
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collected at 3 days, fixed and processed for NeuN labeling and detection by flow cytometry.  The 
blue line corresponds to SIRT1 and/or miR-34a modulation, while the red line corresponds to the 
respective control.  A)  Representative immunoblot showing decreased SIRT1 expression after 
transfection with SIRT1 siRNA.  Ponceau S was used as loading control.  B) Silencing of SIRT1 
increased the percentage of NeuN+ cells.  C) Representative fluorescence microscopy image of 
mouse NS cells expressing GFP after SIRT1 downregulation.  D) Increased percentage of NeuN+ 
cells after simultaneous downregulation of miR-34a and SIRT1.  E) Decreased proportion of 
NeuN+ cells after resveratrol treatment (left) and increased percentage of NeuN+ cells with 
simultaneous SIRT1 activation and miR-34a overexpression (right).  Data represent mean ± SEM 
of at least three independent experiments.  *p < 0.05 from cells transfected with respective 
control.  Scale bar: 40 µm.   
 
Interestingly, downregulation of SIRT1 increased the proportion of NeuN+ cells 
(Fig. 4.3B), confirmed by morphological evaluation (Fig. 4.3C).  Simultaneous silencing 
of miR-34a and SIRT1 resulted in a similar increase by ~ 25% in the percentage of 
NeuN+ cells when compared with control transfected cells ( p < 0.05) (Fig. 4.3D).  The 
effect of SIRT1 activation on NeuN expression was less pronounced, although still 
significant (p < 0.05) (Fig. 4.3E, left).  Importantly, NeuN+ cells increased by almost 40% 
when cells were simultaneously treated with resveratrol and transfected with pre-miR-34a 
(p < 0.05) (Fig. 4.3E, right).  These results suggest that miR-34a regulates the appearance 
of postmitotic neurons by targeting SIRT1 mRNA. 
 
4.4.4 Astrogliogenesis can be modulated by miR-34a through a SIRT1-
independent mechanism 
Transient transfection of miR-34a into mouse NS cells had a minor effect on 
astroglial subpopulation (Fig. 4.1A).  Nevertheless, SIRT1 knockdown consistently 
decreased the percentage of GFAP+ cells by ~ 12% (p < 0.001), while activation of 
SIRT1 increased GFAP+ cells by ~ 45% (p < 0.05) (Fig. 4.4A).  After simultaneous 
silencing of SIRT1 and miR-34a, the proportion of GFAP+ cells was no longer down-
regulated (Fig. 4.4B)  Interestingly, overexpression of miR-34a and simultaneous 
treatment with resveratrol resulted in a significant increase in GFAP+ cells by ~ 3.4 fold 
(p < 0.05) (Fig. 4.4C).  Immunofluorescence analysis of GFAP corroborated this 
observation (Fig. 4.4D).  Therefore, resveratrol treatment further enhanced the effect of 
miR-34a modulation.  As miR-34a negatively regulates SIRT1 expression, we would 
miR-34a regulates neural differentiation 
103 
expect to have an opposite effect of miR-34a on GFAP+ cells.  Thus, our results indicate 
that SIRT1 positively regulates the astrocytic subpopulation.  Moreover, under certain 
conditions, miR-34a regulates astrocytic differentiation through a SIRT1-independent 
mechanism.  
 
 
Figure 4.4. miR-34a positively regulates the astrocytic population under resveratrol 
treatment.  SIRT1 expression was modulated in mouse NS cells after 12 h of induction of 
differentiation.  Inhibition of SIRT1 was achieved by transfecting cells with either scrambled 
control or 100 nM of SIRT1 siRNA.  SIRT1 was activated by treating cells with either DMSO 
(control) or 5 µM of resveratrol.  In parallel experiments, miR-34a expression was also 
modulated.  Cells were collected at 3 days, fixed and processed for GFAP labeling and detection 
by flow cytometry and immunofluorescence.  The blue line corresponds to SIRT1 and/or miR-34a 
modulation, while the red line represents the respective control.  A) Decreased percentage of 
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GFAP+ cells after downregulation of SIRT1 (left), and increased percentage of GFAP+ after 
SIRT1 activation (right).  B) Simultaneous inhibition of SIRT1 and miR-34a reversed the 
phenotype observed after SIRT1 silencing alone.  C) Under resveratrol treatment, overexpression 
of miR-34a resulted in increased proportion of GFAP+ cells.  D) Immunofluorescence showing 
increased number of GFAP+ cells under resveratrol treatment and miR-34a overexpression 
(bottom) when compared with controls (top).  Scale bar: 40 µm.  Images taken with a 
magnification of 400 × are shown in detail.  *p < 0.05 and §p < 0.001 from cells transfected with 
respective control. 
 
4.4.5 miR-34a upregulation increases p53-DNA binding activity 
SIRT1 has been shown to interact with and deacetylate the p53 protein, leading to a 
suppression in its activity (Langley et al., 2002).  The induction of miR-34a during mouse 
NS cell differentiation and the concomitant decrease of SIRT1 suggest that p53 may be 
involved in this regulation.  To test this hypothesis, we upregulated miR-34a expression 
levels and evaluated p53-DNA binding activity by EMSA.  To verify the specificity of 
the complex(es) formed when a p53 consensus oligonucleotide (p53-cons) was used as a 
probe, we performed a supershift assay using an anti-p53 antibody, as well as competition 
assays using oligonucleotides with different affinities for p53 binding, in mouse NS cells 
overexpressing p53.  As shown in Fig. 4.5A, nuclear extracts from mouse NS cells 
overexpressing p53 exhibited very strong DNA-binding activity.  In the presence of the 
p53 antibody, there was a shift of the specific complex, resulting in slower-migrating 
bands (Fig. 4.5A, arrowheads).  Competition assays using 10 and 100-fold molar excess 
of each competitor resulted in reduced efficiency of DNA binding, according to their 
affinity for p53.  In fact, competitor p53-A contains two quarter-sites known to be 
consensus sites for p53 (Wang et al., 1995), while p53-B contains only one.  Therefore, 
the efficiency of competition was proportional to the number of repeats.  As expected, 
competition with unlabeled p53-cons resulted in a significant decrease in the efficiency of 
DNA binding, and this effect was completely abolished when using p53-cons bearing a 
mutation in the consensus site.  Indeed, the formation of p53/p53-cons complex was not 
competed by an unrelated DNA sequence.  Importantly, the EMSA results show that total 
nuclear proteins capable of binding to the p53-cons probe markedly increase under miR-
34a overexpression (Fig. 4.5B).  These results suggest that miR-34a overexpression 
increases p53-DNA binding activity.  Notably, this was not associated with increased cell 
death, as evaluated by PI/Annexin staining (Fig. 4.5C). 
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Figure 4.5. miR-34a overexpression increases p53-DNA binding activity.  Mouse NS cells 
with 3 days of differentiation were transfected with either pre-miR-control or pre-miR-34a for 72 
h.  Cells were then collected for nuclear protein extraction or stained with Annexin-V-APC/PI to 
evaluate cell death.  p53-overexpressing cells were used for supershift and competition 
experiments.  Radio-labeled double-stranded oligonucleotide corresponding to the p53 consensus 
(p53 -cons) was used as a probe.  A) Representative EMSA showing the specificity of the 
complex formed with p53-cons probe.  Supershift experiments were performed using an anti-p53 
antibody (DO-1, Santa Cruz Biotechnology).  Competition experiments were performed by 
adding 10- or 100-fold excess of unlabeled double-stranded oligonucleotides bearing a mutation 
in the consensus site (p53-cons-mut), or containing either two or one of quarter-sites known to be 
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consensus sites for p53 (p53-A and p53-B, respectively) or a non-specific sequence (NS).  B) 
EMSA showing increased p53-DNA binding activity in pre-miR-34a transfected cells for 48 and 
74 h.  C) Representative Annexin V-APC/PI staining showing absence of cell death after miR-34a 
modulation. 
 
4.5 Discussion 
miR-34a is a well-known miRNA involved in various cellular functions that acts as 
a tumor suppressor (Chang et al., 2007b; He et al., 2007a).  In this study, we demonstrate 
a novel function for miR-34a during neuronal differentiation, implicating miR-34a 
expression on the appearance of postmitotic neurons by a mechanism that involves SIRT1 
downregulation.  This mechanism implies also increased p53-DNA binding activity, in 
common with neural differentiation.  
We have previously found that miR-34a expression was concomitant with the 
appearance of postmitotic neurons and astrocytes during mouse NS cell differentiation 
(Aranha et al., 2010).  Here we show that miR-34a promotes the appearance of 
postmitotic neurons.  This is in agreement with previous observations that miR-34a can 
suppress cell-cycle genes and induce a neural phenotype (Wei et al., 2008).  miR-34a may 
have a wide range of molecular targets during cell differentiation.  Here, we confirmed 
and extended other results implicating SIRT1 in the differentiation activity of miR-34a 
(Tarantino et al., 2010a).  In addition, miR-34a can regulate Notch-1 and Notch-2 protein 
expression (Li et al., 2009a), and decrease CDK4 and CDK6 (Navarro et al., 2009), as 
well as MEK1 (Ichimura et al., 2010), which regulate cell cycle progression and inhibit 
cell proliferation, respectively, as a prerequisite for cells to enter differentiation.   
Although constituting an intriguing topic, the role of SIRT1 during neuronal 
differentiation is not entirely new.  The results presented in this study are in accordance 
with recent findings showing that SIRT1 expression is regulated during human embryonic 
stem cell differentiation (Calvanese et al., 2010).  Specifically, SIRT1 down-regulation 
was shown to be necessary for reactivation of key developmental genes, such as the 
neuroretinal morphogenesis effector delta-like protein 4 (DLL4), the T-box transcription 
factor (TBX3), and paired box gene 6 (PAX6).  Similarly, downregulation of SIRT1 
during mouse NS cell differentiation might be necessary for the accomplishment of the 
transition toward postmitotic neurons and completion of a correct neuronal differentiation 
program.  However, the observation that SIRT1 is expressed in β-III Tubulin+ cells at two 
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days of differentiation indicates that SIRT1 is necessary in the initial stages of the 
differentiation process.  In agreement, SIRT1 has been shown to positively regulate 
neuronal differentiation by inhibiting the transactivation of Hes1, a transcription factor 
that negatively regulates cell differentiation (Hisahara et al., 2008).  In addition, loss of 
SIRT1 in embryonic stem cells was shown to delay the switch off of Oct4 and Nanog 
expression, affecting the capacity to exit the pluripotent stem cell program (Ou et al., 
2010).  This suggests that a tight regulation of SIRT1 expression might exist and that 
timing and levels of expression may determine commitment toward a certain neural 
phenotype. 
Our results also demonstrate that SIRT1 expression positively regulates 
astrogliogenesis.  In fact, it has been previously shown that increased SIRT1 activity 
causes differentiation of neural progenitor cells into astrocytes at the expense of neurons 
(Prozorovski et al., 2008).  SIRT1 represses the pro-neuronal basic helix-loop-helix 
(bHLH) transcription factor Mash1 and influences cell-fate decision.  By regulating 
SIRT1 expression in the neuronal subpopulation, miR-34a may impair the developmental 
program toward the astroglial lineage and favor neurogenesis.  Nevertheless, we do not 
exclude the possibility that miR-34a may also contribute to neuronal differentiation by 
additional mechanisms.  This indicates that SIRT1 might play a distinct role on 
differentiation under specific conditions, according to substrate and co-factor availability, 
as well as redox state of the cell.   
miR-34a expression was found not to be involved in SIRT1 downregulation during 
human embryonic stem cell differentiation (Calvanese et al., 2010).  In fact, miR-34a 
expression is not increased after induction of differentiation into embryonic bodies.  
Differences associated with specific properties of each biological model may explain this 
discrepancy.  In addition, it also shows that different mechanisms might exist that 
regulate SIRT1 expression levels. 
We found that transient transfection of miR-34a into mouse NS cells had almost no 
effect on the astrocytic subpopulation, which is in accordance with previous studies 
showing that forced miR-34a expression did not affect human astrocytes (Li et al., 2009).  
Curiously, a positive regulation of miR-34a on GFAP+ cells became notorious after 
increased SIRT1 activity.  Given that miR-34a negatively regulates SIRT1 expression and 
SIRT1 induces the astroglial lineage, we would expect to have an opposite effect of miR-
34a in GFAP+ cells.  This suggests that under certain conditions, miR-34a may have the 
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capacity to influence commitment toward astrogliogenesis by a SIRT1-independent 
mechanism.   
miR-34a is part of the p53 regulatory network (He et al., 2007b).  miR-34a 
transcription is directly activated by p53, and in turn miR-34a regulates the expression of 
some p53 target genes (Chang et al., 2007b; He et al., 2007a; Raver-Shapira et al., 2007).  
Nevertheless, transfection with p53 siRNA did not affect miR-34a expression, suggesting 
that induction of miR-34a during mouse NS cell differentiation is p53 independent (data 
not shown).  These results are in accordance with previous data showing a p53-
independent role for miR-34a during megakaryocytic differentiation of K562 cells 
(Navarro et al., 2009).  Instead, p53 seems to act downstream of miR-34a in this cellular 
context.  Our results suggest that miR-34a indirectly regulates p53, possible through a 
SIRT1-dependent mechanism.  Further, SIRT1 inhibits p53-mediated suppression of 
Nanog expression, which is required to maintain cells in an undifferentiated status  (Han 
et al., 2008).  Increased p53-DNA binding activity resulting from miR-34a 
overexpression may mediate miR-34a induction of postmitotic neurons by controlling cell 
cycle progression of neuronal precursors.  Additional experiments are required to confirm 
whether SIRT1 mediates miR-34a activation of p53.  Nevertheless, the present study 
provides a foundation for the role of miR-34a in differentiation of neural stem cells.   
In conclusion, here we report the role of miR-34a in regulating neural 
differentiation.  In addition, we demonstrate that miR-34a-mediated silencing of SIRT1 
may be necessary for correct establishment of specific differentiation programs during 
neural stem cell differentiation. 
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The studies presented in this thesis contribute to a better understanding of the 
molecular mechanisms controlling neural stem (NS) cell differentiation.  More 
specifically, these studies confirm and extend our knowledge in considering apoptosis-
associated molecules as integral components of the differentiation process. 
In brief, we demonstrated a role for p53 and caspase-3 in the differentiation process 
of NS cells, and suggested that these molecules temporally modulate FOXO3A/Id1 
signaling.  In addition, we implicated apoptosis-associated microRNAs (miRNAs or 
miRs), such as miR-16, let-7a and miR-34a, in neural differentiation of mouse, rat and 
human cells, independently of their role in apoptosis.  Finally, we further explored the 
function of miR-34a in mediating the transition between neural progenitors and post-
mitotic neurons, and implicated SIRT1 and p53 activity in this regulatory network.  The 
data presented here provide new insights into the regulation of neural differentiation by 
apoptosis-associated molecules, and represents a step forward in understanding the 
molecular mechanisms of NS cell differentiation.  In this last concluding chapter, we 
integrate our findings, and address future perspectives arising from these studies. 
The tumor suppressor p53 and caspase-3 have been implicated in the differentiation 
process of subventricular zone (SVZ)- and striatum-derived NS cells, respectively 
(Fernando et al., 2005; Gil-Perotin et al., 2006).  To extend these studies, we investigated 
whether p53 and caspase-3 molecules would also be implicated in the differentiation 
process of NS cells, extracted from E14 mouse embryos.  Our results indicated that NS 
cell differentiation is associated with an increase in active caspase-3, as well as 
phosphorylated p53 (Ser 15), concomitant with increased p53 DNA-binding activity.  We 
also performed functional studies and demonstrated that caspase-3 inhibition decreases 
both neuronal and astroglial subpopulations, while p53 down-regulation affects only the 
neuronal lineage.  It would be interesting to address in the future, whether this strict 
subpopulation effect is due to specific localized expression of p53 in neuronal precursors.  
In addition, most of the relevant p53 transcriptional targets and caspase-3 substrates have 
yet to be determined in a differentiation context.  Experiments aimed at addressing these 
questions should include high-throughput proteomics analysis and genome-wide 
chromatin immunoprecipitation assays.   
Id1 is a bHLH transcription factor that positively contributes to cell cycle 
progression (Hamajima et al., 2010), and is responsible for maintaining the proliferative 
state of cortical progenitors (Ross et al., 2003).  In addition, it has been demonstrated that 
non-phosphorylated FOXO3A transcriptionally represses Id1 expression (Birkenkamp et 
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al., 2007).  Given the fact that differentiation results in progressive loss of self-renewal 
and unrestricted development potential, we dissected the Akt/p-FOXO3A/Id1 pathway 
during NS cell differentiation, and confirmed the downregulation of this signaling 
pathway.  We next addressed whether the involvement of p53 and caspase-3 in NS cell 
differentiation cross-talks with this pathway, thus influencing Id1 expression.  We found 
that in the absence of caspase-3 activity or after siRNA mediated-silencing of p53, the p-
FOXO3A/Id1 pathway is no longer down-regulated, suggesting that the role of p53 and 
caspase-3 during NS cell differentiation relies on a cross-talk with proliferation pathways, 
ultimately leading to down-regulation of molecules responsible for maintaining the 
proliferative state of stem cells, such as Id1. 
The involvement of p53 in the differentiation process may also provide important 
information for future research in the field of induced pluripotent stem (iPS) cells.  It was 
recently shown that inhibition of p53 greatly increases the reprogramming efficiency 
process (Hong et al., 2009).  Nevertheless, if the inactivation of p53 is crucial for 
successful reprogramming, this approach raises concerns about the genomic stability and 
tumorigenecity of iPS cells, and may compromise the differentiation capacity of iPS cells 
into specific lineages.  In addition, efforts to block apoptosis via caspase inhibition for 
therapeutic purposes may have much broader implications than initially thought, 
especially for stem cells. 
Recently, noncoding RNAs belonging to the miRNA family have emerged as a new 
class of cell lineage determinants.  As repressors, miRNAs may promote differentiation 
by limiting the expression of genes that support the self-renewing progenitor state.  
Hence, we were interested in determining whether miRNAs linked to apoptosis are 
involved in the differentiation of NS cells.  To address this issue, we performed 
microarray miRNA profiling in NS cells at different times of differentiation to detect 
miRNA expression.  Our results revealed differential expression of several apoptosis-
associated miRNAs, including miR-16, let-7a and miR-34a, and this was also validated 
by quantitative real time-PCR.  Importantly, we found that expression levels of miR-16, 
let-7a and miR-34a are also modulated in mouse ES cell, PC12 and NT2N differentiation, 
implicating these miRNAs in mammalian neuronal development.  It would be interesting 
to determine the expression patterns of apoptosis-associated miRNAs specifically in 
neuronal and glial lineages, using a system with β-III tubulin-GFP and GFAP-GFP 
expressing cells, respectively.  Dissecting the mechanisms associated with the expression 
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of apoptosis-associated miRNAs is crucial for a better understanding of their role and 
relevance in the differentiation process. 
Contrary to transcription factors, miRNAs usually function as a fine-tuning 
mechanism, and not as an on/off switch.  This may be important for future applications 
involving the modulation of apoptosis-associated pathways by miRNAs, because minor 
changes in activity levels may ultimately dictate the cell choice between cell death and 
differentiation.  By fine-tuning protein expression, miRNA effects are not as dramatic, 
which makes miRNAs potential ideal therapeutic targets.  Further, the ability of a single 
miRNA to control the expression of several mRNAs might be crucial, especially if 
targeted mRNAs belong to a common signaling pathway.  Finally, miRNA processing is 
faster than protein translation, allowing miRNAs to rapidly affect gene expression (Tsang 
et al., 2007).  Modulation of miRNAs for therapeutic purpose is now under investigation 
and represents a promising area for future clinical application. 
It has been reported that miR-34a expression increases during retinoic acid-induced 
differentiation of neuroblastoma cell lines (Welch et al., 2007).  Based on the 
identification of miR-34a as a p53 target (Bommer et al., 2007), we became interested in 
confirming the role of miR-34a in cell differentiation.  We found that miR-34a positively 
regulates the appearance of post-mitotic neurons.  Nevertheless, ectopic expression of 
miR-34a in embryonic mouse central nervous system through in vivo electroporation, and 
the use of miR-34a knockout mice would both add valuable information regarding the 
role of miR-34a in neural differentiation.  In addition, in situ hybridization during mouse 
embryonic development would add evidence for the involvement of miR-34a during 
neuronal development. 
We have also addressed the question of whether p53 is responsible for miR-34a 
induction during NS cell differentiation.  We found that p53 down-regulation using 
siRNA is not associated with decreased miR-34a expression, suggesting that miR-34a 
acts in a p53-independent manner.  Nevertheless it is tempting to speculate that the other 
members of the p53 family, p63 and especially p73 can participate in the regulation of 
miR-34a expression.  For instance, p73 knockout mice display varying degrees of 
abnormal neurological development (Yang et al., 2000), and p73 has been shown to 
induce differentiation in neuroblastoma cells in vitro (De Laurenzi et al., 2000).  
Modulation of p73 expression levels and the use of reporter plasmids carrying wild-type 
and mutated miR-34a sequence for p73 putative binding should be explored in the future.  
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SIRT1 is a validated miR-34a target, recently reported to be involved in miR-34a-
mediated ES cell differentiation (Tarantino et al., 2010b).  Therefore, we became 
interested in assessing whether SIRT1 is involved in miR-34a-mediated NS cell 
differentiation.  Our results showed that miR-34a modulation significantly affects SIRT1 
expression.  Nevertheless, modulation of SIRT1 only slightly influences the proportion of 
post-mitotic neurons, indicating that other miR-34a targets may also contribute to this 
phenotype.  In the future, an attempt should be taken to further identify others miR-34a 
targets.  Differentiation is tightly linked with cell cycle exit, and the capacity of miR-34a 
to modulate cell cycle regulators may suggest their intervention on the transition between 
mitotic neuronal precursors to immature post-mitotic neurons.  
SIRT1 is a NAD-dependent deacetylase, which has been shown to inhibit several 
pro-apoptotic proteins, including p53.  Not surprisingly, miR-34a-mediated 
downregulation of SIRT1 resulted in increased p53 activity (Yamakuchi et al., 2008).  To 
investigate if a similar mechanism is involved in NS cell differentiation, we determined 
p53-DNA binding activity after miR-34a overexpression.  Our results revealed that p53-
DNA binding activity is increased after upregulation of miR-34a.  Given the data 
suggesting a positive regulation of differentiation by p53, miR-34a-mediated induction of 
p53 might result in an amplification of the signal dictating cell differentiation.  Thus, our 
results suggest that miR-34a might be a suitable target for therapeutic intervention. 
Surprisingly, our results showed that miR-34a positively regulates astrocytes.  
However, this was only revealed when cells were pre-treated with the SIRT1-activator, 
resveratrol.  It is thought that miRNAs may act as a buffering system, modulating 
molecules whenever the cell balance is lost.  Therefore, simple inactivation of a miRNA 
may not suffice to collapse the signaling networks in which miRNAs are involved.  
Previous studies showed that for most miRNA genes of C. elegans, single-gene 
knockouts did not result in detectable mutant phenotypes (Miska et al., 2007).  
Alternatively, miRNA functions may be revealed under more sophisticated experimental 
assays that take into account the cell complexity.  It was recently suggested that the use of 
sensitized genetic backgrounds provides an efficient approach for miRNA functional 
analysis (Brenner et al., 2010).  Therefore, especial particular environment might be 
generated after treatment with resveratrol, which in turn may reveal other miR-34a 
functions, such as the capacity to regulate the glial lineage.  Nevertheless, additional 
studies, possibly using genetic backgrounds with reduced processing and activity of all 
Concluding Remarks 
115 
miRNAs or with reduced activity of a wide array of regulatory pathways would be 
necessary to confirm the capacity of miR-34a to regulate astrogliogenesis. 
Accumulating evidence demonstrating a role for apoptosis-associated molecules in 
differentiation has advanced our understanding of the mechanisms regulating cell 
differentiation.  The challenge for the future will be to identify mechanisms and nuances 
that ultimately guide this machinery to either cell death or differentiation, which may 
reveal novel mechanisms regulating neurogenesis as well as new targets for therapeutic 
intervention.  
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